HERBICIDAL MALONAMIDES CONTAINING MONOCYCLIC HETEROAROMATIC RINGS

Abstract
The present invention relates to malonamide compounds of the formula (I) where the variables are as defined in the claims and the description, and to compositions comprising these compounds. The invention also relates to the use of the said malonamide compounds or the corresponding compositions for controlling unwanted vegetation. Furthermore, the invention relates to methods of applying said malonamide compounds or the corresponding compositions.
Description

The present invention relates to malonamide compounds containing monocyclic heteroaromatic rings and compositions comprising the same. The invention also relates to the use of the malonamide compounds containing monocyclic heteroaromatic rings or the corresponding compositions for controlling unwanted vegetation. Furthermore, the invention relates to methods of applying the malonamide compounds containing monocyclic heteroaromatic rings or the corresponding compositions.


BACKGROUND OF THE INVENTION

For the purpose of controlling unwanted vegetation, especially in crops, there is an ongoing need for new herbicides that have high activity and selectivity together with a substantial lack of toxicity for humans and animals.


WO 2012/130798, WO 2014/04882, WO 2014/048882, WO 2018/228985, WO 2018/228986, WO 2019/034602, WO 2019/145245, WO 2020/114932, WO 2020/114934 and WO 2020/182723 describe 3-phenylisoxazoline-5-carboxamides and their use as herbicides.


WO 87/05898 describes the use of malonic acid derivatives for retarding plant growth.


Malonic acid derivatives are also described in U.S. Pat. No. 3,072,473 as plant growth regulants.


The compounds of the prior art often suffer from insufficient herbicidal activity, in particular at low application rates, and/or unsatisfactory selectivity resulting in a low compatibility with crop plants.


Accordingly, it is an object of the present invention to provide further malonamide compounds having a strong herbicidal activity, in particular even at low application rates, a sufficiently low toxicity for humans and animals and/or a high compatibility with crop plants. The malonamide compounds should also show a broad activity spectrum against a large number of different unwanted plants.


These and further objectives are achieved by the compounds of formula (I) defined below including their agriculturally acceptable salts, stereoisomers and tautomers.


SUMMARY OF THE INVENTION

Accordingly, the present invention provides compounds of formula (I)




embedded image


wherein the substituents have the following meanings:

    • Q is a 5- or 6-membered heteroaromatic ring containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of N, O and S as ring members, where the ring carries k substituents RQ1 and n substituents RQ2;
    • RQ1 is halogen, nitro, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, hydroxy-(C1-C3)-alkyl, (C3-C5)-cycloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl or (C2-C3)-haloalkynyl;
    • RQ2 is phenyl-(C1-C3)-alkyl, (C1-C4)-alkylcarbonyl, aminocarbonyl, (C1-C4)-alkylaminocarbonyl, di-(C1-C4-alkyl)aminocarbonyl, (C1-C4)-alkoxycarbonyl, benzyloxycarbonyl, fluorenyloxycarbonyl, allyloxycarbonyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl or phenylsulfonyl, where the aliphatic or aromatic moieties in the 14 last-mentioned radicals are substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • R1 is hydrogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C4)-cycloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy or (C1-C3)-alkoxy-(C1-C3)-alkoxy;
    • R2 is (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C6)-alkenyl, (C3-C6)-alkynyl, or (C1-C3)-alkoxy-(C1-C3)-alkyl, where the aliphatic or cycloaliphatic moieties in the 5 last-mentioned radicals are substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano;
    • R3 is hydrogen, halogen, cyano, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C1-C6)-cyanoalkyl, (C1-C3)-hydroxyalkyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-haloalkoxy-(C1-C3)-alkyl, (C3-C6)-cycloalkyl, (C3-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, (C1-C3)-cyanoalkoxy, (C1-C3)-alkoxy-(C1-C3)-alkoxy, (C3-C6)-cycloalkoxy, (C3-C5)-cycloalkyl-(C1-C3)-alkoxy, (C3-C6)-alkenyloxy, (C3-C6)-alkynyloxy or (C1-C3)-alkylthio;
    • R4 is hydrogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkynyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy or (C1-C3)-alkoxy-(C1-C3)-alkoxy;
    • X is a bond (X0) or a divalent unit selected from the group consisting of (X1), (X2), (X3), (X4), (X5), and (X6):




embedded image




    • R5, R6, R7, R8, R9 and R10, independently of each other and independently of each occurrence, are hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd, NRbCO2Re, Ra; (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, phenyl, imidazolyl, where the 6 last-mentioned aliphatic, cycloaliphatic, aromatic or heteroaromatic radicals are substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano; (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C3-C6)-alkenyloxy, (C3-C6)-alkynyloxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl or (C1-C3)-alkylsulfonyl, where the aliphatic or cycloaliphatic moieties in the 7 last-mentioned radicals are substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and (C1-C2)-alkoxy;

    • Y is hydrogen, cyano, hydroxyl, Z; (C1-C12)-alkyl, (C3-C8)-cycloalkyl, (C2-C12)-alkenyl or (C2-C12)-alkynyl, where the 4 last-mentioned aliphatic or cycloaliphatic radicals are substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxyl, ORd, Z, OZ, NHZ, S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe;

    • Z is a three-, four-, five-, six-, seven- or eight-membered saturated, partly unsaturated, fully unsaturated or aromatic monocyclic, bicyclic or polycyclic ring, except phenyl, which is formed from r carbon atoms, k nitrogen atoms, n sulfur atoms and n oxygen atoms, and which is substituted by m radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb-SO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, Ra, Rc, Re and Rf, and where the sulfur and carbon ring atoms bear n oxo groups;

    • Ra is (C1-C6)-alkyl, (C2-C4)-alkynyl or (C3-C6)-cycloalkyl, where the 3 last-mentioned aliphatic or cycloaliphatic radicals are substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxy, and (C1-C3)-alkoxy;

    • Rb is hydrogen or independently has one of the meanings given for Ra;

    • Rc is fluorine, chlorine, bromine, iodine, cyano, hydroxyl; (C1-C6)-alkoxy, (C3-C6)-alkenyloxy or (C3-C6)-alkynyloxy, where the aliphatic moieties in the 3 last-mentioned radicals are substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;

    • Rd is hydrogen, (C-6)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C3)-alkyl, phenyl-(C1-C3)-alkyl or furanyl-(C1-C3)-alkyl, where the aliphatic, cycloaliphatic, aromatic or heteroaromatic moieties in the 7 last-mentioned radicals are substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano, CO2Ra, CONRbRh, (C-2)-alkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, phenylthio, phenylsulfinyl, and phenylsulfonyl;

    • Re independently has one of the meanings given for Rd;

    • Rf is (C1-C3)-alkyl or (C1-C3)-alkoxy;

    • Rh is hydrogen, (C-6)-alkyl, (C1-C2)-alkoxy, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl or (C1-C6)-alkoxycarbonyl-(C1-C6)-alkyl, where the aliphatic or cycloaliphatic moieties in the 6 last-mentioned radicals are substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano, CO2Ra, and (C1-C2)-alkoxy;

    • each k is independently 0, 1, 2, 3 or 4;

    • each m is independently 0, 1, 2, 3, 4 or 5;

    • each n is independently 0, 1 or 2;

    • each r is independently 1, 2, 3, 4, 5, 6, 7 or 8.

    • and the agriculturally acceptable salts, the stereoisomers and the tautomers thereof.





The invention also relates to a composition comprising at least one compound of formula (I) and at least one auxiliary which is customary for formulating crop protection compounds.


The present invention also provides combinations comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B; different from A) and safeners C (component C).


The invention relates moreover to the use of a compound of formula (I) or of said compositions for controlling unwanted vegetation, and to a method for controlling unwanted vegetation which comprises allowing a herbicidally effective amount of at least one compound of formula (I) or of said compositions to act on plants, their seed and/or their habitat.







DETAILED DESCRIPTION OF THE INVENTION
Definitions

Depending on the kind of substituents, the compounds of formula (I) may have one or more centers of chirality, in which case they may be present as mixtures of enantiomers or diastereomers but also in the form of the pure enantiomers or pure diastereomers. The invention provides both the pure enantiomers or pure diastereomers of the compounds of formula I, and their mixtures and the use according to the invention of the pure enantiomers or pure diastereomers of the compound of formula I or its mixtures. Suitable compounds of formula I also include all possible geometrical stereoisomers (cis/trans isomers) as a specific form of diastereomers and mixtures thereof. Cis/trans isomers may be present with respect to an alkene, carbon-nitrogen double-bond, nitrogen-sulfur double bond, amide group or a cyclic, non-aromatic moiety. The term “stereoisomer(s)” encompasses both optical isomers, such as enantiomers or diastereomers existing due to more than one stereogenic center in the molecule, as well as geometrical isomers (cis/trans isomers). Just by way of example, a stereogenic center is the C atom carrying R5 and R6 in X1 to X6, provided of course that R5 and R6 are different. Another example for a stereogenic center is the C atom carrying OR2 and R3.


If the above-mentioned herbicidal compounds B and/or the safeners C have one or more stereogenic centres they may also be present as enantiomers or diastereomers, and it is possible to use both the pure enantiomers and diastereomers or their mixtures.


If the compounds of formula (I), the herbicidal compounds B and/or the safeners C as described herein have ionizable functional groups, they can also be employed in the form of their agriculturally acceptable salts. Suitable are, in general, the salts of those cations and the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the activity of the active compounds.


Preferred cations are the ions of the alkali metals, preferably of lithium, sodium and potassium, of the alkaline earth metals, preferably of calcium and magnesium, and of the transition metals, preferably of manganese, copper, zinc and iron, further ammonium and substituted ammonium in which one to four hydrogen atoms are replaced by C1-C4-alkyl, hydroxy-C1-C4-alkyl, C1-C4-alkoxy-C1-C4-alkyl, hydroxy-C1-C4-alkoxy-C1-C4-alkyl, phenyl or benzyl, preferably ammonium, methylammonium, isopropylammonium, dimethylammonium, diethylammonium, diisopropylammonium, trimethylammonium, triethylammonium, tris(isopropyl)ammonium, heptylammonium, dodecylammonium, tetradecylammonium, tetramethylammonium, tetraethylammonium, tetrabutylammonium, 2-hydroxyethylammonium (olamine salt), 2-(2-hydroxyeth-1-oxy)eth-1-ylammonium (diglycolamine salt), di(2-hydroxyeth-1-yl)ammonium (diolamine salt), tris(2-hydroxyethyl)ammonium (trolamine salt), tris(2-hydroxypropyl)ammonium, benzyltrimethylammonium, benzyltriethylammonium, N,N,N-trimethylethanolammonium (choline salt), furthermore phosphonium ions, sulfonium ions, preferably tri(C1-C4-alkyl)sulfonium, such as trimethylsulfonium, and sulfoxonium ions, preferably tri(C1-C4-alkyl)sulfoxonium, and finally the salts of polybasic amines such as N,N-bis-(3-aminopropyl)methylamine and diethylenetriamine.


Anions of useful acid addition salts are primarily chloride, bromide, fluoride, iodide, hydrogensulfate, methylsulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate and also the anions of C1-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate.


The compounds (I) may be present in form of different tautomers. For instance, the depicted keto form of the malonamide moiety N(R1)—C(═O)—C(OR2)(R3)—C(═O)—N(R4) can be in equilibrium with its enol forms N(R1)—C(OH)═C(OR2)—C(═O)—N(R4) and N(R1)—C(═O)—C(OR2)═C(OH)—N(R4) (keto-enol tautomery) if R3 is hydrogen.


The same applies if ring Z contains a C(═O) group as ring member neighboured to a CH ring member.


Also if RQ1 is hydroxyl ring Q can be present in the corresponding keto form. For instance, if Q is a pyridine ring carrying in 2-position an OH group, ring Q can be present as its tautomeric form 1,2-dihydropyridin-2-one.


Moreover, if ring Z is a lactam, i.e. contains an amide group as ring member (=unsubstituted, secondary nitrogen ring atom neighboured to a carbon ring atom carrying an oxo group), this ring moiety —N(H)—C(═O)— can be in equilibrium with its tautomeric form —N═C(OH)—.


The same applies to the two mandatorily present amide groups of the malonamide moiety —N(R1)—C(═O)—C(OR2)(R3)—C(═O)—N(R4)— if one or both of R1 and R4 are hydrogen:

    • If only R1 is hydrogen, the malonamide moiety can be present as —N(H)—C(═O)—C(OR2)(R3)—C(═O)—N(R4)— or as —N═C(OH)—C(OR2)(R3)—C(═O)—N(R4)— or as a mixture of the two forms;
    • If only R4 is hydrogen, the malonamide moiety can be present as —N(R1)—C(═O)—C(OR2)(R3)—C(═O)—N(H)— or as —N(R1)—C(═O)—C(OR2)(R3)—C(OH)═N— or as a mixture of the two forms;
    • If both of R1 and R4 are hydrogen, the malonamide moiety can be present as —N(H)—C(═O)—C(OR2)(R3)—C(═O)—N(H)— or as —N═C(OH)—C(OR2)(R3)—C(═O)—N(H)— or as —N(H)—C(═O)—C(OR2)(R3)—C(OH)═N— or as —N═C(OH)—C(OR2)(R3)—C(OH)═N— or as mixture of two, three all four of the above forms.


The amount in which the one or other tautomeric form is present depends on the complete molecular structure and even stronger on the surrounding conditions (presence or absence of solvent, type of solvent, pH, temperature etc.).


The term “undesired vegetation” (“weeds”) is understood to include any vegetation growing in non-crop-areas or at a crop plant site or locus of seeded and otherwise desired crop, where the vegetation is any plant species, including their germinant seeds, emerging seedlings and established vegetation, other than the seeded or desired crop (if any). Weeds, in the broadest sense, are plants considered undesirable in a particular location.


The organic moieties mentioned in the above definitions of the variables are—like the term halogen—collective terms for individual listings of the individual group members. The prefix Cn-Cm indicates in each case the possible number of carbon atoms in the group.


The term “halogen” denotes in each case fluorine, bromine, chlorine or iodine, in particular fluorine, chlorine or bromine.


The term “partially or completely halogenated” will be taken to mean that 1 or more, e.g. 1, 2, 3, 4 or 5 or all of the hydrogen atoms of a given radical have been replaced by a halogen atom, in particular by fluorine or chlorine. A partially or completely halogenated radical is termed below also “halo-radical”. For example, partially or completely halogenated alkyl is also termed haloalkyl.


The term “alkyl” as used herein (and in the alkyl moieties of other groups comprising an alkyl group, e.g. alkoxy, alkylamino, dialkylamino, alkylcarbonyl, alkoxycarbonyl, alkylthio, alkylsulfonyl and alkoxyalkyl) denotes in each case a straight-chain or branched alkyl group having usually from 1 to 12 carbon atoms (═C1-C12-alkyl), frequently from 1 to 6 carbon atoms (═C1-C6-alkyl), in particular 1 to 4 carbon atoms (═C1-C4-alkyl) and especially from 1 to 3 carbon atoms (═C1-C3-alkyl) or 1 or 2 carbon atoms (═C1-C2-alkyl). C1-C2-Alkyl is methyl or ethyl. C1-C3-Alkyl is methyl, ethyl, n-propyl or iso-propyl. Examples of C1-C4-alkyl are methyl, ethyl, n-propyl, iso-propyl, n-butyl, 2-butyl (=sec-butyl), isobutyl and tert-butyl. Examples for C1-C6-alkyl are, in addition to those mentioned for C1-C4-alkyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl. Examples for C1-C8-alkyl are, in addition to those mentioned for C1-C6-alkyl, n-heptyl, 1-methylhexyl, 2-methylhexyl, 3-methylhexyl, 4-methylhexyl, 5-methylhexyl, 1-ethylpentyl, 2-ethylpentyl, 3-ethylpentyl, n-octyl, 1-methylheptyl, 2-methylheptyl, 1-ethylhexyl, 2-ethylhexyl, 1,2-dimethylhexyl, 1-propylpentyl and 2-propylpentyl. Examples for C1-C12-alkyl are, apart those mentioned for C1-C8-alkyl, nonyl, decyl, 2-propylheptyl, 3-propylheptyl, undecyl, dodecyl and positional isomers thereof.


The term “haloalkyl” as used herein (and in the haloalkyl moieties of other groups comprising a haloalkyl group, e.g. haloalkoxy, haloalkylthio, haloalkylcarbonyl, haloalkylsulfonyl and haloalkylsulfinyl), which is also expressed as “alkyl which is partially or fully halogenated”, denotes in each case a straight-chain or branched alkyl group having usually from 1 to 6 carbon atoms (═C1-C6-haloalkyl), more frequently 1 to 3 carbon atoms (═C1-C3-haloalkyl), as defined above, wherein the hydrogen atoms of this group are partially or totally replaced with halogen atoms. Preferred haloalkyl moieties are selected from C1-C3-haloalkyl, specifically from C1-C2-haloalkyl, in particular from fluorinated C1-C2-alkyl. Examples for C1-C2-haloalkyl are fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, chlorofluoromethyl, dichloro-fluoromethyl, chlorodifluoromethyl, bromomethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 1-chloroethyl, 2-chloroethyl, 2,2,-dichloroethyl, 2,2,2-trichloroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 1-bromoethyl, and the like. Examples for C1-C3-haloalkyl are, in addition to those mentioned for C1-C2-haloalkyl, 1-fluoropropyl, 2-fluoropropyl, 3-fluoropropyl, 3,3-difluoropropyl, 3,3,3-trifluoropropyl, heptafluoropropyl, 1,1,1-trifluoroprop-2-yl, 3-chloropropyl, and the like.


The term “hydroxyalkyl” denotes in each case a straight-chain or branched alkyl group having usually from 1 to 6 carbon atoms (═C1-C6-hydroxyalkyl), more frequently 1 to 3 carbon atoms (═C1-C3-hydroxyalkyl), as defined above, wherein one hydrogen atom of this group is replaced with a hydroxyl group. Examples are hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1-hydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 1-hydroxy-2-propyl and the like.


The term “cyanoalkyl” denotes in each case a straight-chain or branched alkyl group having usually from 1 to 6 carbon atoms (═C1-C6-cyanoalkyl), more frequently 1 to 3 carbon atoms (═C1-C3-cyanoalkyl), as defined above, wherein one hydrogen atom of this group is replaced with a cyano group. Examples are cyanomethyl, 1-cyanoethyl, 2-cyanoethyl, 1-cyanopropyl, 2-cyanopropyl, 3-cyanopropyl, 1-cyano-2-propyl and the like.


The term “alkenyl” as used herein denotes in each case a monounsaturated straight-chain or branched hydrocarbon radical having usually 2 to 12 (═C2-C12-alkenyl), preferably 2 to 6 carbon atoms (═C2-C6-alkenyl), e.g. 3 to 6 carbon atoms (═C3-C6-alkenyl), in particular 2 to 4 carbon atoms (═C2-C4-alkenyl) or 2 or 3 carbon atoms (═C2-C3-alkenyl), and a double bond in any position, for example C2-C3-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl or 1-methylethenyl; C2-C4-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl or 2-methyl-2-propenyl; C2-C6-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl, 3,3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl, 1-ethyl-2-methyl-2-propenyl and the like, or C2-C12-alkenyl, such as the radicals mentioned for C2-C6-alkenyl and additionally 1-heptenyl, 2-heptenyl, 3-heptenyl, 1-octenyl, 2-octenyl, 3-octenyl, 4-octenyl, the nonenyls, decenyls, undecenyls, dodecenyls and the positional isomers thereof.


Examples for C3-C6-alkenyl are those mentioned above for C2-C6-alkenyl, except for ethenyl.


The term “haloalkenyl” as used herein, which may also be expressed as “alkenyl which is substituted by halogen”, and the haloalkenyl moieties in haloalkenyloxy and the like refers to unsaturated straight-chain or branched hydrocarbon radicals having 2 to 6 (═C2-C6-haloalkenyl) or 2 to 4 (═C2-C6-haloalkenyl) or 2 to 3 (═C2-C3-haloalkenyl) carbon atoms and a double bond in any position, where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine, for example chlorovinyl, chloroallyl and the like.


The term “alkynyl” as used herein denotes unsaturated straight-chain or branched hydrocarbon radicals having usually 2 to 12 (═C2-C12-alkynyl), frequently 2 to 6 (═C2-C6-alkynyl), preferably 2 to 4 carbon atoms (═C2-C4-alkynyl) or 2 to 3 carbon atoms (═C2-C3-alkynyl) and a triple bond in any position, for example C2-C3-alkynyl, such as ethynyl, 1-propynyl or 2-propynyl; C2-C4-alkynyl, such as ethynyl, 1-propynyl or 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl and the like; C2-C6-alkynyl, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3-methyl-4-pentynyl, 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1,1-dimethyl-2-butynyl, 1,1-dimethyl-3-butynyl, 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl, 1-ethyl-1-methyl-2-propynyl and the like.


The term “haloalkynyl” as used herein, which is also expressed as “alkynyl which is substituted by halogen”, refers to unsaturated straight-chain or branched hydrocarbon radicals having usually 2 to 6 carbon atoms (═C2-C6-haloalkynyl), preferably 2 to 4 carbon atoms (═C2-C4-haloalkynyl) or 2 or 3 carbon atoms (═C2-C3-haloalkynyl), and a triple bond in any position (as mentioned above), where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine.


The term “cycloalkyl” as used herein (and in the cycloalkyl moieties of other groups comprising a cycloalkyl group, e.g. cycloalkoxy and cycloalkylalkyl) denotes in each case a mono- or bicyclic, saturated cycloaliphatic radical having usually from 3 to 6 carbon atoms (═C3-C6-cycloalkyl), 3 to 5 carbon atoms (═C3-C5-cycloalkyl) or 3 to 4 carbon atoms (═C3-C4-cycloalkyl) as (only) ring members. Examples of monocyclic saturated cycloaliphatic radicals having 3 or 4 carbon atoms comprise cyclopropyl and cyclobutyl. Examples of monocyclic saturated cycloaliphatic radicals having 3 to 5 carbon atoms comprise cyclopropyl, cyclobutyl and cyclopentyl. Examples of monocyclic saturated cycloaliphatic radicals having 3 to 6 carbon atoms comprise cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. C5-C6-Cycloalkyl is cyclopentyl or cyclohexyl. Examples of bicyclic radicals having 5 or 6 carbon atoms comprise bicyclo[1.1.1]pentyl and bicyclo[2.1.1]hexyl. Preferably, cycloalkyl is monocyclic.


The term “halocycloalkyl” as used herein (and in the halocycloalkyl moieties of other groups comprising an halocycloalkyl group) denotes in each case a mono- or bicyclic cycloaliphatic radical having usually from 3 to 8 carbon atoms (“C3-C8-halocycloalkyl”), preferably 3 to 5 carbon atoms (“C3-C5-halocycloalkyl”), wherein at least one, e.g. 1, 2, 3, 4 or 5 of the hydrogen atoms are replaced by halogen, in particular by fluorine or chlorine. Examples are 1- and 2-fluorocyclopropyl, 1,2-, 2,2- and 2,3-difluorocyclopropyl, 1,2,2-trifluorocyclopropyl, 2,2,3,3-tetrafluorocyclpropyl, 1- and 2-chlorocyclopropyl, 1,2-, 2,2- and 2,3-dichlorocyclopropyl, 1,2,2-trichlorocyclopropyl, 2,2,3,3-tetrachlorocyclpropyl, 1-, 2- and 3-fluorocyclopentyl, 1,2-, 2,2-, 2,3-, 3,3-, 3,4-, 2,5-difluorocyclopentyl, 1-, 2- and 3-chlorocyclopentyl, 1,2-, 2,2-, 2,3-, 3,3-, 3,4-, 2,5-dichlorocyclopentyl and the like.


The term “alkoxy” as used herein denotes in each case a straight-chain or branched alkyl group usually having from 1 to 6 carbon atoms (═C1-C6-alkoxy), preferably 1 to 3 carbon atoms (═C1-C3-alkoxy), in particular 1 or 2 carbon atoms (═C1-C2-alkoxy), which is bound to the remainder of the molecule via an oxygen atom. C1-C2-Alkoxy is methoxy or ethoxy. C1-C3-Alkoxy is additionally, for example, n-propoxy or 1-methylethoxy (isopropoxy). C1-C6-Alkoxy is additionally, for example, butoxy, 1-methylpropoxy (sec-butoxy), 2-methylpropoxy (isobutoxy) or 1,1-dimethylethoxy (tert-butoxy), pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy or 1-ethyl-2-methylpropoxy.


The term “haloalkoxy” as used herein denotes in each case a straight-chain or branched alkoxy group, as defined above, having from 1 to 6 carbon atoms (═C1-C6-haloalkoxy), preferably 1 to 3 carbon atoms (═C1-C3-haloalkoxy), in particular 1 or 2 carbon atoms (═C1-C2-haloalkoxy), wherein the hydrogen atoms of this group are partially or totally replaced with halogen atoms, in particular fluorine atoms (in this case, the radical is also termed fluorinated alkoxy). C1-C2-Haloalkoxy is, for example, OCH2F, OCHF2, OCF3, OCH2Cl, OCHCl2, OCCl3, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy or OC2F5. C1-C3-Haloalkoxy is additionally, for example, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2—C2F5, OCF2—C2F5, 1-(CH2F)-2-fluoroethoxy, 1-(CH2Cl)-2-chloroethoxy or 1-(CH2Br)-2-bromoethoxy. C1-C6-Haloalkoxy is additionally, for example, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy, 5-fluoropentoxy, 5-chloropentoxy, 5-brompentoxy, 5-iodopentoxy, undecafluoropentoxy, 6-fluorohexoxy, 6-chlorohexoxy, 6-bromohexoxy, 6-iodohexoxy or dodecafluorohexoxy.


The term “cyanoalkoxy” denotes in each case a straight-chain or branched alkyl group having usually from 1 to 6 carbon atoms (═C1-C6-cyanoalkoxy), more frequently 1 to 3 carbon atoms (═C1-C3-cyanoalkoxy), as defined above, wherein one hydrogen atom of this group is replaced with a cyano group. Examples are cyanomethoxy, 1-cyanoethoxy, 2-cyanoethoxy, 1-cyanopropoxy, 2-cyanopropoxy, 3-cyanopropoxy, 1-cyano-2-propoxy and the like.


The term “alkenyloxy” denotes an alkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Alkenyloxy is a C2-C6-alkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Alkenyloxy is a C3-C6-alkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule.


The term “haloalkenyloxy” denotes a haloalkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Haloalkenyloxy is a C2-C6-haloalkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Haloalkenyloxy is a C3-C6-haloalkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule.


The term “alkynyloxy” denotes an alkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Alkynyloxy is a C2-C6-alkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Alkynyloxy is a C3-C6-alkynyl group, as defined above, attached via an atom to the remainder of the molecule.


The term “haloalkynyloxy” denotes a haloalkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Haloalkynyloxy is a C2-C6-haloalkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Haloalkynyloxy is a C3-C6-haloalkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule.


The term “cycloalkoxy” denotes a cycloalkyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Cycloalkoxy is a C3-C6-cycloalkyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. Examples of C3-C6-cycloalkoxy comprise cyclopropoxy, cyclobutoxy, cyclopentoxy and cyclohexoxy.


The term “C1-C3-alkoxy-C1-C3-alkyl” denotes an alkyl group having 1 to 3 carbon atoms, as defined above, where one hydrogen atom is replaced by a C1-C3-alkoxy group, as defined above. Examples are methoxymethyl, ethoxymethyl, propoxymethyl, isopropoxymethyl, 1-methoxyethyl, 1-ethoxyethyl, 1-propoxyethyl, 1-isopropoxyethyl, 2-methoxyethyl, 2-ethoxyethyl, 2-propoxyethyl, 2-isopropoxyethyl, 1-methoxypropyl, 1-ethoxypropyl, 1-propoxypropyl, 1-isopropoxypropyl, 2-methoxypropyl, 2-ethoxypropyl, 2-propoxypropyl, 2-isopropoxypropyl, 3-methoxypropyl, 3-ethoxypropyl, 3-propoxypropyl, 3-isopropoxypropyl, and the like.


The term “C3-C5-cycloalkyl-C1-C3-alkoxy” as used herein, refers to an alkoxy group having 1 to 3 carbon atoms, as defined above, where one hydrogen atom is replaced by a C3-C5-cycloalkyl group, as defined above. Examples are cyclopropyl-methoxy, cyclobutylmethoxy, cyclopentylmethoxy, 1-cyclopropylethoxy, 2-cyclopropylethoxy, 1-cyclobutylethoxy, 2-cyclobutylethoxy, 1-cyclopentylethoxy, 2-cyclopentylethoxy, 1-cyclopropylpropoxy, 2-cyclopropylpropoxy, 3-cyclopropylpropoxy, 1-cyclobutylpropoxy, 2-cyclobutylpropoxy, 3-cyclobutylpropoxy, 1-cyclopentylpropoxy, 2-cyclopentylpropoxy, 3-cyclopentylpropoxy and the like.


The term “alkoxy-alkoxy” as used herein, refers to an alkoxy group, as defined above, where one hydrogen atom is replaced by another alkoxy group, as defined above. The term “C1-C3-alkoxy-C1-C3-alkoxy” as used herein, refers to an alkoxy group having 1 to 3 carbon atoms, as defined above, where one hydrogen atom is replaced by a C1-C3-alkoxy group, as defined above. Examples are methoxymethoxy, ethoxymethoxy, propoxymethoxy, isopropoxymethoxy, 1-methoxyethoxy, 1-ethoxyethoxy, 1-propoxyethoxy, 1-isopropoxyethoxy, 2-methoxyethoxy, 2-ethoxyethoxy, 2-propoxyethoxy, 2-isopropoxyethoxy, 1-methoxypropoxy, 1-ethoxypropoxy, 1-propoxypropoxy, 1-isopropoxypropoxy, 2-methoxypropoxy, 2-ethoxypropoxy, 2-propoxypropoxy, 2-isopropoxypropoxy, 3-methoxypropoxy, 3-ethoxypropoxy, 3-propoxypropoxy, 3-isopropoxypropoxy, and the like.


The term “alkylthio” (also alkylsulfanyl, “alkyl-S” or “alkyl-S(O)k” (wherein k is 0) as used herein denotes in each case a straight-chain or branched saturated alkyl group as defined above, usually comprising 1 to 6 carbon atoms (═C1-C6-alkylthio), preferably 1 to 3 carbon atoms (═C1-C3-alkylthio), which is attached via a sulfur atom at any position in the alkyl group. C1-C2-Alkylthio is methylthio or ethylthio. C1-C3-Alkylthio is additionally, for example, n-propylthio or 1-methylethylthio (isopropylthio). C1-C6-Alkylthio is additionally, for example, butylthio, 1-methylpropylthio (sec-butylthio), 2-methylpropylthio (isobutylthio), 1,1-dimethylethylthio (tert-butylthio), pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 1,1-dimethylpropylthio, 1,2-dimethylpropylthio, 2,2-dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1-methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1,1-dimethylbutylthio, 1,2-dimethylbutylthio, 1,3-dimethylbutylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-dimethylbutylthio, 1-ethylbutylthio, 2-ethylbutylthio, 1,1,2-trimethylpropylthio, 1,2,2-trimethylpropylthio, 1-ethyl-1-methylpropylthio or 1-ethyl-2-methylpropylthio.


The term “haloalkylthio” as used herein refers to an alkylthio group as defined above wherein the hydrogen atoms are partially or completely substituted by fluorine, chlorine, bromine and/or iodine. C1-C2-Haloalkylthio is, for example, SCH2F, SCHF2, SCF3, SCH2Cl, SCHCl2, SCCl3, chlorofluoromethylthio, dichlorofluoromethylthio, chlorodifluoromethylthio, 2-fluoroethylthio, 2-chloroethylthio, 2-bromoethylthio, 2-iodoethylthio, 2,2-difluoroethylthio, 2,2,2-trifluoroethylthio, 2-chloro-2-fluoroethylthio, 2-chloro-2,2-difluoroethylthio, 2,2-dichloro-2-fluoroethylthio, 2,2,2-trichloroethylthio or SC2F5. C1-C4-Haloalkylthio is additionally, for example, 2-fluoropropylthio, 3-fluoropropylthio, 2,2-difluoropropylthio, 2,3-difluoropropylthio, 2-chloropropylthio, 3-chloropropylthio, 2,3-dichloropropylthio, 2-bromopropylthio, 3-bromopropylthio, 3,3,3-trifluoropropylthio, 3,3,3-trichloropropylthio, SCH2—C2F5, SCF2—C2F5, 1-(CH2F)-2-fluoroethylthio, 1-(CH2Cl)-2-chloroethylthio, 1-(CH2Br)-2-bromoethylthio, 4-fluorobutylthio, 4-chlorobutylthio, 4-bromobutylthio or nonafluorobutylthio. C1-C6-Haloalkylthio is additionally, for example, 5-fluoropentylthio, 5-chloropentylthio, 5-brompentylthio, 5-iodopentylthio, undecafluoropentylthio, 6-fluorohexylthio, 6-chlorohexylthio, 6-bromohexylthio, 6-iodohexylthio or dodecafluorohexylthio.


The terms “alkylsulfinyl” and “alkyl-S(O)k” (wherein k is 1) are equivalent and, as used herein, denote an alkyl group, as defined above, attached via a sulfinyl [S(O)] group. For example, the term “C1-C2-alkylsulfinyl” refers to a C1-C2-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term “C1-C3-alkylsulfinyl” refers to a C1-C3-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term “C1-C6-alkylsulfinyl” refers to a C1-C6-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. C1-C2-alkylsulfinyl is methylsulfinyl or ethylsulfinyl. C1-C3-alkylsulfinyl is additionally, for example, n-propylsulfinyl or 1-methylethylsulfinyl (isopropylsulfinyl). C1-C6-alkylsulfinyl is additionally, for example, butylsulfinyl, 1-methylpropylsulfinyl (sec-butylsulfinyl), 2-methylpropylsulfinyl (isobutylsulfinyl), 1,1-dimethylethylsulfinyl (tert-butylsulfinyl), pentylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 1,1-dimethylpropylsulfinyl, 1,2-dimethylpropylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethylpropylsulfinyl, hexylsulfinyl, 1-methylpentylsulfinyl, 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1,1-dimethylbutylsulfinyl, 1,2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulfinyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1-methylpropylsulfinyl or 1-ethyl-2-methylpropylsulfinyl.


The terms “alkylsulfonyl” and “alkyl-S(O)k” (wherein k is 2) are equivalent and, as used herein, denote an alkyl group, as defined above, attached via a sulfonyl [S(O)2] group. The term “C1-C2-alkylsulfonyl” refers to a C1-C2-alkyl group, as defined above, attached via a sulfonyl [S(O)2] group. The term “C1-C3-alkylsulfonyl” refers to a C1-C3-alkyl group, as defined above, attached via a sulfonyl [S(O)2] group. The term “C1-C6-alkylsulfonyl” refers to a C1-C6-alkyl group, as defined above, attached via a sulfonyl [S(O)2] group. C1-C2-alkylsulfonyl is methylsulfonyl or ethylsulfonyl. C1-C3-alkylsulfonyl is additionally, for example, n-propylsulfonyl or 1-methylethylsulfonyl (isopropyl-sulfonyl). C1-C6-alkylsulfonyl is additionally, for example, butylsulfonyl, 1-methylpropylsulfonyl (sec-butylsulfonyl), 2-methylpropylsulfonyl (isobutylsulfonyl), 1,1-dimethylethylsulfonyl (tert-butylsulfonyl), pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, hexylsulfonyl, 1-methylpentylsulfonyl, 2-methylpentylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1,1-dimethylbutylsulfonyl, 1,2-dimethylbutylsulfonyl, 1,3-dimethylbutylsulfonyl, 2,2-dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl, 1-ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1,1,2-trimethylpropylsulfonyl, 1,2,2-trimethylpropylsulfonyl, 1-ethyl-1-methylpropylsulfonyl or 1-ethyl-2-methylpropylsulfonyl.


The substituent “oxo” replaces a CH2 group by a C(═O) group.


The suffix “-carbonyl” in a group denotes in each case that the group is bound to the remainder of the molecule via a carbonyl (C═O) group. This is the case e.g. in alkylcarbonyl, haloalkylcarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonyl, haloalkoxycarbonyl.


The term “alkylcarbonyl” denotes an alkyl group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. C1-C3-Alkylcarbonyl is a C1-C3-alkyl group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. C1-C4-Alkylcarbonyl is a C1-C4-alkyl group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. Examples for C1-C3-alkylcarbonyl are acetyl (methylcarbonyl), propionyl (ethylcarbonyl), propylcarbonyl and isopropylcarbonyl. Examples for C1-C4-alkylcarbonyl are acetyl (methylcarbonyl), propionyl (ethylcarbonyl), propylcarbonyl, isopropylcarbonyl n-butylcarbonyl and the like.


The term “alkoxycarbonyl” denotes an alkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. C1-C3-Alkoxycarbonyl is a C1-C3-alkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. Examples for C1-C3-alkoxycarbonyl are methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl and isopropoxycarbonyl. C1-C6-Alkoxycarbonyl is a C1-C6-alkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. Examples for C1-C6-alkoxycarbonyl are, in addition to those listed for C1-C3-alkoxycarbonyl, n-butoxycarbonyl, sec-butoxycarbonyl, isobutoxycarbonyl, tert-butoxycarbonyl, pentoxycarbonyl and hexoxycarbonyl.


The term “alkoxycarbonyl-alkyl” denotes an alkyl group, as defined above, in which one hydrogen atom is replaced by an alkoxycarbonyl group, as defined above. C1-C6-Alkoxycarbonyl-C1-C6-alkyl is a C1-C6-alkyl group, as defined above, in which one hydrogen atom is replaced by a C1-C6-alkoxycarbonyl group, as defined above.


Aminocarbonyl is a group H2NC(O)—


The term “C1-C4-alkylaminocarbonyl” denotes a group C1-C4-alkyl-N(H)—C(O)—. Examples are methylaminocarbonyl, ethylaminocarbonyl, propylaminocarbonyl, iso-propylaminocarbonyl, n-butylaminocarbonyl, sec-butylaminocarbonylisobutylaminocarbonyl and tert-butylaminocarbonyl.


The term “di-(C1-C4-alkyl)-aminocarbonyl” denotes a group (C1-C4-alkyl)2N—C(O)—.


Examples are dimethylaminocarbonyl, diethylaminocarbonyl, ethylmethylaminocarbonyl, dipropylaminocarbonyl, diisopropylaminocarbonyl, methylpropylaminocarbonyl, methylisopropylaminocarbonyl, ethylpropylaminocarbonyl, ethylisopropylaminocarbonyl, n-butyl-methylaminocarbonyl, n-butyl-ethylaminocarbonyl, n-butyl-propylaminocarbonyl, di-n-butylaminocarbonyl, 2-butyl-methylaminocarbonyl, 2-butyl-ethylaminocarbonyl, 2-butyl-propylaminocarbonyl, isobutyl-methylaminocarbonyl, ethyl-isobutylaminocarbonyl, isobutyl-propylaminocarbonyl, tert-butyl-methylaminocarbonyl, tert-butyl-ethylaminocarbonyl, tert-butyl-propylaminocarbonyl and the like.


Benzyloxycarbonyl is also known as the group Cbz or Z; Fluorenyloxycarbonyl is also known as Fmoc and allyloxycarbonyl is also known as Alloc.


Phenyl-(C1-C3-alkyl) is a C1-C3-alkyl group, as defined above, in which one hydrogen atom is replaced by a phenyl ring (i.e. the attachment to the remainder of the molecule is via the alkyl group). Examples are benzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylpropyl, 2-phenylpropyl, 3-phenylpropyl or 2-phenyl-2-propyl.


Furanyl-(C1-C3-alkyl) is a C1-C3-alkyl group, as defined above, in which one hydrogen atom is replaced by a 2- or 3-furanyl ring (i.e. the attachment to the remainder of the molecule is via the alkyl group). Examples are furan-2-yl-methyl, furan-3-yl-methyl, 1-(furan-2-yl)-ethyl, 1-(furan-3-yl)-ethyl, 2-(furan-2-yl)-ethyl, 2-(furan-3-yl)-ethyl and the like.


Phenylthio is a phenyl ring attached via an S atom to the remainder of the molecule.


Phenylsulfinyl is a phenyl ring attached via a S(O) group to the remainder of the molecule.


Phenylsulfonyl is a phenyl ring attached via a S(O)2 group to the remainder of the molecule.


Bicyclic rings in terms of the present invention contain two rings which have at least one ring atom in common. The term comprises condensed (fused) ring systems, in which the two rings have two neighboring ring atoms in common, as well as spiro systems, in which the rings have only one ring atom in common, and bridged systems with at least three ring atoms in common. If not specified otherwise, the bicyclic rings can be carbocyclic, containing only carbon atoms as ring members, as well as heterocyclic, containing at least one heteroatom or heteroatom group generally selected from N, O S, S(O), and S(O)2 as ring member(s). Further details are given below.


Polycyclic rings contain three or more rings, each of which having at least one ring atom in common with at least one of the other rings of the polycyclic system. The rings can be condensed, spiro-bound or bridged; mixed systems (e.g. one ring is spiro-bound to a condensed system, or a bridged system is condensed with another ring) are also possible. If not specified otherwise, the polycyclic rings can be carbocyclic, containing only carbon atoms as ring members, as well as heterocyclic, containing at least one heteroatom or heteroatom group generally selected from N, O S, S(O), and S(O)2 as ring member(s). Further details are given below.


Z is a three-, four-, five-, six-, seven- or eight-membered saturated, partly unsaturated, fully unsaturated or aromatic monocyclic, bicyclic, or polycyclic ring, except phenyl, which is formed from r carbon atoms (r=1-8), k nitrogen atoms (k=0-4), n sulfur atoms and n oxygen atoms, and where the sulfur and carbon ring atoms bear n oxo groups (n=0-2). One carbon ring atom can of course bear only 0 or 1 oxo groups. If the sulfur atoms bear 1 or 2 oxo groups, this results in heteroatom groups S(O) and S(O)2 as ring members.


The ring Z can thus be carbocyclic (i.e. containing only carbon atoms as ring members; r being here 3 to 8 and k and n as the number of O and S ring atoms being 0) or heterocyclic (i.e. containing also at least one N, O and/or S atom as ring member(s); r being here thus from 1 to 7 and at least one of the n's as the number of O and S ring atoms and/or k being 1).


An unsaturated carbocycle contains at least one C═C double bond(s). An unsaturated heterocycle contains at least one C—C and/or C—N and/or N—N double bond(s).


Partially unsaturated carbocyclic rings contain less than the maximum number of C═C double bond(s) allowed by the ring size. Partially unsaturated heterocyclic rings contain less than the maximum number of C—C and/or C—N and/or N—N double bond(s) allowed by the ring size. A fully (or maximally) unsaturated carbocyclic ring contains as many conjugated C═C double bonds as allowed by the size(s) of the ring(s). Not encompassed in the definition of Z is however phenyl. A fully (or maximally) unsaturated heterocycle contains as many conjugated C—C and/or C—N and/or N—N double bonds as allowed by the size(s) of the ring(s). Maximally unsaturated 5- or 6-membered heteromonocyclic rings are generally aromatic. Exceptions are maximally unsaturated 6-membered rings containing O, S, SO and/or SO2 as ring members, such as pyran and thiopyran, which are not aromatic.


Examples for 3-, 4-, 5-, 6-, 7- or 8-membered saturated monocyclic carbocyclic rings Z are cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl.


Examples for 3-, 4-, 5-, 6-, 7- or 8-membered partly unsaturated or fully unsaturated monocyclic carbocyclic rings Z are cycloprop-1-enyl, cycloprop-2-enyl, cyclobut-1-enyl, cyclobut-2-enyl, cyclobutadienyl, cyclopent-1-enyl, cyclopent-2-enyl, cyclopent-3-enyl, cyclopenta-1,3-dienyl, cyclopenta-1,4-dienyl, cyclopenta-2,4-dienyl, cyclohex-1-enyl, cyclohex-2-enyl, cyclohex-3-enyl, cyclohexa-1,3-dienyl, cyclohexa-1,4-dienyl, cyclohexa-1,5-dienyl, cyclohexa-2,4-dienyl, cyclohexa-2,5-dienyl, cyclohept-1-enyl, cyclohept-2-enyl, cyclohept-3-enyl, cyclohept-4-enyl, cyclohepta-1,3-dienyl, cyclohepta-1,4-dienyl, cyclohepta-1,5-dienyl, cyclohepta-1,6-dienyl, cyclohepta-2,4-dienyl, cyclo-hepta-2,5-dienyl, cyclohepta-2,6-dienyl, cyclohepta-3,5-dienyl, cyclohepta-1,3,5-trienyl, cyclooct-1-enyl, cyclooct-2-enyl, cyclooct-3-enyl, cyclooct-4-enyl, cyclooct-5-enyl, cyclooct-6-enyl, cyclooct-7-enyl, cycloocta-1,3-dienyl, cycloocta-1,4-dienyl, cycloocta-1,5-dienyl, cycloocta-1,6-dienyl, cycloocta-1,7-dienyl, cycloocta-2,4-dienyl, cycloocta-2,5-dienyl, cycloocta-2,6-dienyl, cycloocta-2,7-dienyl, cycloocta-3,5-dienyl, cycloocta-3,6-dienyl, cycloocta-1,3,5-trienyl, cycloocta-1,3,7-trienyl, cycloocta-2,4,6-trienyl, cyclooctatetraenyl.


Examples for 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partly unsaturated, fully unsaturated or aromatic heterocyclic rings Z are:

    • 3-, 4-, 5-, 6-, 7- or 8-membered monocyclic saturated heterocycles: e.g. oxiran-2-yl, thiiran-2-yl, aziridin-1-yl, aziridin-2-yl, oxetan-2-yl, oxetan-3-yl, thietan-2-yl, thietan-3-yl, 1-oxothietan-2-yl, 1-oxothietan-3-yl, 1,1-dioxothietan-2-yl, 1,1-dioxothietan-3-yl, azetidin-1-yl, azetidin-2-yl, azetidin-3-yl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, 1-oxotetrahydrothien-2-yl, 1,1-dioxotetrahydrothien-2-yl, 1-oxotetrahydrothien-3-yl, 1,1-dioxotetrahydrothien-3-yl, 1,3-dioxolan-2-yl, 1,3-dioxolan-4-yl, 1,3-dithiolan-2-yl, 1,3-dithiolan-4-yl, 1,3-oxathiolan-2-yl, 1,3-oxathiolan-4-yl, 1,3-oxathiolan-5-yl, pyrrolidin-1-yl, pyrrolidin-2-yl, pyrrolidin-3-yl, pyrazolidin-1-yl, pyrazolidin-3-yl, pyrazolidin-4-yl, pyrazolidin-5-yl, imidazolidin-1-yl, imidazolidin-2-yl, imidazolidin-4-yl, oxazolidin-2-yl, oxazolidin-3-yl, oxazolidin-4-yl, oxazolidin-5-yl, isoxazolidin-2-yl, isoxazolidin-3-yl, isoxazolidin-4-yl, isoxazolidin-5-yl, thiazolidin-2-yl, thiazolidin-3-yl, thiazolidin-4-yl, thiazolidin-5-yl, isothiazolidin-2-yl, isothiazolidin-3-yl, isothiazolidin-4-yl, isothiazolidin-5-yl, 1,2,4-oxadiazolidin-3-yl, 1,2,4-oxadiazolidin-5-yl, 1,2,4-thiadiazolidin-3-yl, 1,2,4-thiadiazolidin-5-yl, 1,3,4-oxadiazolidin-2-yl, 1,3,4-thiadiazolidin-2-yl, 1,2,4-triazolidin-1-yl, 1,2,4-triazolidin-3-yl, 1,2,4-triazolidin-4-yl, 2-tetrahydropyranyl, 3-tetrahydropyranyl, 4-tetrahydropyranyl, 1,3-dioxan-2-yl, 1,3-dioxan-5-yl, 1,4-dioxan-2-yl, piperidin-1-yl, piperidin-2-yl, piperidin-3-yl, piperidin-4-yl, hexahydropyridazin-1-yl, hexahydropyridazin-3-yl, hexahydropyridazin-4-yl, hexahydropyrimidin-1-yl, hexahydropyrimidin-2-yl, hexahydropyrimidin-4-yl, hexahydropyrimidin-5-yl, piperazin-1-yl, piperazin-2-yl, 1,3,5-hexahydrotriazin-1-yl, 1,3,5-hexahydrotriazin-2-yl, 1,2,4-hexahydrotriazin-1-yl, 1,2,4-hexahydrotriazin-2-yl, 1,2,4-hexahydrotriazin-3-yl, 1,2,4-hexahydrotriazin-4-yl, 1,2,4-hexahydrotriazin-5-yl, 1,2,4-hexahydrotriazin-6-yl, morpholin-2-yl, morpholin-3-yl, morpholin-4-yl, thiomorpholin-2-yl, thiomorpholin-3-yl, thiomorpholin-4-yl, 1-oxothiomorpholin-2-yl, 1-oxothiomorpholin-3-yl, 1-oxothiomorpholin-4-yl, 1,1-dioxothiomorpholin-2-yl, 1,1-dioxothiomorpholin-3-yl, 1,1-dioxothiomorpholin-4-yl, azepan-1-, -2-, -3- or -4-yl, oxepan-2-, -3-, -4- or -5-yl, hexahydro-1,3-diazepinyl, hexahydro-1,4-diazepinyl, hexa-hydro-1,3-oxazepinyl, hexahydro-1,4-oxazepinyl, hexahydro-1,3-dioxepinyl, hexahydro-1,4-dioxepinyl, oxocane, thiocane, azocanyl, [1,3]diazocanyl, [1,4]diazocanyl, [1,5]diazocanyl, [1,5]oxazocanyl and the like;
    • 3-, 4-, 5-, 6-, 7- or 8-membered partially unsaturated heteromonocyclic rings: 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,4-dihydrofuran-2-yl, 2,4-dihydrofuran-3-yl, 2,3-dihydrothien-2-yl, 2,3-dihydrothien-3-yl, 2,4-dihydrothien-2-yl, 2,4-dihydrothien-3-yl, 2-pyrrolin-2-yl, 2-pyrrolin-3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, 2-isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxazolin-4-yl, 3-isoxazolin-4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl, 2-isothiazolin-3-yl, 3-isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl, 4-isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazol-1-yl, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl, 2,3-dihydropyrazol-5-yl, 3,4-dihydropyrazol-1-yl, 3,4-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrooxazol-4-yl, 2,3-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,4-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 2-, 3-, 4-, 5- or 6-di- or tetrahydropyridinyl, 3-di- or tetrahydropyridazinyl, 4-di- or tetrahydropyridazinyl, 2-di- or tetrahydropyrimidinyl, 4-di- or tetrahydropyrimidinyl, 5-di- or tetrahydropyrimidinyl, di- or tetrahydro-pyrazinyl, 1,3,5-di- or tetrahydrotriazin-2-yl, 1,2,4-di- or tetrahydrotriazin-3-yl, 2,3,4,5-tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, 3,4,5,6-tetrahydro[2H]azepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7-tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, tetrahydrooxepinyl, such as 2,3,4,5-tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7-tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, tetrahydro-1,3-diazepinyl, tetrahydro-1,4-diazepinyl, tetrahydro-1,3-oxazepinyl, tetrahydro-1,4-oxazepinyl, tetrahydro-1,3-dioxepinyl, tetrahydro-1,4-dioxepinyl, 1,2,3,4,5,6-hexahydroazocine, 2,3,4,5,6,7-hexahydroazocine, 1,2,3,4,5,8-hexahydroazocine, 1,2,3,4,7,8-hexahydroazocine, 1,2,3,4,5,6-hexahydro-[1,5]diazocine, 1,2,3,4,7,8-hexahydro-[1,5]diazocine and the like;
    • 3-, 4-, 5-, 6-, 7- or 8-membered maximally unsaturated (but not aromatic) heteromonocyclic rings: pyran-2-yl, pyran-3-yl, pyran-4-yl, thiopryran-2-yl, thiopryran-3-yl, thiopryran-4-yl, 1-oxothiopryran-2-yl, 1-oxothiopryran-3-yl, 1-oxothiopryran-4-yl, 1,1-dioxothiopryran-2-yl, 1,1-dioxothiopryran-3-yl, 1,1-dioxothiopryran-4-yl, 2H-oxazin-2-yl, 2H-oxazin-3-yl, 2H-oxazin-4-yl, 2H-oxazin-5-yl, 2H-oxazin-6-yl, 4H-oxazin-3-yl, 4H-oxazin-4-yl, 4H-oxazin-5-yl, 4H-oxazin-6-yl, 6H-oxazin-3-yl, 6H-oxazin-4-yl, 7H-oxazin-5-yl, 8H-oxazin-6-yl, 2H-1,3-oxazin-2-yl, 2H-1,3-oxazin-4-yl, 2H-1,3-oxazin-5-yl, 2H-1,3-oxazin-6-yl, 4H-1,3-oxazin-2-yl, 4H-1,3-oxazin-4-yl, 4H-1,3-oxazin-5-yl, 4H-1,3-oxazin-6-yl, 6H-1,3-oxazin-2-yl, 6H-1,3-oxazin-4-yl, 6H-1,3-oxazin-5-yl, 6H-1,3-oxazin-6-yl, 2H-1,4-oxazin-2-yl, 2H-1,4-oxazin-3-yl, 2H-1,4-oxazin-5-yl, 2H-1,4-oxazin-6-yl, 4H-1,4-oxazin-2-yl, 4H-1,4-oxazin-3-yl, 4H-1,4-oxazin-4-yl, 4H-1,4-oxazin-5-yl, 4H-1,4-oxazin-6-yl, 6H-1,4-oxazin-2-yl, 6H-1,4-oxazin-3-yl, 6H-1,4-oxazin-5-yl, 6H-1,4-oxazin-6-yl, 1,4-dioxine-2-yl, 1,4-oxathiin-2-yl, 1H-azepine, 1H-[1,3]-diazepine, 1H-[1,4]-diazepine, [1,3]diazocine, [1,5]diazocine, [1,5]diazocine and the like
    • 5- or 6-membered monocyclic aromatic heterocyclic rings: e.g. 2-furyl, 3-furyl, 2 thienyl, 3-thienyl, 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 1,-pyrazolyl, 3,-pyrazolyl, 4 pyrazolyl, 5-pyrazolyl, 1 imidazolyl, 2-imidazolyl, 4-imidazolyl, 5-imidazolyl, 2-oxazolyl, 4-oxazolyl, 5 oxazolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, 2-thiazolyl, 4-thiazolyl, 5 thiazolyl, 3-isothiazolyl, 4-isothiazolyl, 5-isothiazolyl, 1,3,4-triazol-1-yl, 1,3,4-triazol-2-yl, 1,3,4-triazol-3-yl, 1,2,3-triazol-1-yl, 1,2,3-triazol-2-yl, 1,2,3-triazol-4-yl, 1,2,5-oxadiazol-3-yl, 1,2,3-oxadiazol-4-yl, 1,2,3-oxadiazol-5-yl, 1,3,4-oxadiazol-2-yl, 1,2,5-thiadiazol-3-yl, 1,2,3-thiadiazol-4-yl, 1,2,3-thiadiazol-5-yl, 1,3,4-thiadiazol-2-yl, 1,2,3,4-tetrazol-1-yl, 1,2,3,4-tetrazol-2-yl, 1,2,3,4-[1H]-tetrazol-5-yl, 1,2,3,4-[2H]-tetrazol-5-yl, 2-pyridinyl, 3-pyridinyl, 4 pyridinyl, 1-oxopyridin-2-yl, 1-oxopyridin-3-yl, 1-oxopyridin-4-yl, 3-pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4 pyrimidinyl, 5-pyrimidinyl, 2-pyrazinyl, 1,3,5-triazin-2-yl, 1,2,4-triazin-3-yl, 1,2,4-triazin-5-yl, 1,2,3,4-tetrazin-1-yl, 1,2,3,4-tetrazin-2-yl, 1,2,3,4-tetrazin-5-yl and the like.


Bicyclic rings are 4- to 8-membered, preferably 5- to 8-membered.


Examples for 5- to 8-membered bicyclic spirocyclic saturated carbocyclic rings comprise spiro[2.2]pentyl, spiro[2.3]hexyl, spiro[2.4]heptyl, spiro[3.3]heptyl, spiro[4.4]nonyl, spiro[5.5]undecyl and the like.


Examples of 5- to 8-membered bicyclic condensed saturated carbocyclic rings comprise bicyclo[3.1.0]hexyl, bicyclo[3.2.0]heptyl, bicyclo[3.3.0]octyl, 1,2,3,3a,4,5,6,6a-octahydropentalenyl, bicyclo[4.2.0]octyl and the like.


Examples of 5- to 8-membered bicyclic bridged saturated carbocyclic rings comprise bicyclo[1.1.1]pentyl, bicyclo[2.1.1]hexyl, bicyclo[2.2.1]heptyl, bicyclo-[3.1.1]heptyl, bicyclo[2.2.2]octyl, bicyclo[3.2.1]octyl and the like.


An example for a 5- to 8-membered polycyclic saturated carbocyclic is cubyl.


An example for a 5- to 8-membered partly unsaturated bicyclic bridged carbocyclic ring is bicyclo[2.2.2]oct-2-enyl.


Examples for saturated 5- to 8-membered bicyclic condensed heterocyclic rings are:




embedded image


Examples for saturated 5- to 8-membered bicyclic spirocyclic heterocyclic rings are:




embedded image


Examples for saturated 5- to 8-membered bicyclic bridged heterocyclic rings are:




embedded image


Examples for partly unsaturated 5- to 8-membered bicyclic bridged heterocyclic rings are:




embedded image


In the above structures # denotes the attachment point to the remainder of the molecule. The attachment point is not restricted to the ring on which this is shown, but can be on either of the two rings, and may be on a carbon or on a nitrogen ring atom. If the rings carry one or more substituents, these may be bound to carbon and/or to nitrogen ring atoms.


Q is a 5- or 6-membered heteroaromatic ring containing 1, 2, 3 or 4 heteroatoms selected from the group consisting of N, O and S as ring members. Examples are. furan-2-yl, furan-3-yl, thien-2-yl, thien-3-yl, pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,3,4-triazol-1-yl, 1,3,4-triazol-2-yl, 1,3,4-triazol-3-yl, 1,2,3-triazol-1-yl, 1,2,3-triazol-2-yl, 1,2,3-triazol-4-yl, 1,2,5-oxadiazol-3-yl, 1,2,3-oxadiazol-4-yl, 1,2,3-oxadiazol-5-yl, 1,3,4-oxadiazol-2-yl, 1,2,5-thiadiazol-3-yl, 1,2,3-thiadiazol-4-yl, 1,2,3-thiadiazol-5-yl, 1,3,4-thiadiazol-2-yl, 1,2,3,4-tetrazol-1-yl, 1,2,3,4-tetrazol-2-yl, 1,2,3,4-[1H]-tetrazol-5-yl, 1,2,3,4-[2H]-tetrazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl, 1,3,5-triazin-2-yl, 1,2,4-triazin-3-yl, 1,2,4-triazin-5-yl, 1,2,3,4-tetrazin-1-yl, 1,2,3,4-tetrazin-2-yl, 1,2,3,4-tetrazin-5-yl and the like.


Examples for 5-membered heteroaromatic rings Q containing 1 or 2 heteroatoms selected from the group consisting of N, O and S as ring members are furan-2-yl, fu-ran-3-yl, thien-2-yl, thien-3-yl, pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl and isothiazol-5-yl.


Examples for 6-membered heteroaromatic rings Q containing 1 or 2 nitrogen ring atoms are pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl and pyrazin-2-yl.


The remarks made below as to preferred embodiments of the variables (substituents) of the compounds of formula I are valid on their own as well as preferably in combination with each other, as well as in combination with the stereoisomers, tautomers or salts thereof. The remarks made below concerning preferred embodiments of the variables further are valid on their own as well as preferably in combination with each other concerning the compounds of formulae I, where applicable, as well as concerning the uses and methods according to the invention and the composition according to the invention.


Preferably, R1 is selected from the group consisting of hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C1-C3)-haloalkyl, (C2-C3)-alkenyl, (C2-C3)-alkynyl and (C1-C3)-alkoxy-(C1-C3)-alkyl. More preferably, R1 is hydrogen, (C1-C3)-alkyl or (C1-C3)-alkoxy-(C1-C3)-alkyl; in particular hydrogen, methyl or methoxymethyl. In particular, R1 is hydrogen or (C1-C3)-alkyl. Specifically, R1 is hydrogen.


Preferably, R4 is selected from the group consisting of hydrogen, (C1-C6)-alkyl and (C3-C6)-cycloalkyl. More preferably, R4 is hydrogen or (C1-C3)-alkyl. In particular, R4 is hydrogen.


Preferably,


R1 is hydrogen or (C1-C3)-alkyl; and


R4 is hydrogen or (C1-C3)-alkyl.


More preferably R1 and R4 are both hydrogen.


Preferably, R2 is selected from the group consisting of (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C6)-alkenyl, (C3-C6)-alkynyl, and (C1-C3)-alkoxy-(C1-C3)-alkyl, each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano. More preferably, R2 is (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C3-C6)-cycloalkyl, (C3-C6)-alkenyl or (C3-C6)-alkynyl. Even more preferably, R2 is (C1-C6)-alkyl, such as (C1-C4)-alkyl. In particular, R2 is methyl or ethyl; specifically methyl.


Preferably, R3 is selected from the group consisting of hydrogen, halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C3-C6)-cycloalkyl, (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C1-C6)-haloalkoxy, (C3-C6)-alkenyloxy, and (C3-C6)-alkynyloxy. More preferably, R3 is hydrogen, halogen, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, (C3-C6)-cycloalkoxy, (C3-C6)-alkenyloxy or (C3-C6)-alkynyloxy. Even more preferably, R3 is hydrogen or halogen; especially hydrogen or fluorine, and is in particular hydrogen.


In the divalent radicals (X1) to (X6), the orientation within the molecule is as depicted, the left arrow representing the bond to the adjacent nitrogen atom and the right arrow representing the bond to Y.


When X is a bond (“X0”), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X1), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X2), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X3), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X4), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X5), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X6), the compound (I) can also be depicted as follows:




embedded image


In the divalent radicals (X1) to (X6), R5-R10, independently of each other and independently of each occurrence, are preferably selected from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd; (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, where the three last-mentioned aliphatic and cycloaliphatic radicals are each independently substituted by m fluorine atoms; (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C2-C6)-alkenyloxy, (C2-C6)-alkynyloxy, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl and (C1-C3)-alkylthio, where the aliphatic and cycloaliphatic moieties in the 7 last-mentioned radicals are each independently substituted by m fluorine atoms.


More preferably, R5-R10, independently of each other and independently of each occurrence, are selected from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd; (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, where the three last-mentioned aliphatic and cycloaliphatic radicals are each independently substituted by m fluorine atoms; (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C2-C6)-alkenyloxy and (C2-C6)-alkynyloxy, where the aliphatic and cycloaliphatic moieties in the four last-mentioned radicals are each independently substituted by m fluorine atoms.


In particular, R5-R10, independently of each other and independently of each occurrence, are selected from the group consisting of hydrogen, fluorine, chlorine, CO2Re, CONRbRd; (C1-C6)-alkyl substituted by m fluorine atoms; and (C1-C6)-alkoxy substituted by m fluorine atoms.


In particular, R5-R10, independently of each other and independently of each occurrence, are selected from the group consisting of hydrogen, halogen, (C1-C6)-alkyl, (C1-C3)-alkoxy and CO2Re. More particularly, R5-R10, independently of each other and independently of each occurrence, are hydrogen or (C1-C6)-alkyl, and specifically hydrogen or methyl.


Non-exhaustive examples for suitable divalent radicals (X1) to (X6) are CH2, CH2CH2, CH(CH3), CH2CH2CH2, CH(CH2CH3), CH(CH3)CH2, C(CH3)2, C(CH3)2CH2, C(iPr)CH3, CH(CH2iPr)CH2, CH2CH═CH, C(CH3)2C═C, CH(CF3)CH2, CH(CH3)CH2O, CH2CH2O, CH(cPr)CH2O, CH(CH2OCH3), CH(CH2CH2SCH3), CH(COOH), CH(COOCH3), CH(COOH)CH2, CH(COOCH3)CH2, CH2C(OH)(CF3), CH(CONHCH3), CH(CONHCH3)CH2 and CH2CH2CONHCH2. cPr is cyclopropyl; iPr is isopropyl.


In a preferred embodiment, X is a bond or the divalent unit (X1). In the latter, preferably, R5 and R6, independently of each other, are hydrogen or (C1-C6)-alkyl, and more preferably hydrogen or methyl. In particular, one of R5 and R6 is hydrogen and the other is methyl, X1 thus being in particular CH(CH3).


Y preferably is selected from the group consisting of hydrogen, cyano, hydroxyl, Z; (C1-C12)-alkyl, (C3-C8)-cycloalkyl, (C2-C12)-alkenyl and (C2-C12)-alkynyl, where the aliphatic and cycloaliphatic moieties in the four last-mentioned radicals are each independently substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxyl, Z, CO2Re, and CONRbRh.


More preferably, Y is selected from the group consisting of hydrogen, cyano, hydroxyl, Z, (C1-C12)-alkyl and (C3-C8)-cycloalkyl, where the aliphatic and cycloaliphatic moieties in the two last-mentioned radicals are each independently substituted by m radicals selected from the group consisting of fluorine, CO2Re, and CONRbRh.


In an alternatively more preferred embodiment, Y is selected from the group consisting of (C1-C12)-alkyl, (C3-C8)-cycloalkyl, (C2-C12)-alkenyl and (C2-C12)-alkynyl, where the aliphatic and cycloaliphatic moieties in the four last-mentioned radicals are each independently substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxyl, ORd, Z, OZ, NHZ, S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe. Even more preferably, Y is selected from the group consisting of (C1-C12)-alkyl, (C3-C8)-cycloalkyl, (C2-C12)-alkenyl and (C2-C12)-alkynyl, where the aliphatic and cycloaliphatic moieties in the four last-mentioned radicals are each independently substituted by m radicals selected from the group consisting of fluorine and CO2Re.


In particular, Y is selected from the group consisting of Z, (C1-C12)-alkyl and (C3-C8)-cycloalkyl, where the aliphatic and cycloaliphatic moieties in the two last-mentioned radicals are each independently substituted by m radicals selected from the group consisting of fluorine, (C1-C2)-alkoxy, CO2Re, and CONRbRh. More particularly, Y is selected from the group consisting of Z and (C1-C12)-alkyl which carries m groups CO2Re. m in this context is preferably 1 or 2 and in particular 1.


In one preferred embodiment, Y is Z.


Representative, non-exhaustive examples for the three-, four-, five-, six-, seven- or eight-membered saturated, partly unsaturated, fully unsaturated or aromatic monocyclic, bicyclic or polycyclic ring Z, (which is not phenyl) are the following structures (and of course also the exemplary rings defined above):




embedded image


embedded image


The rings may additionally be substituted as defined above. The arrow or # represent the bond/attachment point to Y (or NR4, if Y is a bond).


Z is preferably selected from the group consisting of three, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated, including aromatic, monocyclic rings (except for phenyl) which are formed from r carbon atoms and n oxygen atoms, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf, C(Rb)═NORe, Ra, Rc, Re and Rf, and where carbon atoms bear n oxo groups. Among these, preference is given to four-, five- or six-membered saturated, partly or fully unsaturated, including aromatic, monocyclic rings (except for phenyl) which are formed from r carbon atoms and n oxygen atoms, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, Ra, Rc, Re and Rf, and where carbon atoms bear n oxo groups.


In an alternatively preferred embodiment, Z is selected from the group consisting of three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic rings, except phenyl, which are formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which are substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Ra, Rc, Re and Rf, and where the sulfur atoms and carbon atoms bear n oxo groups. among these, preference is given to three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic rings, except phenyl, which are formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which are substituted by m radicals from the group consisting of CO2Re, CONRbRh, Ra, Rc, Re and Rf, and where the sulfur atoms and carbon atoms bear n oxo groups.


More preferably, Z is a three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated monocyclic carbocyclic ring, except phenyl, which is substituted by m radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, Ra, Rc, Re and Rf, and where the carbon ring atoms bear n oxo groups. m is in this context preferably 0, 1, 2 or 3, more preferably 1 or 2, in particular 1. n is in this context preferably 0 or 1, in particular 0.


More preferably, the three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated monocyclic carbocyclic ring Z is substituted by m1 radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRb-CONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe and m2 radicals Ra, Rc, Re and Rf; where m1 has one of the meanings given for m and is preferably 0, 1, 2 or 3, more preferably 1 or 2, in particular 1; and m2 has one of the meanings given for m and is preferably 0, 1 or 2, in particular 0.


Even more preferably, the three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated monocyclic carbocyclic ring Z is substituted by m1 radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe where m1 has one of the meanings given for m and is preferably 0, 1, 2 or 3, more preferably 1 or 2, in particular 1.


More preference is given to Z being a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by m radicals selected from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Ra, Rc, Re and Rf. More preferably, the five- or six-membered saturated or partly unsaturated carbocyclic ring Z is substituted by m1 radicals selected from the group consisting of CO2Re, CONRbRh and CONReSO2Ra, and m2 radicals selected from the group consisting of Ra, Rc, Re and Rf, where m1 has one of the meanings given for m and is preferably 0, 1, 2 or 3, more preferably 1 or 2, in particular 1; and m2 has one of the meanings given for m and is preferably 0, 1 or 2, in particular 0. Even more preferably, the five- or six-membered saturated or partly unsaturated carbocyclic ring Z is substituted by m1 radicals selected from the group consisting of CO2Re, CONRbRh and CONReSO2Ra, where m1 has one of the meanings given for m and is preferably 0, 1, 2 or 3, more preferably 1 or 2, in particular 1 (and by no radicals Ra, Rc, Re and Rf).


Examples for five- or six-membered saturated or partly unsaturated carbocyclic rings are cyclopentyl, cyclopent-1-en-1-yl, cyclopent-2-en-1-yl, cyclopent-3-en-1-yl, cyclo-penta-1,3-dien-1-yl, cyclopenta-1,4-dien-1-yl, cyclopenta-2,4-dien-1-yl, cyclohexyl, cyclohex-1-en-1-yl, cyclohex-2-en-1-yl, cyclohex-3-en-1-yl, cyclohexa-1,3-dien-1-yl, cyclohexa-1,4-dien-1-yl, cyclohexa-1,5-dien-1-yl, cyclohexa-2,4-dien-1-yl and cyclohexa-2,5-dien-1-yl. Among these, preference is given to cyclopentyl, cyclopent-1-en-1-yl, cyclopent-2-en-1-yl, cyclopent-3-en-1-yl and cyclohexyl. A specific example is cyclo-pent-2-en-1-yl.


Non-exhaustive examples for such rings are the following structures:




embedded image


embedded image


In the above structures, # stands for the attachment point to the remainder of the molecule and Rx stands for CO2Re, CONRbRh, CONReSO2Ra, Ra, Rc, Re or Rf. The rings may carry moreover 1 or 2 substituents selected from F, CN methyl, CF3 or methoxy in any position. More preferably, Rx stands for CO2Re, CONRbRh or CONReSO2Ra, and in particular for CO2Re. Re in this context is preferably hydrogen or (C1-C6)-alkyl, more preferably (C1-C4)-alkyl.


Thus, even more preferably, Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl, preferably (C1-C4)-alkyl. m is in this context preferably 1 or 2, more preferably 1. Examples for such rings are the above structures wherein Rx stands for CO2Re, where Re is hydrogen or (C1-C6)-alkyl, preferably (C1-C4)-alkyl.


In particular, Z is a five- or six-membered partly unsaturated carbocyclic ring which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl, preferably (C1-C4)-alkyl. m is in this context preferably 1 or 2, more preferably 1.


More particularly, Z is a five-membered partly unsaturated carbocyclic ring which is substituted by one radical CO2Re, where Re is hydrogen or (C1-C6)-alkyl, preferably (C1-C4)-alkyl. Examples for such rings are




embedded image


wherein Rx stands for CO2Re, where Re is hydrogen or (C1-C6)-alkyl.


Specifically, Z is




embedded image


where Rx is CO2Re, where Re is hydrogen or (C1-C6)-alkyl and is in particular (C1-C4)-alkyl.


In an alternatively preferred embodiment, Z is a three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated heterocyclic ring containing one or two oxygen atoms as ring members, where the ring is substituted by m radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2R3, NRbRe, NRbCORe, NRb-CONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, and where the carbon ring atoms bear n oxo groups. m is in this context preferably 1 or 2, more preferably 1. n is in this context preferably 0 or 1, in particular 0. More preferably, Z is a saturated or partly unsaturated five- or six-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by m radicals CO2Re. Re is in this context preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and m is in this context preferably 1 or 2, more preferably 1. Thus, more particularly, Z is a saturated or partly unsaturated five- or six-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by m radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and m is 1 or 2, preferably 1. Even more particularly, Z is a saturated or partly unsaturated five-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl. and m is in this context preferably 1 or 2, more preferably 1. Specifically, Z is a saturated or partly unsaturated five-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by one radical CO2Re, where Re is hydrogen or (C1-C6)-alkyl.


Examples for three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated heterocyclic rings containing one or two oxygen atoms as ring members are oxiran-2-yl, oxetan-2-yl, oxetan-3-yl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, 1,3-dioxolan-2-yl, 1,3-dioxolan-4-yl, tetrahydropyran-2-yl, tetrahydropyran-3-yl, tetrahydro-pyran-4-yl, 1,3-dioxan-2-yl, 1,3-dioxan-4-yl, 1,3-dioxan-5-yl, 1,4-dioxan-2-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl, 2,5-dihydrofuran-3-yl, 3,6-dihydro-2H-pyran-2-yl, 3,6-dihydro-2H-pyran-3-yl, 3,6-dihydro-2H-pyran-4-yl, 3,6-dihydro-2H-pyran-5-yl, 3,6-dihydro-2H-pyran-6-yl, 3,4-dihydro-2H-pyran-2-yl, 3,4-dihydro-2H-pyran-3-yl, 3,4-dihydro-2H-pyran-4-yl, 3,4-dihydro-2H-pyran-5-yl or 3,4-dihydro-2H-pyran-6-yl.


Examples for saturated or partly unsaturated five- or six-membered heterocyclic rings containing one oxygen atom as ring member are tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydropyran-2-yl, tetrahydropyran-3-yl, tetrahydropyran-4-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl, 2,5-dihydrofuran-3-yl, 3,6-dihydro-2H-pyran-2-yl, 3,6-dihydro-2H-pyran-3-yl, 3,6-dihydro-2H-pyran-4-yl, 3,6-dihydro-2H-pyran-5-yl, 3,6-dihydro-2H-pyran-6-yl, 3,4-dihydro-2H-pyran-2-yl, 3,4-dihydro-2H-pyran-3-yl, 3,4-dihydro-2H-pyran-4-yl, 3,4-dihydro-2H-pyran-5-yl or 3,4-dihydro-2H-pyran-6-yl.


Examples for saturated or partly unsaturated five-membered heterocyclic rings containing one oxygen atom as ring member are tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl, or 2,5-dihydrofuran-3-yl.


Non-exhaustive examples for saturated or partly unsaturated five-membered heterocyclic rings containing one oxygen atom as ring member are the following structures:




embedded image


In the above structures, the wave line stands for the attachment point to the remainder of the molecule and the arrow stands for the attachment point to a substituent CO2Re, CONRbRh, CONReSO2Ra, Ra, Rc, Re or Rf. Said substituent is preferably CO2Re, CONRbRh or CONReSO2Ra, and in particular CO2Re. Re in this context is preferably hydrogen or (C1-C6)-alkyl.


Among the above rings, preference is given to following structures:




embedded image


where again the wave line stands for the attachment point to the remainder of the molecule and the arrow stands for the attachment point to a substituent CO2Re, CONRbRh, CONReSO2Ra, Ra, Rc, Re or Rf. Said substituent is preferably CO2Re, CONRbRh or CONReSO2Ra, and in particular CO2Re. Re in this context is preferably hydrogen or (C1-C6)-alkyl.


Preferably, however, ring Z is carbocyclic.


In another preferred embodiment, Y is (C1-C8)-alkyl which is substituted by m radicals selected from the group consisting of S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRb—SO2Re, NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe. More preferably, Y is (C1-C4)-alkyl which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl and m is 1 or 2. Even more preferably, Y is (C1-C4)-alkyl which is substituted by one radical CO2Re, where Re is hydrogen or (C1-C6)-alkyl, where Re is preferably (C1-C4)-alkyl.


In a preferred embodiment, X is a bond and Y is Z, where Z has one of the above general or preferred meanings.


In another preferred embodiment,

    • X is a divalent unit (X1), where R5 and R6 are as defined above and are in particular independently hydrogen or (C1-C6)-alkyl; and
    • Y is (C1-C8)-alkyl which is substituted by m radicals selected from the group consisting of S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONRe—SO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe.


In an alternative preferred embodiment,

    • X is a bond; and
    • Y is (C1-C8)-alkyl which is substituted by m radicals selected from the group consisting of S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONRe—SO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe.


More preferably,

    • X is a divalent unit (X1), where R5 and R6 are independently hydrogen or methyl; and
    • Y is (C1-C4)-alkyl which is substituted by m radicals selected from the group consisting of CO2Re, CONRbRh and CONReSO2Ra.


In this context, Y is preferably (C1-C4)-alkyl which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl, where Re is preferably (C1-C4)-alkyl.


m in this context is preferably 1.


In an alternative more preferred embodiment,

    • X is a bond; and
    • Y is (C1-C6)-alkyl which is substituted by m radicals selected from the group consisting of CO2Re, CONRbRh and CONReSO2Ra.


In this context, Y is preferably (C1-C6)-alkyl which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl, where Re is preferably (C1-C4)-alkyl. m in this context is preferably 1.


In this latter alternative more preferred embodiment, (C1-C6)-alkyl in Y is preferably a group —C(R51)(R61)—C1-C4-alkyl which is substituted by m radicals selected from the group consisting of CO2Re, CONRbRh and CONReSO2Ra, and R51 and R61 are independently hydrogen or methyl.


In this context, Y is more preferably a group —C(R51)(R61)—C1-C4-alkyl which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl, where Re is preferably (C1-C4)-alkyl; and R51 and R61 are independently hydrogen or methyl.


m in this context is preferably 1.


Q is a preferably 5-membered heteroaromatic ring containing 1 or 2 heteroatoms selected from the group consisting of N, O and S as ring members or a 6-membered heteroaromatic ring containing 1 or 2 nitrogen atoms as ring members, where ring Q carries k substituents RQ1 and n substituents RQ2.


Examples for such rings Q are furan-2-yl, furan-3-yl, thien-2-yl, thien-3-yl, pyrrol-2-yl, pyrrol-3-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl and pyrazin-2-yl.


RQ1 is in this context preferably selected from the group consisting of halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy and (C1-C3)-haloalkoxy.


RQ2 is in this context preferably phenyl-(C1-C3)-alkyl, (C1-C4)-alkylcarbonyl, (C1-C4)-alkylaminocarbonyl, di-(C1-C4-alkyl)aminocarbonyl, (C1-C4)-alkoxycarbonyl, benzyloxycarbonyl, fluorenyloxycarbonyl, allyloxycarbonyl or (C1-C3)-alkoxy-(C1-C3)-alkyl; more preferably benzyl, acetyl, methylaminocarbonyl, dimethylaminocarbonyl, (C1-C4)-alkoxycarbonyl or methoxymethyl, and is in particular (C1-C4)-alkoxycarbonyl.


k is in this context preferably 0, 1, 2 or 3, more preferably 0, 1 or 2, and n is in this context preferably 0 or 1.


More preferably, Q is a 5-membered heteroaromatic ring containing 1 or 2 heteroatoms selected from the group consisting of N, O and S as ring members or a 6-membered heteroaromatic ring containing 1 or 2 nitrogen atoms as ring members, where ring Q carries k substituents RQ1 and n substituents RQ2.


Examples for such 5-membered heteroaromatic rings Q are furan-2-yl, furan-3-yl, thien-2-yl, thien-3-yl, pyrrol-2-yl, pyrrol-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, iso-thiazol-3-yl, isothiazol-4-yl and isothiazol-5-yl.


Examples for such 6-membered heteroaromatic rings Q are pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl and pyrazin-2-yl.


RQ1 in this context is preferably selected from the group consisting of halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy and (C1-C3)-haloalkoxy.


RQ2 in this context is preferably (C1-C4)-alkoxycarbonyl.


k in this context is preferably 0, 1, 2 or 3, and n in this context is preferably 0 or 1.


Particularly preferred rings Q are the following structures:




embedded image




    • i.e. thien-2-yl, thien-3-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl or pyrimidin-5-yl.





These rings carry k substituents RQ1 and n substituents RQ2. RQ1 in this context is preferably selected from the group consisting of halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy and (C1-C3)-haloalkoxy. RQ2 in this context is preferably (C1-C4)-alkoxycarbonyl. k in this context is preferably 0, 1, 2 or 3, more preferably 0, 1 or 2, and n in this context is preferably 0 or 1.


Specifically, Q is isoxazolyl, thienyl or pyridyl (to be more precise thien-2-yl, thien-3-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, pyridin-2-yl, pyridin-3-yl or pyridin-4-yl).


In a preferred embodiment,

    • Q is a 5-membered heteroaromatic ring containing 1 or 2 heteroatoms selected from the group consisting of N, O and S as ring members or a 6-membered heteroaromatic ring containing 1 or 2 nitrogen atoms as ring members, where ring Q carries k substituents RQ1 and n substituents RQ2; where RQ1 is selected from the group consisting of halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy and (C1-C3)-haloalkoxy, and RQ2 is (C1-C4)-alkoxycarbonyl; where k is 0, 1, 2 or 3 and n is 0 or 1;
    • R1 hydrogen;
    • R2 is (C1-C6)-alkyl;
    • R3 is hydrogen or halogen;
    • R4 is hydrogen;
    • X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl and m is 1 or 2; or
    • X is a divalent unit (X1), where R5 and R6 are independently of each other hydrogen or (C1-C6)-alkyl; and Y is (C1-C4)-alkyl which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl and m is 1 or 2.


More preferably,

    • Q is a 5-membered heteroaromatic ring containing 1 or 2 heteroatoms selected from the group consisting of N, O and S as ring members or a 6-membered heteroaromatic ring containing 1 or 2 nitrogen atoms as ring members, where ring Q carries k substituents RQ1 and n substituents RQ2; where RQ1 is selected from the group consisting of halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy and (C1-C3)-haloalkoxy, and RQ2 is (C1-C4)-alkoxycarbonyl; where k is 0, 1, 2 or 3 and n is 0 or 1;
    • R1 hydrogen;
    • R2 is methyl or ethyl;
    • R3 is hydrogen;
    • R4 is hydrogen;
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by one radical CO2Re, where Re is (C1-C6)-alkyl; or
    • X is a divalent unit (X1), where one of R5 and R6 is hydrogen and the other is hydrogen or methyl; and Y is (C1-C4)-alkyl which is substituted by one radical CO2Re, where Re is (C1-C6)-alkyl.


Even more preferably,

    • Q is a 5-membered heteroaromatic ring containing 1 or 2 heteroatoms selected from the group consisting of N, O and S as ring members or a 6-membered heteroaromatic ring containing 1 or 2 nitrogen atoms as ring members, where ring Q carries k substituents RQ1 and n substituents RQ2; where RQ1 is selected from the group consisting of halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy and (C1-C3)-haloalkoxy, and RQ2 is (C1-C4)-alkoxycarbonyl; where k is 0, 1 or 2 and n is 0 or 1;
    • R1 hydrogen;
    • R2 is methyl or ethyl;
    • R3 is hydrogen;
    • R4 is hydrogen;
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by one radical CO2Re, where Re is (C1-C4)-alkyl; or
    • X is a divalent unit (X1), where one of R5 and R6 is hydrogen and the other is hydrogen or methyl; and Y is (C1-C4)-alkyl which is substituted by one radical CO2Re, where Re is (C1-C4)-alkyl.


Specifically,

    • Q is a 5-membered heteroaromatic ring containing 1 or 2 heteroatoms selected from the group consisting of N, O and S as ring members or a 6-membered heteroaromatic ring containing 1 nitrogen atom as ring members, where ring Q carries k substituents RQ1 and n substituents RQ2; where RQ1 is selected from the group consisting of halogen, cyano, (C1-C3)-alkyl and (C1-C3)-alkoxy, and RQ2 is (C1-C4)-alkoxycarbonyl; where k is 0, 1 or 2 and n is 0 or 1;
    • R1 hydrogen;
    • R2 is methyl or ethyl, preferably methyl;
    • R3 is hydrogen;
    • R4 is hydrogen;
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by one radical CO2Re, where Re is (C1-C4)-alkyl; or
    • X is a divalent unit (X1), where one of R5 and R6 is hydrogen and the other is hydrogen or methyl; and Y is (C1-C4)-alkyl which is substituted by one radical CO2Re, where Re is (C1-C4)-alkyl.


In the above particular and specific embodiments, the five-membered partly unsaturated carbocyclic ring Z is preferably a ring Z10 (depicted below), wherein # denotes the attachment point to the remainder of the molecule.


Compounds (I), wherein R1 and R4 are hydrogen and R2, R3 and X—Y in combination have the meanings as defined in each line of table A below are particularly preferred.












TABLE A





No.
R2
R3
—X—Y


















1.
CH3
H
—CH(CH3)—CH2—C(═O)O—CH3


2.
CH3
F
—CH(CH3)—CH2—C(═O)O—CH3


3.
CH3
OCH3
—CH(CH3)—CH2—C(═O)O—CH3


4.
Et
H
—CH(CH3)—CH2—C(═O)O—CH3


5.
Et
F
—CH(CH3)—CH2—C(═O)O—CH3


6.
Et
OCH3
—CH(CH3)—CH2—C(═O)O—CH3


7.
cPr
H
—CH(CH3)—CH2—C(═O)O—CH3


8.
cPr
F
—CH(CH3)—CH2—C(═O)O—CH3


9.
cPr
OCH3
—CH(CH3)—CH2—C(═O)O—CH3


10.
CH3
H
—CH(CH3)—CH2—C(═O)O—CH2CH3


11.
CH3
F
—CH(CH3)—CH2—C(═O)O—CH2CH3


12.
CH3
OCH3
—CH(CH3)—CH2—C(═O)O—CH2CH3


13.
Et
H
—CH(CH3)—CH2—C(═O)O—CH2CH3


14.
Et
F
—CH(CH3)—CH2—C(═O)O—CH2CH3


15.
Et
OCH3
—CH(CH3)—CH2—C(═O)O—CH2CH3


16.
cPr
H
—CH(CH3)—CH2—C(═O)O—CH2CH3


17.
cPr
F
—CH(CH3)—CH2—C(═O)O—CH2CH3


18.
cPr
OCH3
—CH(CH3)—CH2—C(═O)O—CH2CH3


19.
CH3
H
—CH(CH3)—CH2—C(═O)O—CH2CH2CH3


20.
CH3
F
—CH(CH3)—CH2—C(═O)O—CH2CH2CH3


21.
CH3
OCH3
—CH(CH3)—CH2—C(═O)O—CH2CH2CH3


22.
Et
H
—CH(CH3)—CH2—C(═O)O—CH2CH2CH3


23.
Et
F
—CH(CH3)—CH2—C(═O)O—CH2CH2CH3


24.
Et
OCH3
—CH(CH3)—CH2—C(═O)O—CH2CH2CH3


25.
cPr
H
—CH(CH3)—CH2—C(═O)O—CH2CH2CH3


26.
cPr
F
—CH(CH3)—CH2—C(═O)O—CH2CH2CH3


27.
cPr
OCH3
—CH(CH3)—CH2—C(═O)O—CH2CH2CH3


28.
CH3
H
—CH(CH3)—CH2—C(═O)O—CH(CH3)2


29.
CH3
F
—CH(CH3)—CH2—C(═O)O—CH(CH3)2


30.
CH3
OCH3
—CH(CH3)—CH2—C(═O)O—CH(CH3)2


31.
Et
H
—CH(CH3)—CH2—C(═O)O—CH(CH3)2


32.
Et
F
—CH(CH3)—CH2—C(═O)O—CH(CH3)2


33.
Et
OCH3
—CH(CH3)—CH2—C(═O)O—CH(CH3)2


34.
cPr
H
—CH(CH3)—CH2—C(═O)O—CH(CH3)2


35.
cPr
F
—CH(CH3)—CH2—C(═O)O—CH(CH3)2


36.
cPr
OCH3
—CH(CH3)—CH2—C(═O)O—CH(CH3)2


37.
CH3
H
—CH(CH3)—CH2—C(═O)O-cyclopropyl


38.
CH3
F
—CH(CH3)—CH2—C(═O)O-cyclopropyl


39.
CH3
OCH3
—CH(CH3)—CH2—C(═O)O-cyclopropyl


40.
Et
H
—CH(CH3)—CH2—C(═O)O-cyclopropyl


41.
Et
F
—CH(CH3)—CH2—C(═O)O-cyclopropyl


42.
Et
OCH3
—CH(CH3)—CH2—C(═O)O-cyclopropyl


43.
cPr
H
—CH(CH3)—CH2—C(═O)O-cyclopropyl


44.
cPr
F
—CH(CH3)—CH2—C(═O)O-cyclopropyl


45.
cPr
OCH3
—CH(CH3)—CH2—C(═O)O-cyclopropyl


46.
CH3
H
—CH(CH3)—CH2—C(═O)O-cyclobutyl


47.
CH3
F
—CH(CH3)—CH2—C(═O)O-cyclobutyl


48.
CH3
OCH3
—CH(CH3)—CH2—C(═O)O-cyclobutyl


49.
Et
H
—CH(CH3)—CH2—C(═O)O-cyclobutyl


50.
Et
F
—CH(CH3)—CH2—C(═O)O-cyclobutyl


51.
Et
OCH3
—CH(CH3)—CH2—C(═O)O-cyclobutyl


52.
cPr
H
—CH(CH3)—CH2—C(═O)O-cyclobutyl


53.
cPr
F
—CH(CH3)—CH2—C(═O)O-cyclobutyl


54.
cPr
OCH3
—CH(CH3)—CH2—C(═O)O-cyclobutyl


55.
CH3
H
—CH(CH3)—CH2—C(═O)O—CH2-cyclopropyl


56.
CH3
F
—CH(CH3)—CH2—C(═O)O—CH2-cyclopropyl


57.
CH3
OCH3
—CH(CH3)—CH2—C(═O)O—CH2-cyclopropyl


58.
Et
H
—CH(CH3)—CH2—C(═O)O—CH2-cyclopropyl


59.
Et
F
—CH(CH3)—CH2—C(═O)O—CH2-cyclopropyl


60.
Et
OCH3
—CH(CH3)—CH2—C(═O)O—CH2-cyclopropyl


61.
cPr
H
—CH(CH3)—CH2—C(═O)O—CH2-cyclopropyl


62.
cPr
F
—CH(CH3)—CH2—C(═O)O—CH2-cyclopropyl


63.
cPr
OCH3
—CH(CH3)—CH2—C(═O)O—CH2-cyclopropyl


64.
CH3
H
—CH(CH3)—CH2—C(═O)O—CH2CH2OCH3


65.
CH3
F
—CH(CH3)—CH2—C(═O)O—CH2CH2OCH3


66.
CH3
OCH3
—CH(CH3)—CH2—C(═O)O—CH2CH2OCH3


67.
Et
H
—CH(CH3)—CH2—C(═O)O—CH2CH2OCH3


68.
Et
F
—CH(CH3)—CH2—C(═O)O—CH2CH2OCH3


69.
Et
OCH3
—CH(CH3)—CH2—C(═O)O—CH2CH2OCH3


70.
cPr
H
—CH(CH3)—CH2—C(═O)O—CH2CH2OCH3


71.
cPr
F
—CH(CH3)—CH2—C(═O)O—CH2CH2OCH3


72.
cPr
OCH3
—CH(CH3)—CH2—C(═O)O—CH2CH2OCH3


73.
CH3
H
—CH(CH3)—CH2CH2—C(═O)O—CH3


74.
CH3
F
—CH(CH3)—CH2CH2—C(═O)O—CH3


75.
CH3
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH3


76.
Et
H
—CH(CH3)—CH2CH2—C(═O)O—CH3


77.
Et
F
—CH(CH3)—CH2CH2—C(═O)O—CH3


78.
Et
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH3


79.
cPr
H
—CH(CH3)—CH2CH2—C(═O)O—CH3


80.
cPr
F
—CH(CH3)—CH2CH2—C(═O)O—CH3


81.
cPr
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH3


82.
CH3
H
—CH(CH3)—CH2CH2—C(═O)O—CH2CH3


83.
CH3
F
—CH(CH3)—CH2CH2—C(═O)O—CH2CH3


84.
CH3
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2CH3


85.
Et
H
—CH(CH3)—CH2CH2—C(═O)O—CH2CH3


86.
Et
F
—CH(CH3)—CH2CH2—C(═O)O—CH2CH3


87.
Et
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2CH3


88.
cPr
H
—CH(CH3)—CH2CH2—C(═O)O—CH2CH3


89.
cPr
F
—CH(CH3)—CH2CH2—C(═O)O—CH2CH3


90.
cPr
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2CH3


91.
CH3
H
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH3


92.
CH3
F
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH3


93.
CH3
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH3


94.
Et
H
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH3


95.
Et
F
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH3


96.
Et
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH3


97.
cPr
H
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH3


98.
cPr
F
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH3


99.
cPr
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH3


100.
CH3
H
—CH(CH3)—CH2CH2—C(═O)O—CH(CH3)2


101.
CH3
F
—CH(CH3)—CH2CH2—C(═O)O—CH(CH3)2


102.
CH3
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH(CH3)2


103.
Et
H
—CH(CH3)—CH2CH2—C(═O)O—CH(CH3)2


104.
Et
F
—CH(CH3)—CH2CH2—C(═O)O—CH(CH3)2


105.
Et
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH(CH3)2


106.
cPr
H
—CH(CH3)—CH2CH2—C(═O)O—CH(CH3)2


107.
cPr
F
—CH(CH3)—CH2CH2—C(═O)O—CH(CH3)2


108.
cPr
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH(CH3)2


109.
CH3
H
—CH(CH3)—CH2CH2—C(═O)O-cyclopropyl


110.
CH3
F
—CH(CH3)—CH2CH2—C(═O)O-cyclopropyl


111.
CH3
OCH3
—CH(CH3)—CH2CH2—C(═O)O-cyclopropyl


112.
Et
H
—CH(CH3)—CH2CH2—C(═O)O-cyclopropyl


113.
Et
F
—CH(CH3)—CH2CH2—C(═O)O-cyclopropyl


114.
Et
OCH3
—CH(CH3)—CH2CH2—C(═O)O-cyclopropyl


115.
cPr
H
—CH(CH3)—CH2CH2—C(═O)O-cyclopropyl


116.
cPr
F
—CH(CH3)—CH2CH2—C(═O)O-cyclopropyl


117.
cPr
OCH3
—CH(CH3)—CH2CH2—C(═O)O-cyclopropyl


118.
CH3
H
—CH(CH3)—CH2CH2—C(═O)O-cyclobutyl


119.
CH3
F
—CH(CH3)—CH2CH2—C(═O)O-cyclobutyl


120.
CH3
OCH3
—CH(CH3)—CH2CH2—C(═O)O-cyclobutyl


121.
Et
H
—CH(CH3)—CH2CH2—C(═O)O-cyclobutyl


122.
Et
F
—CH(CH3)—CH2CH2—C(═O)O-cyclobutyl


123.
Et
OCH3
—CH(CH3)—CH2CH2—C(═O)O-cyclobutyl


124.
cPr
H
—CH(CH3)—CH2CH2—C(═O)O-cyclobutyl


125.
cPr
F
—CH(CH3)—CH2CH2—C(═O)O-cyclobutyl


126.
cPr
OCH3
—CH(CH3)—CH2CH2—C(═O)O-cyclobutyl


127.
CH3
H
—CH(CH3)—CH2CH2—C(═O)O—CH2-cyclopropyl


128.
CH3
F
—CH(CH3)—CH2CH2—C(═O)O—CH2-cyclopropyl


129.
CH3
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2-cyclopropyl


130.
Et
H
—CH(CH3)—CH2CH2—C(═O)O—CH2-cyclopropyl


131.
Et
F
—CH(CH3)—CH2CH2—C(═O)O—CH2-cyclopropyl


132.
Et
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2-cyclopropyl


133.
cPr
H
—CH(CH3)—CH2CH2—C(═O)O—CH2-cyclopropyl


134.
cPr
F
—CH(CH3)—CH2CH2—C(═O)O—CH2-cyclopropyl


135.
cPr
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2-cyclopropyl


136.
CH3
H
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2OCH3


137.
CH3
F
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2OCH3


138.
CH3
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2OCH3


139.
Et
H
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2OCH3


140.
Et
F
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2OCH3


141.
Et
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2OCH3


142.
cPr
H
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2OCH3


143.
cPr
F
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2OCH3


144.
cPr
OCH3
—CH(CH3)—CH2CH2—C(═O)O—CH2CH2OCH3


145.
CH3
H
—(CH2)3—C(═O)O—CH3


146.
CH3
F
—(CH2)3—C(═O)O—CH3


147.
CH3
OCH3
—(CH2)3—C(═O)O—CH3


148.
Et
H
—(CH2)3—C(═O)O—CH3


149.
Et
F
—(CH2)3—C(═O)O—CH3


150.
Et
OCH3
—(CH2)3—C(═O)O—CH3


151.
cPr
H
—(CH2)3—C(═O)O—CH3


152.
cPr
F
—(CH2)3—C(═O)O—CH3


153.
cPr
OCH3
—(CH2)3—C(═O)O—CH3


154.
CH3
H
—(CH2)3—C(═O)O—CH2CH3


155.
CH3
F
—(CH2)3—C(═O)O—CH2CH3


156.
CH3
OCH3
—(CH2)3—C(═O)O—CH2CH3


157.
Et
H
—(CH2)3—C(═O)O—CH2CH3


158.
Et
F
—(CH2)3—C(═O)O—CH2CH3


159.
Et
OCH3
—(CH2)3—C(═O)O—CH2CH3


160.
cPr
H
—(CH2)3—C(═O)O—CH2CH3


161.
cPr
F
—(CH2)3—C(═O)O—CH2CH3


162.
cPr
OCH3
—(CH2)3—C(═O)O—CH2CH3


163.
CH3
H
—(CH2)3—C(═O)O—CH2CH2CH3


164.
CH3
F
—(CH2)3—C(═O)O—CH2CH2CH3


165.
CH3
OCH3
—(CH2)3—C(═O)O—CH2CH2CH3


166.
Et
H
—(CH2)3—C(═O)O—CH2CH2CH3


167.
Et
F
—(CH2)3—C(═O)O—CH2CH2CH3


168.
Et
OCH3
—(CH2)3—C(═O)O—CH2CH2CH3


169.
cPr
H
—(CH2)3—C(═O)O—CH2CH2CH3


170.
cPr
F
—(CH2)3—C(═O)O—CH2CH2CH3


171.
cPr
OCH3
—(CH2)3—C(═O)O—CH2CH2CH3


172.
CH3
H
—(CH2)3—C(═O)O—CH(CH3)2


173.
CH3
F
—(CH2)3—C(═O)O—CH(CH3)2


174.
CH3
OCH3
—(CH2)3—C(═O)O—CH(CH3)2


175.
Et
H
—(CH2)3—C(═O)O—CH(CH3)2


176.
Et
F
—(CH2)3—C(═O)O—CH(CH3)2


177.
Et
OCH3
—(CH2)3—C(═O)O—CH(CH3)2


178.
cPr
H
—(CH2)3—C(═O)O—CH(CH3)2


179.
cPr
F
—(CH2)3—C(═O)O—CH(CH3)2


180.
cPr
OCH3
—(CH2)3—C(═O)O—CH(CH3)2


181.
CH3
H
—(CH2)3—C(═O)O-cyclopropyl


182.
CH3
F
—(CH2)3—C(═O)O-cyclopropyl


183.
CH3
OCH3
—(CH2)3—C(═O)O-cyclopropyl


184.
Et
H
—(CH2)3—C(═O)O-cyclopropyl


185.
Et
F
—(CH2)3—C(═O)O-cyclopropyl


186.
Et
OCH3
—(CH2)3—C(═O)O-cyclopropyl


187.
cPr
H
—(CH2)3—C(═O)O-cyclopropyl


188.
cPr
F
—(CH2)3—C(═O)O-cyclopropyl


189.
cPr
OCH3
—(CH2)3—C(═O)O-cyclopropyl


190.
CH3
H
—(CH2)3—C(═O)O-cyclobutyl


191.
CH3
F
—(CH2)3—C(═O)O-cyclobutyl


192.
CH3
OCH3
—(CH2)3—C(═O)O-cyclobutyl


193.
Et
H
—(CH2)3—C(═O)O-cyclobutyl


194.
Et
F
—(CH2)3—C(═O)O-cyclobutyl


195.
Et
OCH3
—(CH2)3—C(═O)O-cyclobutyl


196.
cPr
H
—(CH2)3—C(═O)O-cyclobutyl


197.
cPr
F
—(CH2)3—C(═O)O-cyclobutyl


198.
cPr
OCH3
—(CH2)3—C(═O)O-cyclobutyl


199.
CH3
H
—(CH2)3—C(═O)O—CH2-cyclopropyl


200.
CH3
F
—(CH2)3—C(═O)O—CH2-cyclopropyl


201.
CH3
OCH3
—(CH2)3—C(═O)O—CH2-cyclopropyl


202.
Et
H
—(CH2)3—C(═O)O—CH2-cyclopropyl


203.
Et
F
—(CH2)3—C(═O)O—CH2-cyclopropyl


204.
Et
OCH3
—(CH2)3—C(═O)O—CH2-cyclopropyl


205.
cPr
H
—(CH2)3—C(═O)O—CH2-cyclopropyl


206.
cPr
F
—(CH2)3—C(═O)O—CH2-cyclopropyl


207.
cPr
OCH3
—(CH2)3—C(═O)O—CH2-cyclopropyl


208.
CH3
H
—(CH2)3—C(═O)O—CH2CH2OCH3


209.
CH3
F
—(CH2)3—C(═O)O—CH2CH2OCH3


210.
CH3
OCH3
—(CH2)3—C(═O)O—CH2CH2OCH3


211.
Et
H
—(CH2)3—C(═O)O—CH2CH2OCH3


212.
Et
F
—(CH2)3—C(═O)O—CH2CH2OCH3


213.
Et
OCH3
—(CH2)3—C(═O)O—CH2CH2OCH3


214.
cPr
H
—(CH2)3—C(═O)O—CH2CH2OCH3


215.
cPr
F
—(CH2)3—C(═O)O—CH2CH2OCH3


216.
cPr
OCH3
—(CH2)3—C(═O)O—CH2CH2OCH3


217.
CH3
H
Z1, wherein Re is CH3


218.
CH3
F
Z1, wherein Re is CH3


219.
CH3
OCH3
Z1, wherein Re is CH3


220.
Et
H
Z1, wherein Re is CH3


221.
Et
F
Z1, wherein Re is CH3


222.
Et
OCH3
Z1, wherein Re is CH3


223.
cPr
H
Z1, wherein Re is CH3


224.
cPr
F
Z1, wherein Re is CH3


225.
cPr
OCH3
Z1, wherein Re is CH3


226.
CH3
H
Z1, wherein Re is ethyl


227.
CH3
F
Z1, wherein Re is ethyl


228.
CH3
OCH3
Z1, wherein Re is ethyl


229.
Et
H
Z1, wherein Re is ethyl


230.
Et
F
Z1, wherein Re is ethyl


231.
Et
OCH3
Z1, wherein Re is ethyl


232.
cPr
H
Z1, wherein Re is ethyl


233.
cPr
F
Z1, wherein Re is ethyl


234.
cPr
OCH3
Z1, wherein Re is ethyl


235.
CH3
H
Z1, wherein Re is n-propyl


236.
CH3
F
Z1, wherein Re is n-propyl


237.
CH3
OCH3
Z1, wherein Re is n-propyl


238.
Et
H
Z1, wherein Re is n-propyl


239.
Et
F
Z1, wherein Re is n-propyl


240.
Et
OCH3
Z1, wherein Re is n-propyl


241.
cPr
H
Z1, wherein Re is n-propyl


242.
cPr
F
Z1, wherein Re is n-propyl


243.
cPr
OCH3
Z1, wherein Re is n-propyl


244.
CH3
H
Z1, wherein Re is isopropyl


245.
CH3
F
Z1, wherein Re is isopropyl


246.
CH3
OCH3
Z1, wherein Re is isopropyl


247.
Et
H
Z1, wherein Re is isopropyl


248.
Et
F
Z1, wherein Re is isopropyl


249.
Et
OCH3
Z1, wherein Re is isopropyl


250.
cPr
H
Z1, wherein Re is isopropyl


251.
cPr
F
Z1, wherein Re is isopropyl


252.
cPr
OCH3
Z1, wherein Re is isopropyl


253.
CH3
H
Z1, wherein Re is cyclopropyl


254.
CH3
F
Z1, wherein Re is cyclopropyl


255.
CH3
OCH3
Z1, wherein Re is cyclopropyl


256.
Et
H
Z1, wherein Re is cyclopropyl


257.
Et
F
Z1, wherein Re is cyclopropyl


258.
Et
OCH3
Z1, wherein Re is cyclopropyl


259.
cPr
H
Z1, wherein Re is cyclopropyl


260.
cPr
F
Z1, wherein Re is cyclopropyl


261.
cPr
OCH3
Z1, wherein Re is cyclopropyl


262.
CH3
H
Z1, wherein Re is cyclobutyl


263.
CH3
F
Z1, wherein Re is cyclobutyl


264.
CH3
OCH3
Z1, wherein Re is cyclobutyl


265.
Et
H
Z1, wherein Re is cyclobutyl


266.
Et
F
Z1, wherein Re is cyclobutyl


267.
Et
OCH3
Z1, wherein Re is cyclobutyl


268.
cPr
H
Z1, wherein Re is cyclobutyl


269.
cPr
F
Z1, wherein Re is cyclobutyl


270.
cPr
OCH3
Z1, wherein Re is cyclobutyl


271.
CH3
H
Z1, wherein Re is CH2-cyclopropyl


272.
CH3
F
Z1, wherein Re is CH2-cyclopropyl


273.
CH3
OCH3
Z1, wherein Re is CH2-cyclopropyl


274.
Et
H
Z1, wherein Re is CH2-cyclopropyl


275.
Et
F
Z1, wherein Re is CH2-cyclopropyl


276.
Et
OCH3
Z1, wherein Re is CH2-cyclopropyl


277.
cPr
H
Z1, wherein Re is CH2-cyclopropyl


278.
cPr
F
Z1, wherein Re is CH2-cyclopropyl


279.
cPr
OCH3
Z1, wherein Re is CH2-cyclopropyl


280.
CH3
H
Z1, wherein Re is CH2CH2OCH3


281.
CH3
F
Z1, wherein Re is CH2CH2OCH3


282.
CH3
OCH3
Z1, wherein Re is CH2CH2OCH3


283.
Et
H
Z1, wherein Re is CH2CH2OCH3


284.
Et
F
Z1, wherein Re is CH2CH2OCH3


285.
Et
OCH3
Z1, wherein Re is CH2CH2OCH3


286.
cPr
H
Z1, wherein Re is CH2CH2OCH3


287.
cPr
F
Z1, wherein Re is CH2CH2OCH3


288.
cPr
OCH3
Z1, wherein Re is CH2CH2OCH3


289.
CH3
H
Z2, wherein Re is CH3


290.
CH3
F
Z2, wherein Re is CH3


291.
CH3
OCH3
Z2, wherein Re is CH3


292.
Et
H
Z2, wherein Re is CH3


293.
Et
F
Z2, wherein Re is CH3


294.
Et
OCH3
Z2, wherein Re is CH3


295.
cPr
H
Z2, wherein Re is CH3


296.
cPr
F
Z2, wherein Re is CH3


297.
cPr
OCH3
Z2, wherein Re is CH3


298.
CH3
H
Z2, wherein Re is ethyl


299.
CH3
F
Z2, wherein Re is ethyl


300.
CH3
OCH3
Z2, wherein Re is ethyl


301.
Et
H
Z2, wherein Re is ethyl


302.
Et
F
Z2, wherein Re is ethyl


303.
Et
OCH3
Z2, wherein Re is ethyl


304.
cPr
H
Z2, wherein Re is ethyl


305.
cPr
F
Z2, wherein Re is ethyl


306.
cPr
OCH3
Z2, wherein Re is ethyl


307.
CH3
H
Z2, wherein Re is n-propyl


308.
CH3
F
Z2, wherein Re is n-propyl


309.
CH3
OCH3
Z2, wherein Re is n-propyl


310.
Et
H
Z2, wherein Re is n-propyl


311.
Et
F
Z2, wherein Re is n-propyl


312.
Et
OCH3
Z2, wherein Re is n-propyl


313.
cPr
H
Z2, wherein Re is n-propyl


314.
cPr
F
Z2, wherein Re is n-propyl


315.
cPr
OCH3
Z2, wherein Re is n-propyl


316.
CH3
H
Z2, wherein Re is isopropyl


317.
CH3
F
Z2, wherein Re is isopropyl


318.
CH3
OCH3
Z2, wherein Re is isopropyl


319.
Et
H
Z2, wherein Re is isopropyl


320.
Et
F
Z2, wherein Re is isopropyl


321.
Et
OCH3
Z2, wherein Re is isopropyl


322.
cPr
H
Z2, wherein Re is isopropyl


323.
cPr
F
Z2, wherein Re is isopropyl


324.
cPr
OCH3
Z2, wherein Re is isopropyl


325.
CH3
H
Z2, wherein Re is cyclopropyl


326.
CH3
F
Z2, wherein Re is cyclopropyl


327.
CH3
OCH3
Z2, wherein Re is cyclopropyl


328.
Et
H
Z2, wherein Re is cyclopropyl


329.
Et
F
Z2, wherein Re is cyclopropyl


330.
Et
OCH3
Z2, wherein Re is cyclopropyl


331.
cPr
H
Z2, wherein Re is cyclopropyl


332.
cPr
F
Z2, wherein Re is cyclopropyl


333.
cPr
OCH3
Z2, wherein Re is cyclopropyl


334.
CH3
H
Z2, wherein Re is cyclobutyl


335.
CH3
F
Z2, wherein Re is cyclobutyl


336.
CH3
OCH3
Z2, wherein Re is cyclobutyl


337.
Et
H
Z2, wherein Re is cyclobutyl


338.
Et
F
Z2, wherein Re is cyclobutyl


339.
Et
OCH3
Z2, wherein Re is cyclobutyl


340.
cPr
H
Z2, wherein Re is cyclobutyl


341.
cPr
F
Z2, wherein Re is cyclobutyl


342.
cPr
OCH3
Z2, wherein Re is cyclobutyl


343.
CH3
H
Z2, wherein Re is CH2-cyclopropyl


344.
CH3
F
Z2, wherein Re is CH2-cyclopropyl


345.
CH3
OCH3
Z2, wherein Re is CH2-cyclopropyl


346.
Et
H
Z2, wherein Re is CH2-cyclopropyl


347.
Et
F
Z2, wherein Re is CH2-cyclopropyl


348.
Et
OCH3
Z2, wherein Re is CH2-cyclopropyl


349.
cPr
H
Z2, wherein Re is CH2-cyclopropyl


350.
cPr
F
Z2, wherein Re is CH2-cyclopropyl


351.
cPr
OCH3
Z2, wherein Re is CH2-cyclopropyl


352.
CH3
H
Z2, wherein Re is CH2CH2OCH3


353.
CH3
F
Z2, wherein Re is CH2CH2OCH3


354.
CH3
OCH3
Z2, wherein Re is CH2CH2OCH3


355.
Et
H
Z2, wherein Re is CH2CH2OCH3


356.
Et
F
Z2, wherein Re is CH2CH2OCH3


357.
Et
OCH3
Z2, wherein Re is CH2CH2OCH3


358.
cPr
H
Z2, wherein Re is CH2CH2OCH3


359.
cPr
F
Z2, wherein Re is CH2CH2OCH3


360.
cPr
OCH3
Z2, wherein Re is CH2CH2OCH3


361.
CH3
H
Z3, wherein Re is CH3


362.
CH3
F
Z3, wherein Re is CH3


363.
CH3
OCH3
Z3, wherein Re is CH3


364.
Et
H
Z3, wherein Re is CH3


365.
Et
F
Z3, wherein Re is CH3


366.
Et
OCH3
Z3, wherein Re is CH3


367.
cPr
H
Z3, wherein Re is CH3


368.
cPr
F
Z3, wherein Re is CH3


369.
cPr
OCH3
Z3, wherein Re is CH3


370.
CH3
H
Z3, wherein Re is ethyl


371.
CH3
F
Z3, wherein Re is ethyl


372.
CH3
OCH3
Z3, wherein Re is ethyl


373.
Et
H
Z3, wherein Re is ethyl


374.
Et
F
Z3, wherein Re is ethyl


375.
Et
OCH3
Z3, wherein Re is ethyl


376.
cPr
H
Z3, wherein Re is ethyl


377.
cPr
F
Z3, wherein Re is ethyl


378.
cPr
OCH3
Z3, wherein Re is ethyl


379.
CH3
H
Z3, wherein Re is n-propyl


380.
CH3
F
Z3, wherein Re is n-propyl


381.
CH3
OCH3
Z3, wherein Re is n-propyl


382.
Et
H
Z3, wherein Re is n-propyl


383.
Et
F
Z3, wherein Re is n-propyl


384.
Et
OCH3
Z3, wherein Re is n-propyl


385.
cPr
H
Z3, wherein Re is n-propyl


386.
cPr
F
Z3, wherein Re is n-propyl


387.
cPr
OCH3
Z3, wherein Re is n-propyl


388.
CH3
H
Z3, wherein Re is isopropyl


389.
CH3
F
Z3, wherein Re is isopropyl


390.
CH3
OCH3
Z3, wherein Re is isopropyl


391.
Et
H
Z3, wherein Re is isopropyl


392.
Et
F
Z3, wherein Re is isopropyl


393.
Et
OCH3
Z3, wherein Re is isopropyl


394.
cPr
H
Z3, wherein Re is isopropyl


395.
cPr
F
Z3, wherein Re is isopropyl


396.
cPr
OCH3
Z3, wherein Re is isopropyl


397.
CH3
H
Z3, wherein Re is cyclopropyl


398.
CH3
F
Z3, wherein Re is cyclopropyl


399.
CH3
OCH3
Z3, wherein Re is cyclopropyl


400.
Et
H
Z3, wherein Re is cyclopropyl


401.
Et
F
Z3, wherein Re is cyclopropyl


402.
Et
OCH3
Z3, wherein Re is cyclopropyl


403.
cPr
H
Z3, wherein Re is cyclopropyl


404.
cPr
F
Z3, wherein Re is cyclopropyl


405.
cPr
OCH3
Z3, wherein Re is cyclopropyl


406.
CH3
H
Z3, wherein Re is cyclobutyl


407.
CH3
F
Z3, wherein Re is cyclobutyl


408.
CH3
OCH3
Z3, wherein Re is cyclobutyl


409.
Et
H
Z3, wherein Re is cyclobutyl


410.
Et
F
Z3, wherein Re is cyclobutyl


411.
Et
OCH3
Z3, wherein Re is cyclobutyl


412.
cPr
H
Z3, wherein Re is cyclobutyl


413.
cPr
F
Z3, wherein Re is cyclobutyl


414.
cPr
OCH3
Z3, wherein Re is cyclobutyl


415.
CH3
H
Z3, wherein Re is CH2-cyclopropyl


416.
CH3
F
Z3, wherein Re is CH2-cyclopropyl


417.
CH3
OCH3
Z3, wherein Re is CH2-cyclopropyl


418.
Et
H
Z3, wherein Re is CH2-cyclopropyl


419.
Et
F
Z3, wherein Re is CH2-cyclopropyl


420.
Et
OCH3
Z3, wherein Re is CH2-cyclopropyl


421.
cPr
H
Z3, wherein Re is CH2-cyclopropyl


422.
cPr
F
Z3, wherein Re is CH2-cyclopropyl


423.
cPr
OCH3
Z3, wherein Re is CH2-cyclopropyl


424.
CH3
H
Z3, wherein Re is CH2CH2OCH3


425.
CH3
F
Z3, wherein Re is CH2CH2OCH3


426.
CH3
OCH3
Z3, wherein Re is CH2CH2OCH3


427.
Et
H
Z3, wherein Re is CH2CH2OCH3


428.
Et
F
Z3, wherein Re is CH2CH2OCH3


429.
Et
OCH3
Z3, wherein Re is CH2CH2OCH3


430.
cPr
H
Z3, wherein Re is CH2CH2OCH3


431.
cPr
F
Z3, wherein Re is CH2CH2OCH3


432.
cPr
OCH3
Z3, wherein Re is CH2CH2OCH3


433.
CH3
H
Z4, wherein Re is CH3


434.
CH3
F
Z4, wherein Re is CH3


435.
CH3
OCH3
Z4, wherein Re is CH3


436.
Et
H
Z4, wherein Re is CH3


437.
Et
F
Z4, wherein Re is CH3


438.
Et
OCH3
Z4, wherein Re is CH3


439.
cPr
H
Z4, wherein Re is CH3


440.
cPr
F
Z4, wherein Re is CH3


441.
cPr
OCH3
Z4, wherein Re is CH3


442.
CH3
H
Z4, wherein Re is ethyl


443.
CH3
F
Z4, wherein Re is ethyl


444.
CH3
OCH3
Z4, wherein Re is ethyl


445.
Et
H
Z4, wherein Re is ethyl


446.
Et
F
Z4, wherein Re is ethyl


447.
Et
OCH3
Z4, wherein Re is ethyl


448.
cPr
H
Z4, wherein Re is ethyl


449.
cPr
F
Z4, wherein Re is ethyl


450.
cPr
OCH3
Z4, wherein Re is ethyl


451.
CH3
H
Z4, wherein Re is n-propyl


452.
CH3
F
Z4, wherein Re is n-propyl


453.
CH3
OCH3
Z4, wherein Re is n-propyl


454.
Et
H
Z4, wherein Re is n-propyl


455.
Et
F
Z4, wherein Re is n-propyl


456.
Et
OCH3
Z4, wherein Re is n-propyl


457.
cPr
H
Z4, wherein Re is n-propyl


458.
cPr
F
Z4, wherein Re is n-propyl


459.
cPr
OCH3
Z4, wherein Re is n-propyl


460.
CH3
H
Z4, wherein Re is isopropyl


461.
CH3
F
Z4, wherein Re is isopropyl


462.
CH3
OCH3
Z4, wherein Re is isopropyl


463.
Et
H
Z4, wherein Re is isopropyl


464.
Et
F
Z4, wherein Re is isopropyl


465.
Et
OCH3
Z4, wherein Re is isopropyl


466.
cPr
H
Z4, wherein Re is isopropyl


467.
cPr
F
Z4, wherein Re is isopropyl


468.
cPr
OCH3
Z4, wherein Re is isopropyl


469.
CH3
H
Z4, wherein Re is cyclopropyl


470.
CH3
F
Z4, wherein Re is cyclopropyl


471.
CH3
OCH3
Z4, wherein Re is cyclopropyl


472.
Et
H
Z4, wherein Re is cyclopropyl


473.
Et
F
Z4, wherein Re is cyclopropyl


474.
Et
OCH3
Z4, wherein Re is cyclopropyl


475.
cPr
H
Z4, wherein Re is cyclopropyl


476.
cPr
F
Z4, wherein Re is cyclopropyl


477.
cPr
OCH3
Z4, wherein Re is cyclopropyl


478.
CH3
H
Z4, wherein Re is cyclobutyl


479.
CH3
F
Z4, wherein Re is cyclobutyl


480.
CH3
OCH3
Z4, wherein Re is cyclobutyl


481.
Et
H
Z4, wherein Re is cyclobutyl


482.
Et
F
Z4, wherein Re is cyclobutyl


483.
Et
OCH3
Z4, wherein Re is cyclobutyl


484.
cPr
H
Z4, wherein Re is cyclobutyl


485.
cPr
F
Z4, wherein Re is cyclobutyl


486.
cPr
OCH3
Z4, wherein Re is cyclobutyl


487.
CH3
H
Z4, wherein Re is CH2-cyclopropyl


488.
CH3
F
Z4, wherein Re is CH2-cyclopropyl


489.
CH3
OCH3
Z4, wherein Re is CH2-cyclopropyl


490.
Et
H
Z4, wherein Re is CH2-cyclopropyl


491.
Et
F
Z4, wherein Re is CH2-cyclopropyl


492.
Et
OCH3
Z4, wherein Re is CH2-cyclopropyl


493.
cPr
H
Z4, wherein Re is CH2-cyclopropyl


494.
cPr
F
Z4, wherein Re is CH2-cyclopropyl


495.
cPr
OCH3
Z4, wherein Re is CH2-cyclopropyl


496.
CH3
H
Z4, wherein Re is CH2CH2OCH3


497.
CH3
F
Z4, wherein Re is CH2CH2OCH3


498.
CH3
OCH3
Z4, wherein Re is CH2CH2OCH3


499.
Et
H
Z4, wherein Re is CH2CH2OCH3


500.
Et
F
Z4, wherein Re is CH2CH2OCH3


501.
Et
OCH3
Z4, wherein Re is CH2CH2OCH3


502.
cPr
H
Z4, wherein Re is CH2CH2OCH3


503.
cPr
F
Z4, wherein Re is CH2CH2OCH3


504.
cPr
OCH3
Z4, wherein Re is CH2CH2OCH3


505.
CH3
H
Z5, wherein Re is CH3


506.
CH3
F
Z5, wherein Re is CH3


507.
CH3
OCH3
Z5, wherein Re is CH3


508.
Et
H
Z5, wherein Re is CH3


509.
Et
F
Z5, wherein Re is CH3


510.
Et
OCH3
Z5, wherein Re is CH3


511.
cPr
H
Z5, wherein Re is CH3


512.
cPr
F
Z5, wherein Re is CH3


513.
cPr
OCH3
Z5, wherein Re is CH3


514.
CH3
H
Z5, wherein Re is ethyl


515.
CH3
F
Z5, wherein Re is ethyl


516.
CH3
OCH3
Z5, wherein Re is ethyl


517.
Et
H
Z5, wherein Re is ethyl


518.
Et
F
Z5, wherein Re is ethyl


519.
Et
OCH3
Z5, wherein Re is ethyl


520.
cPr
H
Z5, wherein Re is ethyl


521.
cPr
F
Z5, wherein Re is ethyl


522.
cPr
OCH3
Z5, wherein Re is ethyl


523.
CH3
H
Z5, wherein Re is n-propyl


524.
CH3
F
Z5, wherein Re is n-propyl


525.
CH3
OCH3
Z5, wherein Re is n-propyl


526.
Et
H
Z5, wherein Re is n-propyl


527.
Et
F
Z5, wherein Re is n-propyl


528.
Et
OCH3
Z5, wherein Re is n-propyl


529.
cPr
H
Z5, wherein Re is n-propyl


530.
cPr
F
Z5, wherein Re is n-propyl


531.
cPr
OCH3
Z5, wherein Re is n-propyl


532.
CH3
H
Z5, wherein Re is isopropyl


533.
CH3
F
Z5, wherein Re is isopropyl


534.
CH3
OCH3
Z5, wherein Re is isopropyl


535.
Et
H
Z5, wherein Re is isopropyl


536.
Et
F
Z5, wherein Re is isopropyl


537.
Et
OCH3
Z5, wherein Re is isopropyl


538.
cPr
H
Z5, wherein Re is isopropyl


539.
cPr
F
Z5, wherein Re is isopropyl


540.
cPr
OCH3
Z5, wherein Re is isopropyl


541.
CH3
H
Z5, wherein Re is cyclopropyl


542.
CH3
F
Z5, wherein Re is cyclopropyl


543.
CH3
OCH3
Z5, wherein Re is cyclopropyl


544.
Et
H
Z5, wherein Re is cyclopropyl


545.
Et
F
Z5, wherein Re is cyclopropyl


546.
Et
OCH3
Z5, wherein Re is cyclopropyl


547.
cPr
H
Z5, wherein Re is cyclopropyl


548.
cPr
F
Z5, wherein Re is cyclopropyl


549.
cPr
OCH3
Z5, wherein Re is cyclopropyl


550.
CH3
H
Z5, wherein Re is cyclobutyl


551.
CH3
F
Z5, wherein Re is cyclobutyl


552.
CH3
OCH3
Z5, wherein Re is cyclobutyl


553.
Et
H
Z5, wherein Re is cyclobutyl


554.
Et
F
Z5, wherein Re is cyclobutyl


555.
Et
OCH3
Z5, wherein Re is cyclobutyl


556.
cPr
H
Z5, wherein Re is cyclobutyl


557.
cPr
F
Z5, wherein Re is cyclobutyl


558.
cPr
OCH3
Z5, wherein Re is cyclobutyl


559.
CH3
H
Z5, wherein Re is CH2-cyclopropyl


560.
CH3
F
Z5, wherein Re is CH2-cyclopropyl


561.
CH3
OCH3
Z5, wherein Re is CH2-cyclopropyl


562.
Et
H
Z5, wherein Re is CH2-cyclopropyl


563.
Et
F
Z5, wherein Re is CH2-cyclopropyl


564.
Et
OCH3
Z5, wherein Re is CH2-cyclopropyl


565.
cPr
H
Z5, wherein Re is CH2-cyclopropyl


566.
cPr
F
Z5, wherein Re is CH2-cyclopropyl


567.
cPr
OCH3
Z5, wherein Re is CH2-cyclopropyl


568.
CH3
H
Z5, wherein Re is CH2CH2OCH3


569.
CH3
F
Z5, wherein Re is CH2CH2OCH3


570.
CH3
OCH3
Z5, wherein Re is CH2CH2OCH3


571.
Et
H
Z5, wherein Re is CH2CH2OCH3


572.
Et
F
Z5, wherein Re is CH2CH2OCH3


573.
Et
OCH3
Z5, wherein Re is CH2CH2OCH3


574.
cPr
H
Z5, wherein Re is CH2CH2OCH3


575.
cPr
F
Z5, wherein Re is CH2CH2OCH3


576.
cPr
OCH3
Z5, wherein Re is CH2CH2OCH3


577.
CH3
H
Z6, wherein Re is CH3


578.
CH3
F
Z6, wherein Re is CH3


579.
CH3
OCH3
Z6, wherein Re is CH3


580.
Et
H
Z6, wherein Re is CH3


581.
Et
F
Z6, wherein Re is CH3


582.
Et
OCH3
Z6, wherein Re is CH3


583.
cPr
H
Z6, wherein Re is CH3


584.
cPr
F
Z6, wherein Re is CH3


585.
cPr
OCH3
Z6, wherein Re is CH3


586.
CH3
H
Z6, wherein Re is ethyl


587.
CH3
F
Z6, wherein Re is ethyl


588.
CH3
OCH3
Z6, wherein Re is ethyl


589.
Et
H
Z6, wherein Re is ethyl


590.
Et
F
Z6, wherein Re is ethyl


591.
Et
OCH3
Z6, wherein Re is ethyl


592.
cPr
H
Z6, wherein Re is ethyl


593.
cPr
F
Z6, wherein Re is ethyl


594.
cPr
OCH3
Z6, wherein Re is ethyl


595.
CH3
H
Z6, wherein Re is n-propyl


596.
CH3
F
Z6, wherein Re is n-propyl


597.
CH3
OCH3
Z6, wherein Re is n-propyl


598.
Et
H
Z6, wherein Re is n-propyl


599.
Et
F
Z6, wherein Re is n-propyl


600.
Et
OCH3
Z6, wherein Re is n-propyl


601.
cPr
H
Z6, wherein Re is n-propyl


602.
cPr
F
Z6, wherein Re is n-propyl


603.
cPr
OCH3
Z6, wherein Re is n-propyl


604.
CH3
H
Z6, wherein Re is isopropyl


605.
CH3
F
Z6, wherein Re is isopropyl


606.
CH3
OCH3
Z6, wherein Re is isopropyl


607.
Et
H
Z6, wherein Re is isopropyl


608.
Et
F
Z6, wherein Re is isopropyl


609.
Et
OCH3
Z6, wherein Re is isopropyl


610.
cPr
H
Z6, wherein Re is isopropyl


611.
cPr
F
Z6, wherein Re is isopropyl


612.
cPr
OCH3
Z6, wherein Re is isopropyl


613.
CH3
H
Z6, wherein Re is cyclopropyl


614.
CH3
F
Z6, wherein Re is cyclopropyl


615.
CH3
OCH3
Z6, wherein Re is cyclopropyl


616.
Et
H
Z6, wherein Re is cyclopropyl


617.
Et
F
Z6, wherein Re is cyclopropyl


618.
Et
OCH3
Z6, wherein Re is cyclopropyl


619.
cPr
H
Z6, wherein Re is cyclopropyl


620.
cPr
F
Z6, wherein Re is cyclopropyl


621.
cPr
OCH3
Z6, wherein Re is cyclopropyl


622.
CH3
H
Z6, wherein Re is cyclobutyl


623.
CH3
F
Z6, wherein Re is cyclobutyl


624.
CH3
OCH3
Z6, wherein Re is cyclobutyl


625.
Et
H
Z6, wherein Re is cyclobutyl


626.
Et
F
Z6, wherein Re is cyclobutyl


627.
Et
OCH3
Z6, wherein Re is cyclobutyl


628.
cPr
H
Z6, wherein Re is cyclobutyl


629.
cPr
F
Z6, wherein Re is cyclobutyl


630.
cPr
OCH3
Z6, wherein Re is cyclobutyl


631.
CH3
H
Z6, wherein Re is CH2-cyclopropyl


632.
CH3
F
Z6, wherein Re is CH2-cyclopropyl


633.
CH3
OCH3
Z6, wherein Re is CH2-cyclopropyl


634.
Et
H
Z6, wherein Re is CH2-cyclopropyl


635.
Et
F
Z6, wherein Re is CH2-cyclopropyl


636.
Et
OCH3
Z6, wherein Re is CH2-cyclopropyl


637.
cPr
H
Z6, wherein Re is CH2-cyclopropyl


638.
cPr
F
Z6, wherein Re is CH2-cyclopropyl


639.
cPr
OCH3
Z6, wherein Re is CH2-cyclopropyl


640.
CH3
H
Z6, wherein Re is CH2CH2OCH3


641.
CH3
F
Z6, wherein Re is CH2CH2OCH3


642.
CH3
OCH3
Z6, wherein Re is CH2CH2OCH3


643.
Et
H
Z6, wherein Re is CH2CH2OCH3


644.
Et
F
Z6, wherein Re is CH2CH2OCH3


645.
Et
OCH3
Z6, wherein Re is CH2CH2OCH3


646.
cPr
H
Z6, wherein Re is CH2CH2OCH3


647.
cPr
F
Z6, wherein Re is CH2CH2OCH3


648.
cPr
OCH3
Z6, wherein Re is CH2CH2OCH3


649.
CH3
H
Z7, wherein Re is CH3


650.
CH3
F
Z7, wherein Re is CH3


651.
CH3
OCH3
Z7, wherein Re is CH3


652.
Et
H
Z7, wherein Re is CH3


653.
Et
F
Z7, wherein Re is CH3


654.
Et
OCH3
Z7, wherein Re is CH3


655.
cPr
H
Z7, wherein Re is CH3


656.
cPr
F
Z7, wherein Re is CH3


657.
cPr
OCH3
Z7, wherein Re is CH3


658.
CH3
H
Z7, wherein Re is ethyl


659.
CH3
F
Z7, wherein Re is ethyl


660.
CH3
OCH3
Z7, wherein Re is ethyl


661.
Et
H
Z7, wherein Re is ethyl


662.
Et
F
Z7, wherein Re is ethyl


663.
Et
OCH3
Z7, wherein Re is ethyl


664.
cPr
H
Z7, wherein Re is ethyl


665.
cPr
F
Z7, wherein Re is ethyl


666.
cPr
OCH3
Z7, wherein Re is ethyl


667.
CH3
H
Z7, wherein Re is n-propyl


668.
CH3
F
Z7, wherein Re is n-propyl


669.
CH3
OCH3
Z7, wherein Re is n-propyl


670.
Et
H
Z7, wherein Re is n-propyl


671.
Et
F
Z7, wherein Re is n-propyl


672.
Et
OCH3
Z7, wherein Re is n-propyl


673.
cPr
H
Z7, wherein Re is n-propyl


674.
cPr
F
Z7, wherein Re is n-propyl


675.
cPr
OCH3
Z7, wherein Re is n-propyl


676.
CH3
H
Z7, wherein Re is isopropyl


677.
CH3
F
Z7, wherein Re is isopropyl


678.
CH3
OCH3
Z7, wherein Re is isopropyl


679.
Et
H
Z7, wherein Re is isopropyl


680.
Et
F
Z7, wherein Re is isopropyl


681.
Et
OCH3
Z7, wherein Re is isopropyl


682.
cPr
H
Z7, wherein Re is isopropyl


683.
cPr
F
Z7, wherein Re is isopropyl


684.
cPr
OCH3
Z7, wherein Re is isopropyl


685.
CH3
H
Z7, wherein Re is cyclopropyl


686.
CH3
F
Z7, wherein Re is cyclopropyl


687.
CH3
OCH3
Z7, wherein Re is cyclopropyl


688.
Et
H
Z7, wherein Re is cyclopropyl


689.
Et
F
Z7, wherein Re is cyclopropyl


690.
Et
OCH3
Z7, wherein Re is cyclopropyl


691.
cPr
H
Z7, wherein Re is cyclopropyl


692.
cPr
F
Z7, wherein Re is cyclopropyl


693.
cPr
OCH3
Z7, wherein Re is cyclopropyl


694.
CH3
H
Z7, wherein Re is cyclobutyl


695.
CH3
F
Z7, wherein Re is cyclobutyl


696.
CH3
OCH3
Z7, wherein Re is cyclobutyl


697.
Et
H
Z7, wherein Re is cyclobutyl


698.
Et
F
Z7, wherein Re is cyclobutyl


699.
Et
OCH3
Z7, wherein Re is cyclobutyl


700.
cPr
H
Z7, wherein Re is cyclobutyl


701.
cPr
F
Z7, wherein Re is cyclobutyl


702.
cPr
OCH3
Z7, wherein Re is cyclobutyl


703.
CH3
H
Z7, wherein Re is CH2-cyclopropyl


704.
CH3
F
Z7, wherein Re is CH2-cyclopropyl


705.
CH3
OCH3
Z7, wherein Re is CH2-cyclopropyl


706.
Et
H
Z7, wherein Re is CH2-cyclopropyl


707.
Et
F
Z7, wherein Re is CH2-cyclopropyl


708.
Et
OCH3
Z7, wherein Re is CH2-cyclopropyl


709.
cPr
H
Z7, wherein Re is CH2-cyclopropyl


710.
cPr
F
Z7, wherein Re is CH2-cyclopropyl


711.
cPr
OCH3
Z7, wherein Re is CH2-cyclopropyl


712.
CH3
H
Z7, wherein Re is CH2CH2OCH3


713.
CH3
F
Z7, wherein Re is CH2CH2OCH3


714.
CH3
OCH3
Z7, wherein Re is CH2CH2OCH3


715.
Et
H
Z7, wherein Re is CH2CH2OCH3


716.
Et
F
Z7, wherein Re is CH2CH2OCH3


717.
Et
OCH3
Z7, wherein Re is CH2CH2OCH3


718.
cPr
H
Z7, wherein Re is CH2CH2OCH3


719.
cPr
F
Z7, wherein Re is CH2CH2OCH3


720.
cPr
OCH3
Z7, wherein Re is CH2CH2OCH3


721.
CH3
H
Z8, wherein Re is CH3


722.
CH3
F
Z8, wherein Re is CH3


723.
CH3
OCH3
Z8, wherein Re is CH3


724.
Et
H
Z8, wherein Re is CH3


725.
Et
F
Z8, wherein Re is CH3


726.
Et
OCH3
Z8, wherein Re is CH3


727.
cPr
H
Z8, wherein Re is CH3


728.
cPr
F
Z8, wherein Re is CH3


729.
cPr
OCH3
Z8, wherein Re is CH3


730.
CH3
H
Z8, wherein Re is ethyl


731.
CH3
F
Z8, wherein Re is ethyl


732.
CH3
OCH3
Z8, wherein Re is ethyl


733.
Et
H
Z8, wherein Re is ethyl


734.
Et
F
Z8, wherein Re is ethyl


735.
Et
OCH3
Z8, wherein Re is ethyl


736.
cPr
H
Z8, wherein Re is ethyl


737.
cPr
F
Z8, wherein Re is ethyl


738.
cPr
OCH3
Z8, wherein Re is ethyl


739.
CH3
H
Z8, wherein Re is n-propyl


740.
CH3
F
Z8, wherein Re is n-propyl


741.
CH3
OCH3
Z8, wherein Re is n-propyl


742.
Et
H
Z8, wherein Re is n-propyl


743.
Et
F
Z8, wherein Re is n-propyl


744.
Et
OCH3
Z8, wherein Re is n-propyl


745.
cPr
H
Z8, wherein Re is n-propyl


746.
cPr
F
Z8, wherein Re is n-propyl


747.
cPr
OCH3
Z8, wherein Re is n-propyl


748.
CH3
H
Z8, wherein Re is isopropyl


749.
CH3
F
Z8, wherein Re is isopropyl


750.
CH3
OCH3
Z8, wherein Re is isopropyl


751.
Et
H
Z8, wherein Re is isopropyl


752.
Et
F
Z8, wherein Re is isopropyl


753.
Et
OCH3
Z8, wherein Re is isopropyl


754.
cPr
H
Z8, wherein Re is isopropyl


755.
cPr
F
Z8, wherein Re is isopropyl


756.
cPr
OCH3
Z8, wherein Re is isopropyl


757.
CH3
H
Z8, wherein Re is cyclopropyl


758.
CH3
F
Z8, wherein Re is cyclopropyl


759.
CH3
OCH3
Z8, wherein Re is cyclopropyl


760.
Et
H
Z8, wherein Re is cyclopropyl


761.
Et
F
Z8, wherein Re is cyclopropyl


762.
Et
OCH3
Z8, wherein Re is cyclopropyl


763.
cPr
H
Z8, wherein Re is cyclopropyl


764.
cPr
F
Z8, wherein Re is cyclopropyl


765.
cPr
OCH3
Z8, wherein Re is cyclopropyl


766.
CH3
H
Z8, wherein Re is cyclobutyl


767.
CH3
F
Z8, wherein Re is cyclobutyl


768.
CH3
OCH3
Z8, wherein Re is cyclobutyl


769.
Et
H
Z8, wherein Re is cyclobutyl


770.
Et
F
Z8, wherein Re is cyclobutyl


771.
Et
OCH3
Z8, wherein Re is cyclobutyl


772.
cPr
H
Z8, wherein Re is cyclobutyl


773.
cPr
F
Z8, wherein Re is cyclobutyl


774.
cPr
OCH3
Z8, wherein Re is cyclobutyl


775.
CH3
H
Z8, wherein Re is CH2-cyclopropyl


776.
CH3
F
Z8, wherein Re is CH2-cyclopropyl


777.
CH3
OCH3
Z8, wherein Re is CH2-cyclopropyl


778.
Et
H
Z8, wherein Re is CH2-cyclopropyl


779.
Et
F
Z8, wherein Re is CH2-cyclopropyl


780.
Et
OCH3
Z8, wherein Re is CH2-cyclopropyl


781.
cPr
H
Z8, wherein Re is CH2-cyclopropyl


782.
cPr
F
Z8, wherein Re is CH2-cyclopropyl


783.
cPr
OCH3
Z8, wherein Re is CH2-cyclopropyl


784.
CH3
H
Z8, wherein Re is CH2CH2OCH3


785.
CH3
F
Z8, wherein Re is CH2CH2OCH3


786.
CH3
OCH3
Z8, wherein Re is CH2CH2OCH3


787.
Et
H
Z8, wherein Re is CH2CH2OCH3


788.
Et
F
Z8, wherein Re is CH2CH2OCH3


789.
Et
OCH3
Z8, wherein Re is CH2CH2OCH3


790.
cPr
H
Z8, wherein Re is CH2CH2OCH3


791.
cPr
F
Z8, wherein Re is CH2CH2OCH3


792.
cPr
OCH3
Z8, wherein Re is CH2CH2OCH3


793.
CH3
H
Z9, wherein Re is CH3


794.
CH3
F
Z9, wherein Re is CH3


795.
CH3
OCH3
Z9, wherein Re is CH3


796.
Et
H
Z9, wherein Re is CH3


797.
Et
F
Z9, wherein Re is CH3


798.
Et
OCH3
Z9, wherein Re is CH3


799.
cPr
H
Z9, wherein Re is CH3


800.
cPr
F
Z9, wherein Re is CH3


801.
cPr
OCH3
Z9, wherein Re is CH3


802.
CH3
H
Z9, wherein Re is ethyl


803.
CH3
F
Z9, wherein Re is ethyl


804.
CH3
OCH3
Z9, wherein Re is ethyl


805.
Et
H
Z9, wherein Re is ethyl


806.
Et
F
Z9, wherein Re is ethyl


807.
Et
OCH3
Z9, wherein Re is ethyl


808.
cPr
H
Z9, wherein Re is ethyl


809.
cPr
F
Z9, wherein Re is ethyl


810.
cPr
OCH3
Z9, wherein Re is ethyl


811.
CH3
H
Z9, wherein Re is n-propyl


812.
CH3
F
Z9, wherein Re is n-propyl


813.
CH3
OCH3
Z9, wherein Re is n-propyl


814.
Et
H
Z9, wherein Re is n-propyl


815.
Et
F
Z9, wherein Re is n-propyl


816.
Et
OCH3
Z9, wherein Re is n-propyl


817.
cPr
H
Z9, wherein Re is n-propyl


818.
cPr
F
Z9, wherein Re is n-propyl


819.
cPr
OCH3
Z9, wherein Re is n-propyl


820.
CH3
H
Z9, wherein Re is isopropyl


821.
CH3
F
Z9, wherein Re is isopropyl


822.
CH3
OCH3
Z9, wherein Re is isopropyl


823.
Et
H
Z9, wherein Re is isopropyl


824.
Et
F
Z9, wherein Re is isopropyl


825.
Et
OCH3
Z9, wherein Re is isopropyl


826.
cPr
H
Z9, wherein Re is isopropyl


827.
cPr
F
Z9, wherein Re is isopropyl


828.
cPr
OCH3
Z9, wherein Re is isopropyl


829.
CH3
H
Z9, wherein Re is cyclopropyl


830.
CH3
F
Z9, wherein Re is cyclopropyl


831.
CH3
OCH3
Z9, wherein Re is cyclopropyl


832.
Et
H
Z9, wherein Re is cyclopropyl


833.
Et
F
Z9, wherein Re is cyclopropyl


834.
Et
OCH3
Z9, wherein Re is cyclopropyl


835.
cPr
H
Z9, wherein Re is cyclopropyl


836.
cPr
F
Z9, wherein Re is cyclopropyl


837.
cPr
OCH3
Z9, wherein Re is cyclopropyl


838.
CH3
H
Z9, wherein Re is cyclobutyl


839.
CH3
F
Z9, wherein Re is cyclobutyl


840.
CH3
OCH3
Z9, wherein Re is cyclobutyl


841.
Et
H
Z9, wherein Re is cyclobutyl


842.
Et
F
Z9, wherein Re is cyclobutyl


843.
Et
OCH3
Z9, wherein Re is cyclobutyl


844.
cPr
H
Z9, wherein Re is cyclobutyl


845.
cPr
F
Z9, wherein Re is cyclobutyl


846.
cPr
OCH3
Z9, wherein Re is cyclobutyl


847.
CH3
H
Z9, wherein Re is CH2-cyclopropyl


848.
CH3
F
Z9, wherein Re is CH2-cyclopropyl


849.
CH3
OCH3
Z9, wherein Re is CH2-cyclopropyl


850.
Et
H
Z9, wherein Re is CH2-cyclopropyl


851.
Et
F
Z9, wherein Re is CH2-cyclopropyl


852.
Et
OCH3
Z9, wherein Re is CH2-cyclopropyl


853.
cPr
H
Z9, wherein Re is CH2-cyclopropyl


854.
cPr
F
Z9, wherein Re is CH2-cyclopropyl


855.
cPr
OCH3
Z9, wherein Re is CH2-cyclopropyl


856.
CH3
H
Z9, wherein Re is CH2CH2OCH3


857.
CH3
F
Z9, wherein Re is CH2CH2OCH3


858.
CH3
OCH3
Z9, wherein Re is CH2CH2OCH3


859.
Et
H
Z9, wherein Re is CH2CH2OCH3


860.
Et
F
Z9, wherein Re is CH2CH2OCH3


861.
Et
OCH3
Z9, wherein Re is CH2CH2OCH3


862.
cPr
H
Z9, wherein Re is CH2CH2OCH3


863.
cPr
F
Z9, wherein Re is CH2CH2OCH3


864.
cPr
OCH3
Z9, wherein Re is CH2CH2OCH3


865.
CH3
H
Z10, wherein Re is CH3


866.
CH3
F
Z10, wherein Re is CH3


867.
CH3
OCH3
Z10, wherein Re is CH3


868.
Et
H
Z10, wherein Re is CH3


869.
Et
F
Z10, wherein Re is CH3


870.
Et
OCH3
Z10, wherein Re is CH3


871.
cPr
H
Z10, wherein Re is CH3


872.
cPr
F
Z10, wherein Re is CH3


873.
cPr
OCH3
Z10, wherein Re is CH3


874.
CH3
H
Z10, wherein Re is ethyl


875.
CH3
F
Z10, wherein Re is ethyl


876.
CH3
OCH3
Z10, wherein Re is ethyl


877.
Et
H
Z10, wherein Re is ethyl


878.
Et
F
Z10, wherein Re is ethyl


879.
Et
OCH3
Z10, wherein Re is ethyl


880.
cPr
H
Z10, wherein Re is ethyl


881.
cPr
F
Z10, wherein Re is ethyl


882.
cPr
OCH3
Z10, wherein Re is ethyl


883.
CH3
H
Z10, wherein Re is n-propyl


884.
CH3
F
Z10, wherein Re is n-propyl


885.
CH3
OCH3
Z10, wherein Re is n-propyl


886.
Et
H
Z10, wherein Re is n-propyl


887.
Et
F
Z10, wherein Re is n-propyl


888.
Et
OCH3
Z10, wherein Re is n-propyl


889.
cPr
H
Z10, wherein Re is n-propyl


890.
cPr
F
Z10, wherein Re is n-propyl


891.
cPr
OCH3
Z10, wherein Re is n-propyl


892.
CH3
H
Z10, wherein Re is isopropyl


893.
CH3
F
Z10, wherein Re is isopropyl


894.
CH3
OCH3
Z10, wherein Re is isopropyl


895.
Et
H
Z10, wherein Re is isopropyl


896.
Et
F
Z10, wherein Re is isopropyl


897.
Et
OCH3
Z10, wherein Re is isopropyl


898.
cPr
H
Z10, wherein Re is isopropyl


899.
cPr
F
Z10, wherein Re is isopropyl


900.
cPr
OCH3
Z10, wherein Re is isopropyl


901.
CH3
H
Z10, wherein Re is cyclopropyl


902.
CH3
F
Z10, wherein Re is cyclopropyl


903.
CH3
OCH3
Z10, wherein Re is cyclopropyl


904.
Et
H
Z10, wherein Re is cyclopropyl


905.
Et
F
Z10, wherein Re is cyclopropyl


906.
Et
OCH3
Z10, wherein Re is cyclopropyl


907.
cPr
H
Z10, wherein Re is cyclopropyl


908.
cPr
F
Z10, wherein Re is cyclopropyl


909.
cPr
OCH3
Z10, wherein Re is cyclopropyl


910.
CH3
H
Z10, wherein Re is cyclobutyl


911.
CH3
F
Z10, wherein Re is cyclobutyl


912.
CH3
OCH3
Z10, wherein Re is cyclobutyl


913.
Et
H
Z10, wherein Re is cyclobutyl


914.
Et
F
Z10, wherein Re is cyclobutyl


915.
Et
OCH3
Z10, wherein Re is cyclobutyl


916.
cPr
H
Z10, wherein Re is cyclobutyl


917.
cPr
F
Z10, wherein Re is cyclobutyl


918.
cPr
OCH3
Z10, wherein Re is cyclobutyl


919.
CH3
H
Z10, wherein Re is CH2-cyclopropyl


920.
CH3
F
Z10, wherein Re is CH2-cyclopropyl


921.
CH3
OCH3
Z10, wherein Re is CH2-cyclopropyl


922.
Et
H
Z10, wherein Re is CH2-cyclopropyl


923.
Et
F
Z10, wherein Re is CH2-cyclopropyl


924.
Et
OCH3
Z10, wherein Re is CH2-cyclopropyl


925.
cPr
H
Z10, wherein Re is CH2-cyclopropyl


926.
cPr
F
Z10, wherein Re is CH2-cyclopropyl


927.
cPr
OCH3
Z10, wherein Re is CH2-cyclopropyl


928.
CH3
H
Z10, wherein Re is CH2CH2OCH3


929.
CH3
F
Z10, wherein Re is CH2CH2OCH3


930.
CH3
OCH3
Z10, wherein Re is CH2CH2OCH3


931.
Et
H
Z10, wherein Re is CH2CH2OCH3


932.
Et
F
Z10, wherein Re is CH2CH2OCH3


933.
Et
OCH3
Z10, wherein Re is CH2CH2OCH3


934.
cPr
H
Z10, wherein Re is CH2CH2OCH3


935.
cPr
F
Z10, wherein Re is CH2CH2OCH3


936.
cPr
OCH3
Z10, wherein Re is CH2CH2OCH3


937.
CH3
H
Z11, wherein Re is CH3


938.
CH3
F
Z11, wherein Re is CH3


939.
CH3
OCH3
Z11, wherein Re is CH3


940.
Et
H
Z11, wherein Re is CH3


941.
Et
F
Z11, wherein Re is CH3


942.
Et
OCH3
Z11, wherein Re is CH3


943.
cPr
H
Z11, wherein Re is CH3


944.
cPr
F
Z11, wherein Re is CH3


945.
cPr
OCH3
Z11, wherein Re is CH3


946.
CH3
H
Z11, wherein Re is ethyl


947.
CH3
F
Z11, wherein Re is ethyl


948.
CH3
OCH3
Z11, wherein Re is ethyl


949.
Et
H
Z11, wherein Re is ethyl


950.
Et
F
Z11, wherein Re is ethyl


951.
Et
OCH3
Z11, wherein Re is ethyl


952.
cPr
H
Z11, wherein Re is ethyl


953.
cPr
F
Z11, wherein Re is ethyl


954.
cPr
OCH3
Z11, wherein Re is ethyl


955.
CH3
H
Z11, wherein Re is n-propyl


956.
CH3
F
Z11, wherein Re is n-propyl


957.
CH3
OCH3
Z11, wherein Re is n-propyl


958.
Et
H
Z11, wherein Re is n-propyl


959.
Et
F
Z11, wherein Re is n-propyl


960.
Et
OCH3
Z11, wherein Re is n-propyl


961.
cPr
H
Z11, wherein Re is n-propyl


962.
cPr
F
Z11, wherein Re is n-propyl


963.
cPr
OCH3
Z11, wherein Re is n-propyl


964.
CH3
H
Z11, wherein Re is isopropyl


965.
CH3
F
Z11, wherein Re is isopropyl


966.
CH3
OCH3
Z11, wherein Re is isopropyl


967.
Et
H
Z11, wherein Re is isopropyl


968.
Et
F
Z11, wherein Re is isopropyl


969.
Et
OCH3
Z11, wherein Re is isopropyl


970.
cPr
H
Z11, wherein Re is isopropyl


971.
cPr
F
Z11, wherein Re is isopropyl


972.
cPr
OCH3
Z11, wherein Re is isopropyl


973.
CH3
H
Z11, wherein Re is cyclopropyl


974.
CH3
F
Z11, wherein Re is cyclopropyl


975.
CH3
OCH3
Z11, wherein Re is cyclopropyl


976.
Et
H
Z11, wherein Re is cyclopropyl


977.
Et
F
Z11, wherein Re is cyclopropyl


978.
Et
OCH3
Z11, wherein Re is cyclopropyl


979.
cPr
H
Z11, wherein Re is cyclopropyl


980.
cPr
F
Z11, wherein Re is cyclopropyl


981.
cPr
OCH3
Z11, wherein Re is cyclopropyl


982.
CH3
H
Z11, wherein Re is cyclobutyl


983.
CH3
F
Z11, wherein Re is cyclobutyl


984.
CH3
OCH3
Z11, wherein Re is cyclobutyl


985.
Et
H
Z11, wherein Re is cyclobutyl


986.
Et
F
Z11, wherein Re is cyclobutyl


987.
Et
OCH3
Z11, wherein Re is cyclobutyl


988.
cPr
H
Z11, wherein Re is cyclobutyl


989.
cPr
F
Z11, wherein Re is cyclobutyl


990.
cPr
OCH3
Z11, wherein Re is cyclobutyl


991.
CH3
H
Z11, wherein Re is CH2-cyclopropyl


992.
CH3
F
Z11, wherein Re is CH2-cyclopropyl


993.
CH3
OCH3
Z11, wherein Re is CH2-cyclopropyl


994.
Et
H
Z11, wherein Re is CH2-cyclopropyl


995.
Et
F
Z11, wherein Re is CH2-cyclopropyl


996.
Et
OCH3
Z11, wherein Re is CH2-cyclopropyl


997.
cPr
H
Z11, wherein Re is CH2-cyclopropyl


998.
cPr
F
Z11, wherein Re is CH2-cyclopropyl


999.
cPr
OCH3
Z11, wherein Re is CH2-cyclopropyl


1000.
CH3
H
Z11, wherein Re is CH2CH2OCH3


1001.
CH3
F
Z11, wherein Re is CH2CH2OCH3


1002.
CH3
OCH3
Z11, wherein Re is CH2CH2OCH3


1003.
Et
H
Z11, wherein Re is CH2CH2OCH3


1004.
Et
F
Z11, wherein Re is CH2CH2OCH3


1005.
Et
OCH3
Z11, wherein Re is CH2CH2OCH3


1006.
cPr
H
Z11, wherein Re is CH2CH2OCH3


1007.
cPr
F
Z11, wherein Re is CH2CH2OCH3


1008.
cPr
OCH3
Z11, wherein Re is CH2CH2OCH3


1009.
CH3
H
Z12, wherein Re is CH3


1010.
CH3
F
Z12, wherein Re is CH3


1011.
CH3
OCH3
Z12, wherein Re is CH3


1012.
Et
H
Z12, wherein Re is CH3


1013.
Et
F
Z12, wherein Re is CH3


1014.
Et
OCH3
Z12, wherein Re is CH3


1015.
cPr
H
Z12, wherein Re is CH3


1016.
cPr
F
Z12, wherein Re is CH3


1017.
cPr
OCH3
Z12, wherein Re is CH3


1018.
CH3
H
Z12, wherein Re is ethyl


1019.
CH3
F
Z12, wherein Re is ethyl


1020.
CH3
OCH3
Z12, wherein Re is ethyl


1021.
Et
H
Z12, wherein Re is ethyl


1022.
Et
F
Z12, wherein Re is ethyl


1023.
Et
OCH3
Z12, wherein Re is ethyl


1024.
cPr
H
Z12, wherein Re is ethyl


1025.
cPr
F
Z12, wherein Re is ethyl


1026.
cPr
OCH3
Z12, wherein Re is ethyl


1027.
CH3
H
Z12, wherein Re is n-propyl


1028.
CH3
F
Z12, wherein Re is n-propyl


1029.
CH3
OCH3
Z12, wherein Re is n-propyl


1030.
Et
H
Z12, wherein Re is n-propyl


1031.
Et
F
Z12, wherein Re is n-propyl


1032.
Et
OCH3
Z12, wherein Re is n-propyl


1033.
cPr
H
Z12, wherein Re is n-propyl


1034.
cPr
F
Z12, wherein Re is n-propyl


1035.
cPr
OCH3
Z12, wherein Re is n-propyl


1036.
CH3
H
Z12, wherein Re is isopropyl


1037.
CH3
F
Z12, wherein Re is isopropyl


1038.
CH3
OCH3
Z12, wherein Re is isopropyl


1039.
Et
H
Z12, wherein Re is isopropyl


1040.
Et
F
Z12, wherein Re is isopropyl


1041.
Et
OCH3
Z12, wherein Re is isopropyl


1042.
cPr
H
Z12, wherein Re is isopropyl


1043.
cPr
F
Z12, wherein Re is isopropyl


1044.
cPr
OCH3
Z12, wherein Re is isopropyl


1045.
CH3
H
Z12, wherein Re is cyclopropyl


1046.
CH3
F
Z12, wherein Re is cyclopropyl


1047.
CH3
OCH3
Z12, wherein Re is cyclopropyl


1048.
Et
H
Z12, wherein Re is cyclopropyl


1049.
Et
F
Z12, wherein Re is cyclopropyl


1050.
Et
OCH3
Z12, wherein Re is cyclopropyl


1051.
cPr
H
Z12, wherein Re is cyclopropyl


1052.
cPr
F
Z12, wherein Re is cyclopropyl


1053.
cPr
OCH3
Z12, wherein Re is cyclopropyl


1054.
CH3
H
Z12, wherein Re is cyclobutyl


1055.
CH3
F
Z12, wherein Re is cyclobutyl


1056.
CH3
OCH3
Z12, wherein Re is cyclobutyl


1057.
Et
H
Z12, wherein Re is cyclobutyl


1058.
Et
F
Z12, wherein Re is cyclobutyl


1059.
Et
OCH3
Z12, wherein Re is cyclobutyl


1060.
cPr
H
Z12, wherein Re is cyclobutyl


1061.
cPr
F
Z12, wherein Re is cyclobutyl


1062.
cPr
OCH3
Z12, wherein Re is cyclobutyl


1063.
CH3
H
Z12, wherein Re is CH2-cyclopropyl


1064.
CH3
F
Z12, wherein Re is CH2-cyclopropyl


1065.
CH3
OCH3
Z12, wherein Re is CH2-cyclopropyl


1066.
Et
H
Z12, wherein Re is CH2-cyclopropyl


1067.
Et
F
Z12, wherein Re is CH2-cyclopropyl


1068.
Et
OCH3
Z12, wherein Re is CH2-cyclopropyl


1069.
cPr
H
Z12, wherein Re is CH2-cyclopropyl


1070.
cPr
F
Z12, wherein Re is CH2-cyclopropyl


1071.
cPr
OCH3
Z12, wherein Re is CH2-cyclopropyl


1072.
CH3
H
Z12, wherein Re is CH2CH2OCH3


1073.
CH3
F
Z12, wherein Re is CH2CH2OCH3


1074.
CH3
OCH3
Z12, wherein Re is CH2CH2OCH3


1075.
Et
H
Z12, wherein Re is CH2CH2OCH3


1076.
Et
F
Z12, wherein Re is CH2CH2OCH3


1077.
Et
OCH3
Z12, wherein Re is CH2CH2OCH3


1078.
cPr
H
Z12, wherein Re is CH2CH2OCH3


1079.
cPr
F
Z12, wherein Re is CH2CH2OCH3


1080.
cPr
OCH3
Z12, wherein Re is CH2CH2OCH3


1081.
CH3
H
Z13, wherein Re is CH3


1082.
CH3
F
Z13, wherein Re is CH3


1083.
CH3
OCH3
Z13, wherein Re is CH3


1084.
Et
H
Z13, wherein Re is CH3


1085.
Et
F
Z13, wherein Re is CH3


1086.
Et
OCH3
Z13, wherein Re is CH3


1087.
cPr
H
Z13, wherein Re is CH3


1088.
cPr
F
Z13, wherein Re is CH3


1089.
cPr
OCH3
Z13, wherein Re is CH3


1090.
CH3
H
Z13, wherein Re is ethyl


1091.
CH3
F
Z13, wherein Re is ethyl


1092.
CH3
OCH3
Z13, wherein Re is ethyl


1093.
Et
H
Z13, wherein Re is ethyl


1094.
Et
F
Z13, wherein Re is ethyl


1095.
Et
OCH3
Z13, wherein Re is ethyl


1096.
cPr
H
Z13, wherein Re is ethyl


1097.
cPr
F
Z13, wherein Re is ethyl


1098.
cPr
OCH3
Z13, wherein Re is ethyl


1099.
CH3
H
Z13, wherein Re is n-propyl


1100.
CH3
F
Z13, wherein Re is n-propyl


1101.
CH3
OCH3
Z13, wherein Re is n-propyl


1102.
Et
H
Z13, wherein Re is n-propyl


1103.
Et
F
Z13, wherein Re is n-propyl


1104.
Et
OCH3
Z13, wherein Re is n-propyl


1105.
cPr
H
Z13, wherein Re is n-propyl


1106.
cPr
F
Z13, wherein Re is n-propyl


1107.
cPr
OCH3
Z13, wherein Re is n-propyl


1108.
CH3
H
Z13, wherein Re is isopropyl


1109.
CH3
F
Z13, wherein Re is isopropyl


1110.
CH3
OCH3
Z13, wherein Re is isopropyl


1111.
Et
H
Z13, wherein Re is isopropyl


1112.
Et
F
Z13, wherein Re is isopropyl


1113.
Et
OCH3
Z13, wherein Re is isopropyl


1114.
cPr
H
Z13, wherein Re is isopropyl


1115.
cPr
F
Z13, wherein Re is isopropyl


1116.
cPr
OCH3
Z13, wherein Re is isopropyl


1117.
CH3
H
Z13, wherein Re is cyclopropyl


1118.
CH3
F
Z13, wherein Re is cyclopropyl


1119.
CH3
OCH3
Z13, wherein Re is cyclopropyl


1120.
Et
H
Z13, wherein Re is cyclopropyl


1121.
Et
F
Z13, wherein Re is cyclopropyl


1122.
Et
OCH3
Z13, wherein Re is cyclopropyl


1123.
cPr
H
Z13, wherein Re is cyclopropyl


1124.
cPr
F
Z13, wherein Re is cyclopropyl


1125.
cPr
OCH3
Z13, wherein Re is cyclopropyl


1126.
CH3
H
Z13, wherein Re is cyclobutyl


1127.
CH3
F
Z13, wherein Re is cyclobutyl


1128.
CH3
OCH3
Z13, wherein Re is cyclobutyl


1129.
Et
H
Z13, wherein Re is cyclobutyl


1130.
Et
F
Z13, wherein Re is cyclobutyl


1131.
Et
OCH3
Z13, wherein Re is cyclobutyl


1132.
cPr
H
Z13, wherein Re is cyclobutyl


1133.
cPr
F
Z13, wherein Re is cyclobutyl


1134.
cPr
OCH3
Z13, wherein Re is cyclobutyl


1135.
CH3
H
Z13, wherein Re is CH2-cyclopropyl


1136.
CH3
F
Z13, wherein Re is CH2-cyclopropyl


1137.
CH3
OCH3
Z13, wherein Re is CH2-cyclopropyl


1138.
Et
H
Z13, wherein Re is CH2-cyclopropyl


1139.
Et
F
Z13, wherein Re is CH2-cyclopropyl


1140.
Et
OCH3
Z13, wherein Re is CH2-cyclopropyl


1141.
cPr
H
Z13, wherein Re is CH2-cyclopropyl


1142.
cPr
F
Z13, wherein Re is CH2-cyclopropyl


1143.
cPr
OCH3
Z13, wherein Re is CH2-cyclopropyl


1144.
CH3
H
Z13, wherein Re is CH2CH2OCH3


1145.
CH3
F
Z13, wherein Re is CH2CH2OCH3


1146.
CH3
OCH3
Z13, wherein Re is CH2CH2OCH3


1147.
Et
H
Z13, wherein Re is CH2CH2OCH3


1148.
Et
F
Z13, wherein Re is CH2CH2OCH3


1149.
Et
OCH3
Z13, wherein Re is CH2CH2OCH3


1150.
cPr
H
Z13, wherein Re is CH2CH2OCH3


1151.
cPr
F
Z13, wherein Re is CH2CH2OCH3


1152.
cPr
OCH3
Z13, wherein Re is CH2CH2OCH3


1153.
CH3
H
Z14, wherein Re is CH3


1154.
CH3
F
Z14, wherein Re is CH3


1155.
CH3
OCH3
Z14, wherein Re is CH3


1156.
Et
H
Z14, wherein Re is CH3


1157.
Et
F
Z14, wherein Re is CH3


1158.
Et
OCH3
Z14, wherein Re is CH3


1159.
cPr
H
Z14, wherein Re is CH3


1160.
cPr
F
Z14, wherein Re is CH3


1161.
cPr
OCH3
Z14, wherein Re is CH3


1162.
CH3
H
Z14, wherein Re is ethyl


1163.
CH3
F
Z14, wherein Re is ethyl


1164.
CH3
OCH3
Z14, wherein Re is ethyl


1165.
Et
H
Z14, wherein Re is ethyl


1166.
Et
F
Z14, wherein Re is ethyl


1167.
Et
OCH3
Z14, wherein Re is ethyl


1168.
cPr
H
Z14, wherein Re is ethyl


1169.
cPr
F
Z14, wherein Re is ethyl


1170.
cPr
OCH3
Z14, wherein Re is ethyl


1171.
CH3
H
Z14, wherein Re is n-propyl


1172.
CH3
F
Z14, wherein Re is n-propyl


1173.
CH3
OCH3
Z14, wherein Re is n-propyl


1174.
Et
H
Z14, wherein Re is n-propyl


1175.
Et
F
Z14, wherein Re is n-propyl


1176.
Et
OCH3
Z14, wherein Re is n-propyl


1177.
cPr
H
Z14, wherein Re is n-propyl


1178.
cPr
F
Z14, wherein Re is n-propyl


1179.
cPr
OCH3
Z14, wherein Re is n-propyl


1180.
CH3
H
Z14, wherein Re is isopropyl


1181.
CH3
F
Z14, wherein Re is isopropyl


1182.
CH3
OCH3
Z14, wherein Re is isopropyl


1183.
Et
H
Z14, wherein Re is isopropyl


1184.
Et
F
Z14, wherein Re is isopropyl


1185.
Et
OCH3
Z14, wherein Re is isopropyl


1186.
cPr
H
Z14, wherein Re is isopropyl


1187.
cPr
F
Z14, wherein Re is isopropyl


1188.
cPr
OCH3
Z14, wherein Re is isopropyl


1189.
CH3
H
Z14, wherein Re is cyclopropyl


1190.
CH3
F
Z14, wherein Re is cyclopropyl


1191.
CH3
OCH3
Z14, wherein Re is cyclopropyl


1192.
Et
H
Z14, wherein Re is cyclopropyl


1193.
Et
F
Z14, wherein Re is cyclopropyl


1194.
Et
OCH3
Z14, wherein Re is cyclopropyl


1195.
cPr
H
Z14, wherein Re is cyclopropyl


1196.
cPr
F
Z14, wherein Re is cyclopropyl


1197.
cPr
OCH3
Z14, wherein Re is cyclopropyl


1198.
CH3
H
Z14, wherein Re is cyclobutyl


1199.
CH3
F
Z14, wherein Re is cyclobutyl


1200.
CH3
OCH3
Z14, wherein Re is cyclobutyl


1201.
Et
H
Z14, wherein Re is cyclobutyl


1202.
Et
F
Z14, wherein Re is cyclobutyl


1203.
Et
OCH3
Z14, wherein Re is cyclobutyl


1204.
cPr
H
Z14, wherein Re is cyclobutyl


1205.
cPr
F
Z14, wherein Re is cyclobutyl


1206.
cPr
OCH3
Z14, wherein Re is cyclobutyl


1207.
CH3
H
Z14, wherein Re is CH2-cyclopropyl


1208.
CH3
F
Z14, wherein Re is CH2-cyclopropyl


1209.
CH3
OCH3
Z14, wherein Re is CH2-cyclopropyl


1210.
Et
H
Z14, wherein Re is CH2-cyclopropyl


1211.
Et
F
Z14, wherein Re is CH2-cyclopropyl


1212.
Et
OCH3
Z14, wherein Re is CH2-cyclopropyl


1213.
cPr
H
Z14, wherein Re is CH2-cyclopropyl


1214.
cPr
F
Z14, wherein Re is CH2-cyclopropyl


1215.
cPr
OCH3
Z14, wherein Re is CH2-cyclopropyl


1216.
CH3
H
Z14, wherein Re is CH2CH2OCH3


1217.
CH3
F
Z14, wherein Re is CH2CH2OCH3


1218.
CH3
OCH3
Z14, wherein Re is CH2CH2OCH3


1219.
Et
H
Z14, wherein Re is CH2CH2OCH3


1220.
Et
F
Z14, wherein Re is CH2CH2OCH3


1221.
Et
OCH3
Z14, wherein Re is CH2CH2OCH3


1222.
cPr
H
Z14, wherein Re is CH2CH2OCH3


1223.
cPr
F
Z14, wherein Re is CH2CH2OCH3


1224.
cPr
OCH3
Z14, wherein Re is CH2CH2OCH3


1225.
CH3
H
Z15, wherein Re is CH3


1226.
CH3
F
Z15, wherein Re is CH3


1227.
CH3
OCH3
Z15, wherein Re is CH3


1228.
Et
H
Z15, wherein Re is CH3


1229.
Et
F
Z15, wherein Re is CH3


1230.
Et
OCH3
Z15, wherein Re is CH3


1231.
cPr
H
Z15, wherein Re is CH3


1232.
cPr
F
Z15, wherein Re is CH3


1233.
cPr
OCH3
Z15, wherein Re is CH3


1234.
CH3
H
Z15, wherein Re is ethyl


1235.
CH3
F
Z15, wherein Re is ethyl


1236.
CH3
OCH3
Z15, wherein Re is ethyl


1237.
Et
H
Z15, wherein Re is ethyl


1238.
Et
F
Z15, wherein Re is ethyl


1239.
Et
OCH3
Z15, wherein Re is ethyl


1240.
cPr
H
Z15, wherein Re is ethyl


1241.
cPr
F
Z15, wherein Re is ethyl


1242.
cPr
OCH3
Z15, wherein Re is ethyl


1243.
CH3
H
Z15, wherein Re is n-propyl


1244.
CH3
F
Z15, wherein Re is n-propyl


1245.
CH3
OCH3
Z15, wherein Re is n-propyl


1246.
Et
H
Z15, wherein Re is n-propyl


1247.
Et
F
Z15, wherein Re is n-propyl


1248.
Et
OCH3
Z15, wherein Re is n-propyl


1249.
cPr
H
Z15, wherein Re is n-propyl


1250.
cPr
F
Z15, wherein Re is n-propyl


1251.
cPr
OCH3
Z15, wherein Re is n-propyl


1252.
CH3
H
Z15, wherein Re is isopropyl


1253.
CH3
F
Z15, wherein Re is isopropyl


1254.
CH3
OCH3
Z15, wherein Re is isopropyl


1255.
Et
H
Z15, wherein Re is isopropyl


1256.
Et
F
Z15, wherein Re is isopropyl


1257.
Et
OCH3
Z15, wherein Re is isopropyl


1258.
cPr
H
Z15, wherein Re is isopropyl


1259.
cPr
F
Z15, wherein Re is isopropyl


1260.
cPr
OCH3
Z15, wherein Re is isopropyl


1261.
CH3
H
Z15, wherein Re is cyclopropyl


1262.
CH3
F
Z15, wherein Re is cyclopropyl


1263.
CH3
OCH3
Z15, wherein Re is cyclopropyl


1264.
Et
H
Z15, wherein Re is cyclopropyl


1265.
Et
F
Z15, wherein Re is cyclopropyl


1266.
Et
OCH3
Z15, wherein Re is cyclopropyl


1267.
cPr
H
Z15, wherein Re is cyclopropyl


1268.
cPr
F
Z15, wherein Re is cyclopropyl


1269.
cPr
OCH3
Z15, wherein Re is cyclopropyl


1270.
CH3
H
Z15, wherein Re is cyclobutyl


1271.
CH3
F
Z15, wherein Re is cyclobutyl


1272.
CH3
OCH3
Z15, wherein Re is cyclobutyl


1273.
Et
H
Z15, wherein Re is cyclobutyl


1274.
Et
F
Z15, wherein Re is cyclobutyl


1275.
Et
OCH3
Z15, wherein Re is cyclobutyl


1276.
cPr
H
Z15, wherein Re is cyclobutyl


1277.
cPr
F
Z15, wherein Re is cyclobutyl


1278.
cPr
OCH3
Z15, wherein Re is cyclobutyl


1279.
CH3
H
Z15, wherein Re is CH2-cyclopropyl


1280.
CH3
F
Z15, wherein Re is CH2-cyclopropyl


1281.
CH3
OCH3
Z15, wherein Re is CH2-cyclopropyl


1282.
Et
H
Z15, wherein Re is CH2-cyclopropyl


1283.
Et
F
Z15, wherein Re is CH2-cyclopropyl


1284.
Et
OCH3
Z15, wherein Re is CH2-cyclopropyl


1285.
cPr
H
Z15, wherein Re is CH2-cyclopropyl


1286.
cPr
F
Z15, wherein Re is CH2-cyclopropyl


1287.
cPr
OCH3
Z15, wherein Re is CH2-cyclopropyl


1288.
CH3
H
Z15, wherein Re is CH2CH2OCH3


1289.
CH3
F
Z15, wherein Re is CH2CH2OCH3


1290.
CH3
OCH3
Z15, wherein Re is CH2CH2OCH3


1291.
Et
H
Z15, wherein Re is CH2CH2OCH3


1292.
Et
F
Z15, wherein Re is CH2CH2OCH3


1293.
Et
OCH3
Z15, wherein Re is CH2CH2OCH3


1294.
cPr
H
Z15, wherein Re is CH2CH2OCH3


1295.
cPr
F
Z15, wherein Re is CH2CH2OCH3


1296.
cPr
OCH3
Z15, wherein Re is CH2CH2OCH3


1297.
CH3
H
Z16, wherein Re is CH3


1298.
CH3
F
Z16, wherein Re is CH3


1299.
CH3
OCH3
Z16, wherein Re is CH3


1300.
Et
H
Z16, wherein Re is CH3


1301.
Et
F
Z16, wherein Re is CH3


1302.
Et
OCH3
Z16, wherein Re is CH3


1303.
cPr
H
Z16, wherein Re is CH3


1304.
cPr
F
Z16, wherein Re is CH3


1305.
cPr
OCH3
Z16, wherein Re is CH3


1306.
CH3
H
Z16, wherein Re is ethyl


1307.
CH3
F
Z16, wherein Re is ethyl


1308.
CH3
OCH3
Z16, wherein Re is ethyl


1309.
Et
H
Z16, wherein Re is ethyl


1310.
Et
F
Z16, wherein Re is ethyl


1311.
Et
OCH3
Z16, wherein Re is ethyl


1312.
cPr
H
Z16, wherein Re is ethyl


1313.
cPr
F
Z16, wherein Re is ethyl


1314.
cPr
OCH3
Z16, wherein Re is ethyl


1315.
CH3
H
Z16, wherein Re is n-propyl


1316.
CH3
F
Z16, wherein Re is n-propyl


1317.
CH3
OCH3
Z16, wherein Re is n-propyl


1318.
Et
H
Z16, wherein Re is n-propyl


1319.
Et
F
Z16, wherein Re is n-propyl


1320.
Et
OCH3
Z16, wherein Re is n-propyl


1321.
cPr
H
Z16, wherein Re is n-propyl


1322.
cPr
F
Z16, wherein Re is n-propyl


1323.
cPr
OCH3
Z16, wherein Re is n-propyl


1324.
CH3
H
Z16, wherein Re is isopropyl


1325.
CH3
F
Z16, wherein Re is isopropyl


1326.
CH3
OCH3
Z16, wherein Re is isopropyl


1327.
Et
H
Z16, wherein Re is isopropyl


1328.
Et
F
Z16, wherein Re is isopropyl


1329.
Et
OCH3
Z16, wherein Re is isopropyl


1330.
cPr
H
Z16, wherein Re is isopropyl


1331.
cPr
F
Z16, wherein Re is isopropyl


1332.
cPr
OCH3
Z16, wherein Re is isopropyl


1333.
CH3
H
Z16, wherein Re is cyclopropyl


1334.
CH3
F
Z16, wherein Re is cyclopropyl


1335.
CH3
OCH3
Z16, wherein Re is cyclopropyl


1336.
Et
H
Z16, wherein Re is cyclopropyl


1337.
Et
F
Z16, wherein Re is cyclopropyl


1338.
Et
OCH3
Z16, wherein Re is cyclopropyl


1339.
cPr
H
Z16, wherein Re is cyclopropyl


1340.
cPr
F
Z16, wherein Re is cyclopropyl


1341.
cPr
OCH3
Z16, wherein Re is cyclopropyl


1342.
CH3
H
Z16, wherein Re is cyclobutyl


1343.
CH3
F
Z16, wherein Re is cyclobutyl


1344.
CH3
OCH3
Z16, wherein Re is cyclobutyl


1345.
Et
H
Z16, wherein Re is cyclobutyl


1346.
Et
F
Z16, wherein Re is cyclobutyl


1347.
Et
OCH3
Z16, wherein Re is cyclobutyl


1348.
cPr
H
Z16, wherein Re is cyclobutyl


1349.
cPr
F
Z16, wherein Re is cyclobutyl


1350.
cPr
OCH3
Z16, wherein Re is cyclobutyl


1351.
CH3
H
Z16, wherein Re is CH2-cyclopropyl


1352.
CH3
F
Z16, wherein Re is CH2-cyclopropyl


1353.
CH3
OCH3
Z16, wherein Re is CH2-cyclopropyl


1354.
Et
H
Z16, wherein Re is CH2-cyclopropyl


1355.
Et
F
Z16, wherein Re is CH2-cyclopropyl


1356.
Et
OCH3
Z16, wherein Re is CH2-cyclopropyl


1357.
cPr
H
Z16, wherein Re is CH2-cyclopropyl


1358.
cPr
F
Z16, wherein Re is CH2-cyclopropyl


1359.
cPr
OCH3
Z16, wherein Re is CH2-cyclopropyl


1360.
CH3
H
Z16, wherein Re is CH2CH2OCH3


1361.
CH3
F
Z16, wherein Re is CH2CH2OCH3


1362.
CH3
OCH3
Z16, wherein Re is CH2CH2OCH3


1363.
Et
H
Z16, wherein Re is CH2CH2OCH3


1364.
Et
F
Z16, wherein Re is CH2CH2OCH3


1365.
Et
OCH3
Z16, wherein Re is CH2CH2OCH3


1366.
cPr
H
Z16, wherein Re is CH2CH2OCH3


1367.
cPr
F
Z16, wherein Re is CH2CH2OCH3


1368.
cPr
OCH3
Z16, wherein Re is CH2CH2OCH3


1369.
CH3
H
Z17, wherein Re is CH3


1370.
CH3
F
Z17, wherein Re is CH3


1371.
CH3
OCH3
Z17, wherein Re is CH3


1372.
Et
H
Z17, wherein Re is CH3


1373.
Et
F
Z17, wherein Re is CH3


1374.
Et
OCH3
Z17, wherein Re is CH3


1375.
cPr
H
Z17, wherein Re is CH3


1376.
cPr
F
Z17, wherein Re is CH3


1377.
cPr
OCH3
Z17, wherein Re is CH3


1378.
CH3
H
Z17, wherein Re is ethyl


1379.
CH3
F
Z17, wherein Re is ethyl


1380.
CH3
OCH3
Z17, wherein Re is ethyl


1381.
Et
H
Z17, wherein Re is ethyl


1382.
Et
F
Z17, wherein Re is ethyl


1383.
Et
OCH3
Z17, wherein Re is ethyl


1384.
cPr
H
Z17, wherein Re is ethyl


1385.
cPr
F
Z17, wherein Re is ethyl


1386.
cPr
OCH3
Z17, wherein Re is ethyl


1387.
CH3
H
Z17, wherein Re is n-propyl


1388.
CH3
F
Z17, wherein Re is n-propyl


1389.
CH3
OCH3
Z17, wherein Re is n-propyl


1390.
Et
H
Z17, wherein Re is n-propyl


1391.
Et
F
Z17, wherein Re is n-propyl


1392.
Et
OCH3
Z17, wherein Re is n-propyl


1393.
cPr
H
Z17, wherein Re is n-propyl


1394.
cPr
F
Z17, wherein Re is n-propyl


1395.
cPr
OCH3
Z17, wherein Re is n-propyl


1396.
CH3
H
Z17, wherein Re is isopropyl


1397.
CH3
F
Z17, wherein Re is isopropyl


1398.
CH3
OCH3
Z17, wherein Re is isopropyl


1399.
Et
H
Z17, wherein Re is isopropyl


1400.
Et
F
Z17, wherein Re is isopropyl


1401.
Et
OCH3
Z17, wherein Re is isopropyl


1402.
cPr
H
Z17, wherein Re is isopropyl


1403.
cPr
F
Z17, wherein Re is isopropyl


1404.
cPr
OCH3
Z17, wherein Re is isopropyl


1405.
CH3
H
Z17, wherein Re is cyclopropyl


1406.
CH3
F
Z17, wherein Re is cyclopropyl


1407.
CH3
OCH3
Z17, wherein Re is cyclopropyl


1408.
Et
H
Z17, wherein Re is cyclopropyl


1409.
Et
F
Z17, wherein Re is cyclopropyl


1410.
Et
OCH3
Z17, wherein Re is cyclopropyl


1411.
cPr
H
Z17, wherein Re is cyclopropyl


1412.
cPr
F
Z17, wherein Re is cyclopropyl


1413.
cPr
OCH3
Z17, wherein Re is cyclopropyl


1414.
CH3
H
Z17, wherein Re is cyclobutyl


1415.
CH3
F
Z17, wherein Re is cyclobutyl


1416.
CH3
OCH3
Z17, wherein Re is cyclobutyl


1417.
Et
H
Z17, wherein Re is cyclobutyl


1418.
Et
F
Z17, wherein Re is cyclobutyl


1419.
Et
OCH3
Z17, wherein Re is cyclobutyl


1420.
cPr
H
Z17, wherein Re is cyclobutyl


1421.
cPr
F
Z17, wherein Re is cyclobutyl


1422.
cPr
OCH3
Z17, wherein Re is cyclobutyl


1423.
CH3
H
Z17, wherein Re is CH2-cyclopropyl


1424.
CH3
F
Z17, wherein Re is CH2-cyclopropyl


1425.
CH3
OCH3
Z17, wherein Re is CH2-cyclopropyl


1426.
Et
H
Z17, wherein Re is CH2-cyclopropyl


1427.
Et
F
Z17, wherein Re is CH2-cyclopropyl


1428.
Et
OCH3
Z17, wherein Re is CH2-cyclopropyl


1429.
cPr
H
Z17, wherein Re is CH2-cyclopropyl


1430.
cPr
F
Z17, wherein Re is CH2-cyclopropyl


1431.
cPr
OCH3
Z17, wherein Re is CH2-cyclopropyl


1432.
CH3
H
Z17, wherein Re is CH2CH2OCH3


1433.
CH3
F
Z17, wherein Re is CH2CH2OCH3


1434.
CH3
OCH3
Z17, wherein Re is CH2CH2OCH3


1435.
Et
H
Z17, wherein Re is CH2CH2OCH3


1436.
Et
F
Z17, wherein Re is CH2CH2OCH3


1437.
Et
OCH3
Z17, wherein Re is CH2CH2OCH3


1438.
cPr
H
Z17, wherein Re is CH2CH2OCH3


1439.
cPr
F
Z17, wherein Re is CH2CH2OCH3


1440.
cPr
OCH3
Z17, wherein Re is CH2CH2OCH3


1441.
CH3
H
Z18, wherein Re is CH3


1442.
CH3
F
Z18, wherein Re is CH3


1443.
CH3
OCH3
Z18, wherein Re is CH3


1444.
Et
H
Z18, wherein Re is CH3


1445.
Et
F
Z18, wherein Re is CH3


1446.
Et
OCH3
Z18, wherein Re is CH3


1447.
cPr
H
Z18, wherein Re is CH3


1448.
cPr
F
Z18, wherein Re is CH3


1449.
cPr
OCH3
Z18, wherein Re is CH3


1450.
CH3
H
Z18, wherein Re is ethyl


1451.
CH3
F
Z18, wherein Re is ethyl


1452.
CH3
OCH3
Z18, wherein Re is ethyl


1453.
Et
H
Z18, wherein Re is ethyl


1454.
Et
F
Z18, wherein Re is ethyl


1455.
Et
OCH3
Z18, wherein Re is ethyl


1456.
cPr
H
Z18, wherein Re is ethyl


1457.
cPr
F
Z18, wherein Re is ethyl


1458.
cPr
OCH3
Z18, wherein Re is ethyl


1459.
CH3
H
Z18, wherein Re is n-propyl


1460.
CH3
F
Z18, wherein Re is n-propyl


1461.
CH3
OCH3
Z18, wherein Re is n-propyl


1462.
Et
H
Z18, wherein Re is n-propyl


1463.
Et
F
Z18, wherein Re is n-propyl


1464.
Et
OCH3
Z18, wherein Re is n-propyl


1465.
cPr
H
Z18, wherein Re is n-propyl


1466.
cPr
F
Z18, wherein Re is n-propyl


1467.
cPr
OCH3
Z18, wherein Re is n-propyl


1468.
CH3
H
Z18, wherein Re is isopropyl


1469.
CH3
F
Z18, wherein Re is isopropyl


1470.
CH3
OCH3
Z18, wherein Re is isopropyl


1471.
Et
H
Z18, wherein Re is isopropyl


1472.
Et
F
Z18, wherein Re is isopropyl


1473.
Et
OCH3
Z18, wherein Re is isopropyl


1474.
cPr
H
Z18, wherein Re is isopropyl


1475.
cPr
F
Z18, wherein Re is isopropyl


1476.
cPr
OCH3
Z18, wherein Re is isopropyl


1477.
CH3
H
Z18, wherein Re is cyclopropyl


1478.
CH3
F
Z18, wherein Re is cyclopropyl


1479.
CH3
OCH3
Z18, wherein Re is cyclopropyl


1480.
Et
H
Z18, wherein Re is cyclopropyl


1481.
Et
F
Z18, wherein Re is cyclopropyl


1482.
Et
OCH3
Z18, wherein Re is cyclopropyl


1483.
cPr
H
Z18, wherein Re is cyclopropyl


1484.
cPr
F
Z18, wherein Re is cyclopropyl


1485.
cPr
OCH3
Z18, wherein Re is cyclopropyl


1486.
CH3
H
Z18, wherein Re is cyclobutyl


1487.
CH3
F
Z18, wherein Re is cyclobutyl


1488.
CH3
OCH3
Z18, wherein Re is cyclobutyl


1489.
Et
H
Z18, wherein Re is cyclobutyl


1490.
Et
F
Z18, wherein Re is cyclobutyl


1491.
Et
OCH3
Z18, wherein Re is cyclobutyl


1492.
cPr
H
Z18, wherein Re is cyclobutyl


1493.
cPr
F
Z18, wherein Re is cyclobutyl


1494.
cPr
OCH3
Z18, wherein Re is cyclobutyl


1495.
CH3
H
Z18, wherein Re is CH2-cyclopropyl


1496.
CH3
F
Z18, wherein Re is CH2-cyclopropyl


1497.
CH3
OCH3
Z18, wherein Re is CH2-cyclopropyl


1498.
Et
H
Z18, wherein Re is CH2-cyclopropyl


1499.
Et
F
Z18, wherein Re is CH2-cyclopropyl


1500.
Et
OCH3
Z18, wherein Re is CH2-cyclopropyl


1501.
cPr
H
Z18, wherein Re is CH2-cyclopropyl


1502.
cPr
F
Z18, wherein Re is CH2-cyclopropyl


1503.
cPr
OCH3
Z18, wherein Re is CH2-cyclopropyl


1504.
CH3
H
Z18, wherein Re is CH2CH2OCH3


1505.
CH3
F
Z18, wherein Re is CH2CH2OCH3


1506.
CH3
OCH3
Z18, wherein Re is CH2CH2OCH3


1507.
Et
H
Z18, wherein Re is CH2CH2OCH3


1508.
Et
F
Z18, wherein Re is CH2CH2OCH3


1509.
Et
OCH3
Z18, wherein Re is CH2CH2OCH3


1510.
cPr
H
Z18, wherein Re is CH2CH2OCH3


1511.
cPr
F
Z18, wherein Re is CH2CH2OCH3


1512.
cPr
OCH3
Z18, wherein Re is CH2CH2OCH3


1513.
CH3
H
Z19, wherein Re is CH3


1514.
CH3
F
Z19, wherein Re is CH3


1515.
CH3
OCH3
Z19, wherein Re is CH3


1516.
Et
H
Z19, wherein Re is CH3


1517.
Et
F
Z19, wherein Re is CH3


1518.
Et
OCH3
Z19, wherein Re is CH3


1519.
cPr
H
Z19, wherein Re is CH3


1520.
cPr
F
Z19, wherein Re is CH3


1521.
cPr
OCH3
Z19, wherein Re is CH3


1522.
CH3
H
Z19, wherein Re is ethyl


1523.
CH3
F
Z19, wherein Re is ethyl


1524.
CH3
OCH3
Z19, wherein Re is ethyl


1525.
Et
H
Z19, wherein Re is ethyl


1526.
Et
F
Z19, wherein Re is ethyl


1527.
Et
OCH3
Z19, wherein Re is ethyl


1528.
cPr
H
Z19, wherein Re is ethyl


1529.
cPr
F
Z19, wherein Re is ethyl


1530.
cPr
OCH3
Z19, wherein Re is ethyl


1531.
CH3
H
Z19, wherein Re is n-propyl


1532.
CH3
F
Z19, wherein Re is n-propyl


1533.
CH3
OCH3
Z19, wherein Re is n-propyl


1534.
Et
H
Z19, wherein Re is n-propyl


1535.
Et
F
Z19, wherein Re is n-propyl


1536.
Et
OCH3
Z19, wherein Re is n-propyl


1537.
cPr
H
Z19, wherein Re is n-propyl


1538.
cPr
F
Z19, wherein Re is n-propyl


1539.
cPr
OCH3
Z19, wherein Re is n-propyl


1540.
CH3
H
Z19, wherein Re is isopropyl


1541.
CH3
F
Z19, wherein Re is isopropyl


1542.
CH3
OCH3
Z19, wherein Re is isopropyl


1543.
Et
H
Z19, wherein Re is isopropyl


1544.
Et
F
Z19, wherein Re is isopropyl


1545.
Et
OCH3
Z19, wherein Re is isopropyl


1546.
cPr
H
Z19, wherein Re is isopropyl


1547.
cPr
F
Z19, wherein Re is isopropyl


1548.
cPr
OCH3
Z19, wherein Re is isopropyl


1549.
CH3
H
Z19, wherein Re is cyclopropyl


1550.
CH3
F
Z19, wherein Re is cyclopropyl


1551.
CH3
OCH3
Z19, wherein Re is cyclopropyl


1552.
Et
H
Z19, wherein Re is cyclopropyl


1553.
Et
F
Z19, wherein Re is cyclopropyl


1554.
Et
OCH3
Z19, wherein Re is cyclopropyl


1555.
cPr
H
Z19, wherein Re is cyclopropyl


1556.
cPr
F
Z19, wherein Re is cyclopropyl


1557.
cPr
OCH3
Z19, wherein Re is cyclopropyl


1558.
CH3
H
Z19, wherein Re is cyclobutyl


1559.
CH3
F
Z19, wherein Re is cyclobutyl


1560.
CH3
OCH3
Z19, wherein Re is cyclobutyl


1561.
Et
H
Z19, wherein Re is cyclobutyl


1562.
Et
F
Z19, wherein Re is cyclobutyl


1563.
Et
OCH3
Z19, wherein Re is cyclobutyl


1564.
cPr
H
Z19, wherein Re is cyclobutyl


1565.
cPr
F
Z19, wherein Re is cyclobutyl


1566.
cPr
OCH3
Z19, wherein Re is cyclobutyl


1567.
CH3
H
Z19, wherein Re is CH2-cyclopropyl


1568.
CH3
F
Z19, wherein Re is CH2-cyclopropyl


1569.
CH3
OCH3
Z19, wherein Re is CH2-cyclopropyl


1570.
Et
H
Z19, wherein Re is CH2-cyclopropyl


1571.
Et
F
Z19, wherein Re is CH2-cyclopropyl


1572.
Et
OCH3
Z19, wherein Re is CH2-cyclopropyl


1573.
cPr
H
Z19, wherein Re is CH2-cyclopropyl


1574.
cPr
F
Z19, wherein Re is CH2-cyclopropyl


1575.
cPr
OCH3
Z19, wherein Re is CH2-cyclopropyl


1576.
CH3
H
Z19, wherein Re is CH2CH2OCH3


1577.
CH3
F
Z19, wherein Re is CH2CH2OCH3


1578.
CH3
OCH3
Z19, wherein Re is CH2CH2OCH3


1579.
Et
H
Z19, wherein Re is CH2CH2OCH3


1580.
Et
F
Z19, wherein Re is CH2CH2OCH3


1581.
Et
OCH3
Z19, wherein Re is CH2CH2OCH3


1582.
cPr
H
Z19, wherein Re is CH2CH2OCH3


1583.
cPr
F
Z19, wherein Re is CH2CH2OCH3


1584.
cPr
OCH3
Z19, wherein Re is CH2CH2OCH3


1585.
CH3
H
Z20, wherein Re is CH3


1586.
CH3
F
Z20, wherein Re is CH3


1587.
CH3
OCH3
Z20, wherein Re is CH3


1588.
Et
H
Z20, wherein Re is CH3


1589.
Et
F
Z20, wherein Re is CH3


1590.
Et
OCH3
Z20, wherein Re is CH3


1591.
cPr
H
Z20, wherein Re is CH3


1592.
cPr
F
Z20, wherein Re is CH3


1593.
cPr
OCH3
Z20, wherein Re is CH3


1594.
CH3
H
Z20, wherein Re is ethyl


1595.
CH3
F
Z20, wherein Re is ethyl


1596.
CH3
OCH3
Z20, wherein Re is ethyl


1597.
Et
H
Z20, wherein Re is ethyl


1598.
Et
F
Z20, wherein Re is ethyl


1599.
Et
OCH3
Z20, wherein Re is ethyl


1600.
cPr
H
Z20, wherein Re is ethyl


1601.
cPr
F
Z20, wherein Re is ethyl


1602.
cPr
OCH3
Z20, wherein Re is ethyl


1603.
CH3
H
Z20, wherein Re is n-propyl


1604.
CH3
F
Z20, wherein Re is n-propyl


1605.
CH3
OCH3
Z20, wherein Re is n-propyl


1606.
Et
H
Z20, wherein Re is n-propyl


1607.
Et
F
Z20, wherein Re is n-propyl


1608.
Et
OCH3
Z20, wherein Re is n-propyl


1609.
cPr
H
Z20, wherein Re is n-propyl


1610.
cPr
F
Z20, wherein Re is n-propyl


1611.
cPr
OCH3
Z20, wherein Re is n-propyl


1612.
CH3
H
Z20, wherein Re is isopropyl


1613.
CH3
F
Z20, wherein Re is isopropyl


1614.
CH3
OCH3
Z20, wherein Re is isopropyl


1615.
Et
H
Z20, wherein Re is isopropyl


1616.
Et
F
Z20, wherein Re is isopropyl


1617.
Et
OCH3
Z20, wherein Re is isopropyl


1618.
cPr
H
Z20, wherein Re is isopropyl


1619.
cPr
F
Z20, wherein Re is isopropyl


1620.
cPr
OCH3
Z20, wherein Re is isopropyl


1621.
CH3
H
Z20, wherein Re is cyclopropyl


1622.
CH3
F
Z20, wherein Re is cyclopropyl


1623.
CH3
OCH3
Z20, wherein Re is cyclopropyl


1624.
Et
H
Z20, wherein Re is cyclopropyl


1625.
Et
F
Z20, wherein Re is cyclopropyl


1626.
Et
OCH3
Z20, wherein Re is cyclopropyl


1627.
cPr
H
Z20, wherein Re is cyclopropyl


1628.
cPr
F
Z20, wherein Re is cyclopropyl


1629.
cPr
OCH3
Z20, wherein Re is cyclopropyl


1630.
CH3
H
Z20, wherein Re is cyclobutyl


1631.
CH3
F
Z20, wherein Re is cyclobutyl


1632.
CH3
OCH3
Z20, wherein Re is cyclobutyl


1633.
Et
H
Z20, wherein Re is cyclobutyl


1634.
Et
F
Z20, wherein Re is cyclobutyl


1635.
Et
OCH3
Z20, wherein Re is cyclobutyl


1636.
cPr
H
Z20, wherein Re is cyclobutyl


1637.
cPr
F
Z20, wherein Re is cyclobutyl


1638.
cPr
OCH3
Z20, wherein Re is cyclobutyl


1639.
CH3
H
Z20, wherein Re is CH2-cyclopropyl


1640.
CH3
F
Z20, wherein Re is CH2-cyclopropyl


1641.
CH3
OCH3
Z20, wherein Re is CH2-cyclopropyl


1642.
Et
H
Z20, wherein Re is CH2-cyclopropyl


1643.
Et
F
Z20, wherein Re is CH2-cyclopropyl


1644.
Et
OCH3
Z20, wherein Re is CH2-cyclopropyl


1645.
cPr
H
Z20, wherein Re is CH2-cyclopropyl


1646.
cPr
F
Z20, wherein Re is CH2-cyclopropyl


1647.
cPr
OCH3
Z20, wherein Re is CH2-cyclopropyl


1648.
CH3
H
Z20, wherein Re is CH2CH2OCH3


1649.
CH3
F
Z20, wherein Re is CH2CH2OCH3


1650.
CH3
OCH3
Z20, wherein Re is CH2CH2OCH3


1651.
Et
H
Z20, wherein Re is CH2CH2OCH3


1652.
Et
F
Z20, wherein Re is CH2CH2OCH3


1653.
Et
OCH3
Z20, wherein Re is CH2CH2OCH3


1654.
cPr
H
Z20, wherein Re is CH2CH2OCH3


1655.
cPr
F
Z20, wherein Re is CH2CH2OCH3


1656.
cPr
OCH3
Z20, wherein Re is CH2CH2OCH3


1657.
CH3
H
Z21, wherein Re is CH3


1658.
CH3
F
Z21, wherein Re is CH3


1659.
CH3
OCH3
Z21, wherein Re is CH3


1660.
Et
H
Z21, wherein Re is CH3


1661.
Et
F
Z21, wherein Re is CH3


1662.
Et
OCH3
Z21, wherein Re is CH3


1663.
cPr
H
Z21, wherein Re is CH3


1664.
cPr
F
Z21, wherein Re is CH3


1665.
cPr
OCH3
Z21, wherein Re is CH3


1666.
CH3
H
Z21, wherein Re is ethyl


1667.
CH3
F
Z21, wherein Re is ethyl


1668.
CH3
OCH3
Z21, wherein Re is ethyl


1669.
Et
H
Z21, wherein Re is ethyl


1670.
Et
F
Z21, wherein Re is ethyl


1671.
Et
OCH3
Z21, wherein Re is ethyl


1672.
cPr
H
Z21, wherein Re is ethyl


1673.
cPr
F
Z21, wherein Re is ethyl


1674.
cPr
OCH3
Z21, wherein Re is ethyl


1675.
CH3
H
Z21, wherein Re is n-propyl


1676.
CH3
F
Z21, wherein Re is n-propyl


1677.
CH3
OCH3
Z21, wherein Re is n-propyl


1678.
Et
H
Z21, wherein Re is n-propyl


1679.
Et
F
Z21, wherein Re is n-propyl


1680.
Et
OCH3
Z21, wherein Re is n-propyl


1681.
cPr
H
Z21, wherein Re is n-propyl


1682.
cPr
F
Z21, wherein Re is n-propyl


1683.
cPr
OCH3
Z21, wherein Re is n-propyl


1684.
CH3
H
Z21, wherein Re is isopropyl


1685.
CH3
F
Z21, wherein Re is isopropyl


1686.
CH3
OCH3
Z21, wherein Re is isopropyl


1687.
Et
H
Z21, wherein Re is isopropyl


1688.
Et
F
Z21, wherein Re is isopropyl


1689.
Et
OCH3
Z21, wherein Re is isopropyl


1690.
cPr
H
Z21, wherein Re is isopropyl


1691.
cPr
F
Z21, wherein Re is isopropyl


1692.
cPr
OCH3
Z21, wherein Re is isopropyl


1693.
CH3
H
Z21, wherein Re is cyclopropyl


1694.
CH3
F
Z21, wherein Re is cyclopropyl


1695.
CH3
OCH3
Z21, wherein Re is cyclopropyl


1696.
Et
H
Z21, wherein Re is cyclopropyl


1697.
Et
F
Z21, wherein Re is cyclopropyl


1698.
Et
OCH3
Z21, wherein Re is cyclopropyl


1699.
cPr
H
Z21, wherein Re is cyclopropyl


1700.
cPr
F
Z21, wherein Re is cyclopropyl


1701.
cPr
OCH3
Z21, wherein Re is cyclopropyl


1702.
CH3
H
Z21, wherein Re is cyclobutyl


1703.
CH3
F
Z21, wherein Re is cyclobutyl


1704.
CH3
OCH3
Z21, wherein Re is cyclobutyl


1705.
Et
H
Z21, wherein Re is cyclobutyl


1706.
Et
F
Z21, wherein Re is cyclobutyl


1707.
Et
OCH3
Z21, wherein Re is cyclobutyl


1708.
cPr
H
Z21, wherein Re is cyclobutyl


1709.
cPr
F
Z21, wherein Re is cyclobutyl


1710.
cPr
OCH3
Z21, wherein Re is cyclobutyl


1711.
CH3
H
Z21, wherein Re is CH2-cyclopropyl


1712.
CH3
F
Z21, wherein Re is CH2-cyclopropyl


1713.
CH3
OCH3
Z21, wherein Re is CH2-cyclopropyl


1714.
Et
H
Z21, wherein Re is CH2-cyclopropyl


1715.
Et
F
Z21, wherein Re is CH2-cyclopropyl


1716.
Et
OCH3
Z21, wherein Re is CH2-cyclopropyl


1717.
cPr
H
Z21, wherein Re is CH2-cyclopropyl


1718.
cPr
F
Z21, wherein Re is CH2-cyclopropyl


1719.
cPr
OCH3
Z21, wherein Re is CH2-cyclopropyl


1720.
CH3
H
Z21, wherein Re is CH2CH2OCH3


1721.
CH3
F
Z21, wherein Re is CH2CH2OCH3


1722.
CH3
OCH3
Z21, wherein Re is CH2CH2OCH3


1723.
Et
H
Z21, wherein Re is CH2CH2OCH3


1724.
Et
F
Z21, wherein Re is CH2CH2OCH3


1725.
Et
OCH3
Z21, wherein Re is CH2CH2OCH3


1726.
cPr
H
Z21, wherein Re is CH2CH2OCH3


1727.
cPr
F
Z21, wherein Re is CH2CH2OCH3


1728.
cPr
OCH3
Z21, wherein Re is CH2CH2OCH3


1729.
CH3
H
Z22, wherein Re is CH3


1730.
CH3
F
Z22, wherein Re is CH3


1731.
CH3
OCH3
Z22, wherein Re is CH3


1732.
Et
H
Z22, wherein Re is CH3


1733.
Et
F
Z22, wherein Re is CH3


1734.
Et
OCH3
Z22, wherein Re is CH3


1735.
cPr
H
Z22, wherein Re is CH3


1736.
cPr
F
Z22, wherein Re is CH3


1737.
cPr
OCH3
Z22, wherein Re is CH3


1738.
CH3
H
Z22, wherein Re is ethyl


1739.
CH3
F
Z22, wherein Re is ethyl


1740.
CH3
OCH3
Z22, wherein Re is ethyl


1741.
Et
H
Z22, wherein Re is ethyl


1742.
Et
F
Z22, wherein Re is ethyl


1743.
Et
OCH3
Z22, wherein Re is ethyl


1744.
cPr
H
Z22, wherein Re is ethyl


1745.
cPr
F
Z22, wherein Re is ethyl


1746.
cPr
OCH3
Z22, wherein Re is ethyl


1747.
CH3
H
Z22, wherein Re is n-propyl


1748.
CH3
F
Z22, wherein Re is n-propyl


1749.
CH3
OCH3
Z22, wherein Re is n-propyl


1750.
Et
H
Z22, wherein Re is n-propyl


1751.
Et
F
Z22, wherein Re is n-propyl


1752.
Et
OCH3
Z22, wherein Re is n-propyl


1753.
cPr
H
Z22, wherein Re is n-propyl


1754.
cPr
F
Z22, wherein Re is n-propyl


1755.
cPr
OCH3
Z22, wherein Re is n-propyl


1756.
CH3
H
Z22, wherein Re is isopropyl


1757.
CH3
F
Z22, wherein Re is isopropyl


1758.
CH3
OCH3
Z22, wherein Re is isopropyl


1759.
Et
H
Z22, wherein Re is isopropyl


1760.
Et
F
Z22, wherein Re is isopropyl


1761.
Et
OCH3
Z22, wherein Re is isopropyl


1762.
cPr
H
Z22, wherein Re is isopropyl


1763.
cPr
F
Z22, wherein Re is isopropyl


1764.
cPr
OCH3
Z22, wherein Re is isopropyl


1765.
CH3
H
Z22, wherein Re is cyclopropyl


1766.
CH3
F
Z22, wherein Re is cyclopropyl


1767.
CH3
OCH3
Z22, wherein Re is cyclopropyl


1768.
Et
H
Z22, wherein Re is cyclopropyl


1769.
Et
F
Z22, wherein Re is cyclopropyl


1770.
Et
OCH3
Z22, wherein Re is cyclopropyl


1771.
cPr
H
Z22, wherein Re is cyclopropyl


1772.
cPr
F
Z22, wherein Re is cyclopropyl


1773.
cPr
OCH3
Z22, wherein Re is cyclopropyl


1774.
CH3
H
Z22, wherein Re is cyclobutyl


1775.
CH3
F
Z22, wherein Re is cyclobutyl


1776.
CH3
OCH3
Z22, wherein Re is cyclobutyl


1777.
Et
H
Z22, wherein Re is cyclobutyl


1778.
Et
F
Z22, wherein Re is cyclobutyl


1779.
Et
OCH3
Z22, wherein Re is cyclobutyl


1780.
cPr
H
Z22, wherein Re is cyclobutyl


1781.
cPr
F
Z22, wherein Re is cyclobutyl


1782.
cPr
OCH3
Z22, wherein Re is cyclobutyl


1783.
CH3
H
Z22, wherein Re is CH2-cyclopropyl


1784.
CH3
F
Z22, wherein Re is CH2-cyclopropyl


1785.
CH3
OCH3
Z22, wherein Re is CH2-cyclopropyl


1786.
Et
H
Z22, wherein Re is CH2-cyclopropyl


1787.
Et
F
Z22, wherein Re is CH2-cyclopropyl


1788.
Et
OCH3
Z22, wherein Re is CH2-cyclopropyl


1789.
cPr
H
Z22, wherein Re is CH2-cyclopropyl


1790.
cPr
F
Z22, wherein Re is CH2-cyclopropyl


1791.
cPr
OCH3
Z22, wherein Re is CH2-cyclopropyl


1792.
CH3
H
Z22, wherein Re is CH2CH2OCH3


1793.
CH3
F
Z22, wherein Re is CH2CH2OCH3


1794.
CH3
OCH3
Z22, wherein Re is CH2CH2OCH3


1795.
Et
H
Z22, wherein Re is CH2CH2OCH3


1796.
Et
F
Z22, wherein Re is CH2CH2OCH3


1797.
Et
OCH3
Z22, wherein Re is CH2CH2OCH3


1798.
cPr
H
Z22, wherein Re is CH2CH2OCH3


1799.
cPr
F
Z22, wherein Re is CH2CH2OCH3


1800.
cPr
OCH3
Z22, wherein Re is CH2CH2OCH3


1801.
CH3
H
Z23, wherein Re is CH3


1802.
CH3
F
Z23, wherein Re is CH3


1803.
CH3
OCH3
Z23, wherein Re is CH3


1804.
Et
H
Z23, wherein Re is CH3


1805.
Et
F
Z23, wherein Re is CH3


1806.
Et
OCH3
Z23, wherein Re is CH3


1807.
cPr
H
Z23, wherein Re is CH3


1808.
cPr
F
Z23, wherein Re is CH3


1809.
cPr
OCH3
Z23, wherein Re is CH3


1810.
CH3
H
Z23, wherein Re is ethyl


1811.
CH3
F
Z23, wherein Re is ethyl


1812.
CH3
OCH3
Z23, wherein Re is ethyl


1813.
Et
H
Z23, wherein Re is ethyl


1814.
Et
F
Z23, wherein Re is ethyl


1815.
Et
OCH3
Z23, wherein Re is ethyl


1816.
cPr
H
Z23, wherein Re is ethyl


1817.
cPr
F
Z23, wherein Re is ethyl


1818.
cPr
OCH3
Z23, wherein Re is ethyl


1819.
CH3
H
Z23, wherein Re is n-propyl


1820.
CH3
F
Z23, wherein Re is n-propyl


1821.
CH3
OCH3
Z23, wherein Re is n-propyl


1822.
Et
H
Z23, wherein Re is n-propyl


1823.
Et
F
Z23, wherein Re is n-propyl


1824.
Et
OCH3
Z23, wherein Re is n-propyl


1825.
cPr
H
Z23, wherein Re is n-propyl


1826.
cPr
F
Z23, wherein Re is n-propyl


1827.
cPr
OCH3
Z23, wherein Re is n-propyl


1828.
CH3
H
Z23, wherein Re is isopropyl


1829.
CH3
F
Z23, wherein Re is isopropyl


1830.
CH3
OCH3
Z23, wherein Re is isopropyl


1831.
Et
H
Z23, wherein Re is isopropyl


1832.
Et
F
Z23, wherein Re is isopropyl


1833.
Et
OCH3
Z23, wherein Re is isopropyl


1834.
cPr
H
Z23, wherein Re is isopropyl


1835.
cPr
F
Z23, wherein Re is isopropyl


1836.
cPr
OCH3
Z23, wherein Re is isopropyl


1837.
CH3
H
Z23, wherein Re is cyclopropyl


1838.
CH3
F
Z23, wherein Re is cyclopropyl


1839.
CH3
OCH3
Z23, wherein Re is cyclopropyl


1840.
Et
H
Z23, wherein Re is cyclopropyl


1841.
Et
F
Z23, wherein Re is cyclopropyl


1842.
Et
OCH3
Z23, wherein Re is cyclopropyl


1843.
cPr
H
Z23, wherein Re is cyclopropyl


1844.
cPr
F
Z23, wherein Re is cyclopropyl


1845.
cPr
OCH3
Z23, wherein Re is cyclopropyl


1846.
CH3
H
Z23, wherein Re is cyclobutyl


1847.
CH3
F
Z23, wherein Re is cyclobutyl


1848.
CH3
OCH3
Z23, wherein Re is cyclobutyl


1849.
Et
H
Z23, wherein Re is cyclobutyl


1850.
Et
F
Z23, wherein Re is cyclobutyl


1851.
Et
OCH3
Z23, wherein Re is cyclobutyl


1852.
cPr
H
Z23, wherein Re is cyclobutyl


1853.
cPr
F
Z23, wherein Re is cyclobutyl


1854.
cPr
OCH3
Z23, wherein Re is cyclobutyl


1855.
CH3
H
Z23, wherein Re is CH2-cyclopropyl


1856.
CH3
F
Z23, wherein Re is CH2-cyclopropyl


1857.
CH3
OCH3
Z23, wherein Re is CH2-cyclopropyl


1858.
Et
H
Z23, wherein Re is CH2-cyclopropyl


1859.
Et
F
Z23, wherein Re is CH2-cyclopropyl


1860.
Et
OCH3
Z23, wherein Re is CH2-cyclopropyl


1861.
cPr
H
Z23, wherein Re is CH2-cyclopropyl


1862.
cPr
F
Z23, wherein Re is CH2-cyclopropyl


1863.
cPr
OCH3
Z23, wherein Re is CH2-cyclopropyl


1864.
CH3
H
Z23, wherein Re is CH2CH2OCH3


1865.
CH3
F
Z23, wherein Re is CH2CH2OCH3


1866.
CH3
OCH3
Z23, wherein Re is CH2CH2OCH3


1867.
Et
H
Z23, wherein Re is CH2CH2OCH3


1868.
Et
F
Z23, wherein Re is CH2CH2OCH3


1869.
Et
OCH3
Z23, wherein Re is CH2CH2OCH3


1870.
cPr
H
Z23, wherein Re is CH2CH2OCH3


1871.
cPr
F
Z23, wherein Re is CH2CH2OCH3


1872.
cPr
OCH3
Z23, wherein Re is CH2CH2OCH3


1873.
CH3
H
Z24, wherein Re is CH3


1874.
CH3
F
Z24, wherein Re is CH3


1875.
CH3
OCH3
Z24, wherein Re is CH3


1876.
Et
H
Z24, wherein Re is CH3


1877.
Et
F
Z24, wherein Re is CH3


1878.
Et
OCH3
Z24, wherein Re is CH3


1879.
cPr
H
Z24, wherein Re is CH3


1880.
cPr
F
Z24, wherein Re is CH3


1881.
cPr
OCH3
Z24, wherein Re is CH3


1882.
CH3
H
Z24, wherein Re is ethyl


1883.
CH3
F
Z24, wherein Re is ethyl


1884.
CH3
OCH3
Z24, wherein Re is ethyl


1885.
Et
H
Z24, wherein Re is ethyl


1886.
Et
F
Z24, wherein Re is ethyl


1887.
Et
OCH3
Z24, wherein Re is ethyl


1888.
cPr
H
Z24, wherein Re is ethyl


1889.
cPr
F
Z24, wherein Re is ethyl


1890.
cPr
OCH3
Z24, wherein Re is ethyl


1891.
CH3
H
Z24, wherein Re is n-propyl


1892.
CH3
F
Z24, wherein Re is n-propyl


1893.
CH3
OCH3
Z24, wherein Re is n-propyl


1894.
Et
H
Z24, wherein Re is n-propyl


1895.
Et
F
Z24, wherein Re is n-propyl


1896.
Et
OCH3
Z24, wherein Re is n-propyl


1897.
cPr
H
Z24, wherein Re is n-propyl


1898.
cPr
F
Z24, wherein Re is n-propyl


1899.
cPr
OCH3
Z24, wherein Re is n-propyl


1900.
CH3
H
Z24, wherein Re is isopropyl


1901.
CH3
F
Z24, wherein Re is isopropyl


1902.
CH3
OCH3
Z24, wherein Re is isopropyl


1903.
Et
H
Z24, wherein Re is isopropyl


1904.
Et
F
Z24, wherein Re is isopropyl


1905.
Et
OCH3
Z24, wherein Re is isopropyl


1906.
cPr
H
Z24, wherein Re is isopropyl


1907.
cPr
F
Z24, wherein Re is isopropyl


1908.
cPr
OCH3
Z24, wherein Re is isopropyl


1909.
CH3
H
Z24, wherein Re is cyclopropyl


1910.
CH3
F
Z24, wherein Re is cyclopropyl


1911.
CH3
OCH3
Z24, wherein Re is cyclopropyl


1912.
Et
H
Z24, wherein Re is cyclopropyl


1913.
Et
F
Z24, wherein Re is cyclopropyl


1914.
Et
OCH3
Z24, wherein Re is cyclopropyl


1915.
cPr
H
Z24, wherein Re is cyclopropyl


1916.
cPr
F
Z24, wherein Re is cyclopropyl


1917.
cPr
OCH3
Z24, wherein Re is cyclopropyl


1918.
CH3
H
Z24, wherein Re is cyclobutyl


1919.
CH3
F
Z24, wherein Re is cyclobutyl


1920.
CH3
OCH3
Z24, wherein Re is cyclobutyl


1921.
Et
H
Z24, wherein Re is cyclobutyl


1922.
Et
F
Z24, wherein Re is cyclobutyl


1923.
Et
OCH3
Z24, wherein Re is cyclobutyl


1924.
cPr
H
Z24, wherein Re is cyclobutyl


1925.
cPr
F
Z24, wherein Re is cyclobutyl


1926.
cPr
OCH3
Z24, wherein Re is cyclobutyl


1927.
CH3
H
Z24, wherein Re is CH2-cyclopropyl


1928.
CH3
F
Z24, wherein Re is CH2-cyclopropyl


1929.
CH3
OCH3
Z24, wherein Re is CH2-cyclopropyl


1930.
Et
H
Z24, wherein Re is CH2-cyclopropyl


1931.
Et
F
Z24, wherein Re is CH2-cyclopropyl


1932.
Et
OCH3
Z24, wherein Re is CH2-cyclopropyl


1933.
cPr
H
Z24, wherein Re is CH2-cyclopropyl


1934.
cPr
F
Z24, wherein Re is CH2-cyclopropyl


1935.
cPr
OCH3
Z24, wherein Re is CH2-cyclopropyl


1936.
CH3
H
Z24, wherein Re is CH2CH2OCH3


1937.
CH3
F
Z24, wherein Re is CH2CH2OCH3


1938.
CH3
OCH3
Z24, wherein Re is CH2CH2OCH3


1939.
Et
H
Z24, wherein Re is CH2CH2OCH3


1940.
Et
F
Z24, wherein Re is CH2CH2OCH3


1941.
Et
OCH3
Z24, wherein Re is CH2CH2OCH3


1942.
cPr
H
Z24, wherein Re is CH2CH2OCH3


1943.
cPr
F
Z24, wherein Re is CH2CH2OCH3


1944.
cPr
OCH3
Z24, wherein Re is CH2CH2OCH3


1945.
CH3
H
Z25, wherein Re is CH3


1946.
CH3
F
Z25, wherein Re is CH3


1947.
CH3
OCH3
Z25, wherein Re is CH3


1948.
Et
H
Z25, wherein Re is CH3


1949.
Et
F
Z25, wherein Re is CH3


1950.
Et
OCH3
Z25, wherein Re is CH3


1951.
cPr
H
Z25, wherein Re is CH3


1952.
cPr
F
Z25, wherein Re is CH3


1953.
cPr
OCH3
Z25, wherein Re is CH3


1954.
CH3
H
Z25, wherein Re is ethyl


1955.
CH3
F
Z25, wherein Re is ethyl


1956.
CH3
OCH3
Z25, wherein Re is ethyl


1957.
Et
H
Z25, wherein Re is ethyl


1958.
Et
F
Z25, wherein Re is ethyl


1959.
Et
OCH3
Z25, wherein Re is ethyl


1960.
cPr
H
Z25, wherein Re is ethyl


1961.
cPr
F
Z25, wherein Re is ethyl


1962.
cPr
OCH3
Z25, wherein Re is ethyl


1963.
CH3
H
Z25, wherein Re is n-propyl


1964.
CH3
F
Z25, wherein Re is n-propyl


1965.
CH3
OCH3
Z25, wherein Re is n-propyl


1966.
Et
H
Z25, wherein Re is n-propyl


1967.
Et
F
Z25, wherein Re is n-propyl


1968.
Et
OCH3
Z25, wherein Re is n-propyl


1969.
cPr
H
Z25, wherein Re is n-propyl


1970.
cPr
F
Z25, wherein Re is n-propyl


1971.
cPr
OCH3
Z25, wherein Re is n-propyl


1972.
CH3
H
Z25, wherein Re is isopropyl


1973.
CH3
F
Z25, wherein Re is isopropyl


1974.
CH3
OCH3
Z25, wherein Re is isopropyl


1975.
Et
H
Z25, wherein Re is isopropyl


1976.
Et
F
Z25, wherein Re is isopropyl


1977.
Et
OCH3
Z25, wherein Re is isopropyl


1978.
cPr
H
Z25, wherein Re is isopropyl


1979.
cPr
F
Z25, wherein Re is isopropyl


1980.
cPr
OCH3
Z25, wherein Re is isopropyl


1981.
CH3
H
Z25, wherein Re is cyclopropyl


1982.
CH3
F
Z25, wherein Re is cyclopropyl


1983.
CH3
OCH3
Z25, wherein Re is cyclopropyl


1984.
Et
H
Z25, wherein Re is cyclopropyl


1985.
Et
F
Z25, wherein Re is cyclopropyl


1986.
Et
OCH3
Z25, wherein Re is cyclopropyl


1987.
cPI
H
Z25, wherein Re is cyclopropyl


1988.
cPr
F
Z25, wherein Re is cyclopropyl


1989.
cPr
OCH3
Z25, wherein Re is cyclopropyl


1990.
CH3
H
Z25, wherein Re is cyclobutyl


1991.
CH3
F
Z25, wherein Re is cyclobutyl


1992.
CH3
OCH3
Z25, wherein Re is cyclobutyl


1993.
Et
H
Z25, wherein Re is cyclobutyl


1994.
Et
F
Z25, wherein Re is cyclobutyl


1995.
Et
OCH3
Z25, wherein Re is cyclobutyl


1996.
cPr
H
Z25, wherein Re is cyclobutyl


1997.
cPr
F
Z25, wherein Re is cyclobutyl


1998.
cPr
OCH3
Z25, wherein Re is cyclobutyl


1999.
CH3
H
Z25, wherein Re is CH2-cyclopropyl


2000.
CH3
F
Z25, wherein Re is CH2-cyclopropyl


2001.
CH3
OCH3
Z25, wherein Re is CH2-cyclopropyl


2002.
Et
H
Z25, wherein Re is CH2-cyclopropyl


2003.
Et
F
Z25, wherein Re is CH2-cyclopropyl


2004.
Et
OCH3
Z25, wherein Re is CH2-cyclopropyl


2005.
cPr
H
Z25, wherein Re is CH2-cyclopropyl


2006.
cPr
F
Z25, wherein Re is CH2-cyclopropyl


2007.
cPr
OCH3
Z25, wherein Re is CH2-cyclopropyl


2008.
CH3
H
Z25, wherein Re is CH2CH2OCH3


2009.
CH3
F
Z25, wherein Re is CH2CH2OCH3


2010.
CH3
OCH3
Z25, wherein Re is CH2CH2OCH3


2011.
Et
H
Z25, wherein Re is CH2CH2OCH3


2012.
Et
F
Z25, wherein Re is CH2CH2OCH3


2013.
Et
OCH3
Z25, wherein Re is CH2CH2OCH3


2014.
cPr
H
Z25, wherein Re is CH2CH2OCH3


2015.
cPr
F
Z25, wherein Re is CH2CH2OCH3


2016.
cPr
OCH3
Z25, wherein Re is CH2CH2OCH3


2017.
CH3
H
Z26, wherein Re is CH3


2018.
CH3
F
Z26, wherein Re is CH3


2019.
CH3
OCH3
Z26, wherein Re is CH3


2020.
Et
H
Z26, wherein Re is CH3


2021.
Et
F
Z26, wherein Re is CH3


2022.
Et
OCH3
Z26, wherein Re is CH3


2023.
cPr
H
Z26, wherein Re is CH3


2024.
cPr
F
Z26, wherein Re is CH3


2025.
cPr
OCH3
Z26, wherein Re is CH3


2026.
CH3
H
Z26, wherein Re is ethyl


2027.
CH3
F
Z26, wherein Re is ethyl


2028.
CH3
OCH3
Z26, wherein Re is ethyl


2029.
Et
H
Z26, wherein Re is ethyl


2030.
Et
F
Z26, wherein Re is ethyl


2031.
Et
OCH3
Z26, wherein Re is ethyl


2032.
cPr
H
Z26, wherein Re is ethyl


2033.
cPr
F
Z26, wherein Re is ethyl


2034.
cPr
OCH3
Z26, wherein Re is ethyl


2035.
CH3
H
Z26, wherein Re is n-propyl


2036.
CH3
F
Z26, wherein Re is n-propyl


2037.
CH3
OCH3
Z26, wherein Re is n-propyl


2038.
Et
H
Z26, wherein Re is n-propyl


2039.
Et
F
Z26, wherein Re is n-propyl


2040.
Et
OCH3
Z26, wherein Re is n-propyl


2041.
cPr
H
Z26, wherein Re is n-propyl


2042.
cPr
F
Z26, wherein Re is n-propyl


2043.
cPr
OCH3
Z26, wherein Re is n-propyl


2044.
CH3
H
Z26, wherein Re is isopropyl


2045.
CH3
F
Z26, wherein Re is isopropyl


2046.
CH3
OCH3
Z26, wherein Re is isopropyl


2047.
Et
H
Z26, wherein Re is isopropyl


2048.
Et
F
Z26, wherein Re is isopropyl


2049.
Et
OCH3
Z26, wherein Re is isopropyl


2050.
cPr
H
Z26, wherein Re is isopropyl


2051.
cPr
F
Z26, wherein Re is isopropyl


2052.
cPr
OCH3
Z26, wherein Re is isopropyl


2053.
CH3
H
Z26, wherein Re is cyclopropyl


2054.
CH3
F
Z26, wherein Re is cyclopropyl


2055.
CH3
OCH3
Z26, wherein Re is cyclopropyl


2056.
Et
H
Z26, wherein Re is cyclopropyl


2057.
Et
F
Z26, wherein Re is cyclopropyl


2058.
Et
OCH3
Z26, wherein Re is cyclopropyl


2059.
cPr
H
Z26, wherein Re is cyclopropyl


2060.
cPr
F
Z26, wherein Re is cyclopropyl


2061.
cPr
OCH3
Z26, wherein Re is cyclopropyl


2062.
CH3
H
Z26, wherein Re is cyclobutyl


2063.
CH3
F
Z26, wherein Re is cyclobutyl


2064.
CH3
OCH3
Z26, wherein Re is cyclobutyl


2065.
Et
H
Z26, wherein Re is cyclobutyl


2066.
Et
F
Z26, wherein Re is cyclobutyl


2067.
Et
OCH3
Z26, wherein Re is cyclobutyl


2068.
cPr
H
Z26, wherein Re is cyclobutyl


2069.
cPr
F
Z26, wherein Re is cyclobutyl


2070.
cPr
OCH3
Z26, wherein Re is cyclobutyl


2071.
CH3
H
Z26, wherein Re is CH2-cyclopropyl


2072.
CH3
F
Z26, wherein Re is CH2-cyclopropyl


2073.
CH3
OCH3
Z26, wherein Re is CH2-cyclopropyl


2074.
Et
H
Z26, wherein Re is CH2-cyclopropyl


2075.
Et
F
Z26, wherein Re is CH2-cyclopropyl


2076.
Et
OCH3
Z26, wherein Re is CH2-cyclopropyl


2077.
cPr
H
Z26, wherein Re is CH2-cyclopropyl


2078.
cPr
F
Z26, wherein Re is CH2-cyclopropyl


2079.
cPr
OCH3
Z26, wherein Re is CH2-cyclopropyl


2080.
CH3
H
Z26, wherein Re is CH2CH2OCH3


2081.
CH3
F
Z26, wherein Re is CH2CH2OCH3


2082.
CH3
OCH3
Z26, wherein Re is CH2CH2OCH3


2083.
Et
H
Z26, wherein Re is CH2CH2OCH3


2084.
Et
F
Z26, wherein Re is CH2CH2OCH3


2085.
Et
OCH3
Z26, wherein Re is CH2CH2OCH3


2086.
cPr
H
Z26, wherein Re is CH2CH2OCH3


2087.
cPr
F
Z26, wherein Re is CH2CH2OCH3


2088.
cPr
OCH3
Z26, wherein Re is CH2CH2OCH3


2089.
CH3
H
Z27, wherein Re is CH3


2090.
CH3
F
Z27, wherein Re is CH3


2091.
CH3
OCH3
Z27, wherein Re is CH3


2092.
Et
H
Z27, wherein Re is CH3


2093.
Et
F
Z27, wherein Re is CH3


2094.
Et
OCH3
Z27, wherein Re is CH3


2095.
cPr
H
Z27, wherein Re is CH3


2096.
cPr
F
Z27, wherein Re is CH3


2097.
cPr
OCH3
Z27, wherein Re is CH3


2098.
CH3
H
Z27, wherein Re is ethyl


2099.
CH3
F
Z27, wherein Re is ethyl


2100.
CH3
OCH3
Z27, wherein Re is ethyl


2101.
Et
H
Z27, wherein Re is ethyl


2102.
Et
F
Z27, wherein Re is ethyl


2103.
Et
OCH3
Z27, wherein Re is ethyl


2104.
cPr
H
Z27, wherein Re is ethyl


2105.
cPr
F
Z27, wherein Re is ethyl


2106.
cPr
OCH3
Z27, wherein Re is ethyl


2107.
CH3
H
Z27, wherein Re is n-propyl


2108.
CH3
F
Z27, wherein Re is n-propyl


2109.
CH3
OCH3
Z27, wherein Re is n-propyl


2110.
Et
H
Z27, wherein Re is n-propyl


2111.
Et
F
Z27, wherein Re is n-propyl


2112.
Et
OCH3
Z27, wherein Re is n-propyl


2113.
cPr
H
Z27, wherein Re is n-propyl


2114.
cPr
F
Z27, wherein Re is n-propyl


2115.
cPr
OCH3
Z27, wherein Re is n-propyl


2116.
CH3
H
Z27, wherein Re is isopropyl


2117.
CH3
F
Z27, wherein Re is isopropyl


2118.
CH3
OCH3
Z27, wherein Re is isopropyl


2119.
Et
H
Z27, wherein Re is isopropyl


2120.
Et
F
Z27, wherein Re is isopropyl


2121.
Et
OCH3
Z27, wherein Re is isopropyl


2122.
cPr
H
Z27, wherein Re is isopropyl


2123.
cPr
F
Z27, wherein Re is isopropyl


2124.
cPr
OCH3
Z27, wherein Re is isopropyl


2125.
CH3
H
Z27, wherein Re is cyclopropyl


2126.
CH3
F
Z27, wherein Re is cyclopropyl


2127.
CH3
OCH3
Z27, wherein Re is cyclopropyl


2128.
Et
H
Z27, wherein Re is cyclopropyl


2129.
Et
F
Z27, wherein Re is cyclopropyl


2130.
Et
OCH3
Z27, wherein Re is cyclopropyl


2131.
cPr
H
Z27, wherein Re is cyclopropyl


2132.
cPr
F
Z27, wherein Re is cyclopropyl


2133.
cPr
OCH3
Z27, wherein Re is cyclopropyl


2134.
CH3
H
Z27, wherein Re is cyclobutyl


2135.
CH3
F
Z27, wherein Re is cyclobutyl


2136.
CH3
OCH3
Z27, wherein Re is cyclobutyl


2137.
Et
H
Z27, wherein Re is cyclobutyl


2138.
Et
F
Z27, wherein Re is cyclobutyl


2139.
Et
OCH3
Z27, wherein Re is cyclobutyl


2140.
cPr
H
Z27, wherein Re is cyclobutyl


2141.
cPr
F
Z27, wherein Re is cyclobutyl


2142.
cPr
OCH3
Z27, wherein Re is cyclobutyl


2143.
CH3
H
Z27, wherein Re is CH2-cyclopropyl


2144.
CH3
F
Z27, wherein Re is CH2-cyclopropyl


2145.
CH3
OCH3
Z27, wherein Re is CH2-cyclopropyl


2146.
Et
H
Z27, wherein Re is CH2-cyclopropyl


2147.
Et
F
Z27, wherein Re is CH2-cyclopropyl


2148.
Et
OCH3
Z27, wherein Re is CH2-cyclopropyl


2149.
cPr
H
Z27, wherein Re is CH2-cyclopropyl


2150.
cPr
F
Z27, wherein Re is CH2-cyclopropyl


2151.
cPr
OCH3
Z27, wherein Re is CH2-cyclopropyl


2152.
CH3
H
Z27, wherein Re is CH2CH2OCH3


2153.
CH3
F
Z27, wherein Re is CH2CH2OCH3


2154.
CH3
OCH3
Z27, wherein Re is CH2CH2OCH3


2155.
Et
H
Z27, wherein Re is CH2CH2OCH3


2156.
Et
F
Z27, wherein Re is CH2CH2OCH3


2157.
Et
OCH3
Z27, wherein Re is CH2CH2OCH3


2158.
cPr
H
Z27, wherein Re is CH2CH2OCH3


2159.
cPr
F
Z27, wherein Re is CH2CH2OCH3


2160.
cPr
OCH3
Z27, wherein Re is CH2CH2OCH3


2161.
CH3
H
Z28, wherein Re is CH3


2162.
CH3
F
Z28, wherein Re is CH3


2163.
CH3
OCH3
Z28, wherein Re is CH3


2164.
Et
H
Z28, wherein Re is CH3


2165.
Et
F
Z28, wherein Re is CH3


2166.
Et
OCH3
Z28, wherein Re is CH3


2167.
cPr
H
Z28, wherein Re is CH3


2168.
cPr
F
Z28, wherein Re is CH3


2169.
cPr
OCH3
Z28, wherein Re is CH3


2170.
CH3
H
Z28, wherein Re is ethyl


2171.
CH3
F
Z28, wherein Re is ethyl


2172.
CH3
OCH3
Z28, wherein Re is ethyl


2173.
Et
H
Z28, wherein Re is ethyl


2174.
Et
F
Z28, wherein Re is ethyl


2175.
Et
OCH3
Z28, wherein Re is ethyl


2176.
cPr
H
Z28, wherein Re is ethyl


2177.
cPr
F
Z28, wherein Re is ethyl


2178.
cPr
OCH3
Z28, wherein Re is ethyl


2179.
CH3
H
Z28, wherein Re is n-propyl


2180.
CH3
F
Z28, wherein Re is n-propyl


2181.
CH3
OCH3
Z28, wherein Re is n-propyl


2182.
Et
H
Z28, wherein Re is n-propyl


2183.
Et
F
Z28, wherein Re is n-propyl


2184.
Et
OCH3
Z28, wherein Re is n-propyl


2185.
cPr
H
Z28, wherein Re is n-propyl


2186.
cPr
F
Z28, wherein Re is n-propyl


2187.
cPr
OCH3
Z28, wherein Re is n-propyl


2188.
CH3
H
Z28, wherein Re is isopropyl


2189.
CH3
F
Z28, wherein Re is isopropyl


2190.
CH3
OCH3
Z28, wherein Re is isopropyl


2191.
Et
H
Z28, wherein Re is isopropyl


2192.
Et
F
Z28, wherein Re is isopropyl


2193.
Et
OCH3
Z28, wherein Re is isopropyl


2194.
cPr
H
Z28, wherein Re is isopropyl


2195.
cPr
F
Z28, wherein Re is isopropyl


2196.
cPr
OCH3
Z28, wherein Re is isopropyl


2197.
CH3
H
Z28, wherein Re is cyclopropyl


2198.
CH3
F
Z28, wherein Re is cyclopropyl


2199.
CH3
OCH3
Z28, wherein Re is cyclopropyl


2200.
Et
H
Z28, wherein Re is cyclopropyl


2201.
Et
F
Z28, wherein Re is cyclopropyl


2202.
Et
OCH3
Z28, wherein Re is cyclopropyl


2203.
cPr
H
Z28, wherein Re is cyclopropyl


2204.
cPr
F
Z28, wherein Re is cyclopropyl


2205.
cPr
OCH3
Z28, wherein Re is cyclopropyl


2206.
CH3
H
Z28, wherein Re is cyclobutyl


2207.
CH3
F
Z28, wherein Re is cyclobutyl


2208.
CH3
OCH3
Z28, wherein Re is cyclobutyl


2209.
Et
H
Z28, wherein Re is cyclobutyl


2210.
Et
F
Z28, wherein Re is cyclobutyl


2211.
Et
OCH3
Z28, wherein Re is cyclobutyl


2212.
cPr
H
Z28, wherein Re is cyclobutyl


2213.
cPr
F
Z28, wherein Re is cyclobutyl


2214.
cPr
OCH3
Z28, wherein Re is cyclobutyl


2215.
CH3
H
Z28, wherein Re is CH2-cyclopropyl


2216.
CH3
F
Z28, wherein Re is CH2-cyclopropyl


2217.
CH3
OCH3
Z28, wherein Re is CH2-cyclopropyl


2218.
Et
H
Z28, wherein Re is CH2-cyclopropyl


2219.
Et
F
Z28, wherein Re is CH2-cyclopropyl


2220.
Et
OCH3
Z28, wherein Re is CH2-cyclopropyl


2221.
cPr
H
Z28, wherein Re is CH2-cyclopropyl


2222.
cPr
F
Z28, wherein Re is CH2-cyclopropyl


2223.
cPr
OCH3
Z28, wherein Re is CH2-cyclopropyl


2224.
CH3
H
Z28, wherein Re is CH2CH2OCH3


2225.
CH3
F
Z28, wherein Re is CH2CH2OCH3


2226.
CH3
OCH3
Z28, wherein Re is CH2CH2OCH3


2227.
Et
H
Z28, wherein Re is CH2CH2OCH3


2228.
Et
F
Z28, wherein Re is CH2CH2OCH3


2229.
Et
OCH3
Z28, wherein Re is CH2CH2OCH3


2230.
cPr
H
Z28, wherein Re is CH2CH2OCH3


2231.
cPr
F
Z28, wherein Re is CH2CH2OCH3


2232.
cPr
OCH3
Z28, wherein Re is CH2CH2OCH3


2233.
CH3
H
Z29, wherein Re is CH3


2234.
CH3
F
Z29, wherein Re is CH3


2235.
CH3
OCH3
Z29, wherein Re is CH3


2236.
Et
H
Z29, wherein Re is CH3


2237.
Et
F
Z29, wherein Re is CH3


2238.
Et
OCH3
Z29, wherein Re is CH3


2239.
cPr
H
Z29, wherein Re is CH3


2240.
cPr
F
Z29, wherein Re is CH3


2241.
cPr
OCH3
Z29, wherein Re is CH3


2242.
CH3
H
Z29, wherein Re is ethyl


2243.
CH3
F
Z29, wherein Re is ethyl


2244.
CH3
OCH3
Z29, wherein Re is ethyl


2245.
Et
H
Z29, wherein Re is ethyl


2246.
Et
F
Z29, wherein Re is ethyl


2247.
Et
OCH3
Z29, wherein Re is ethyl


2248.
cPr
H
Z29, wherein Re is ethyl


2249.
cPr
F
Z29, wherein Re is ethyl


2250.
cPr
OCH3
Z29, wherein Re is ethyl


2251.
CH3
H
Z29, wherein Re is n-propyl


2252.
CH3
F
Z29, wherein Re is n-propyl


2253.
CH3
OCH3
Z29, wherein Re is n-propyl


2254.
Et
H
Z29, wherein Re is n-propyl


2255.
Et
F
Z29, wherein Re is n-propyl


2256.
Et
OCH3
Z29, wherein Re is n-propyl


2257.
cPr
H
Z29, wherein Re is n-propyl


2258.
cPr
F
Z29, wherein Re is n-propyl


2259.
cPr
OCH3
Z29, wherein Re is n-propyl


2260.
CH3
H
Z29, wherein Re is isopropyl


2261.
CH3
F
Z29, wherein Re is isopropyl


2262.
CH3
OCH3
Z29, wherein Re is isopropyl


2263.
Et
H
Z29, wherein Re is isopropyl


2264.
Et
F
Z29, wherein Re is isopropyl


2265.
Et
OCH3
Z29, wherein Re is isopropyl


2266.
cPr
H
Z29, wherein Re is isopropyl


2267.
cPr
F
Z29, wherein Re is isopropyl


2268.
cPr
OCH3
Z29, wherein Re is isopropyl


2269.
CH3
H
Z29, wherein Re is cyclopropyl


2270.
CH3
F
Z29, wherein Re is cyclopropyl


2271.
CH3
OCH3
Z29, wherein Re is cyclopropyl


2272.
Et
H
Z29, wherein Re is cyclopropyl


2273.
Et
F
Z29, wherein Re is cyclopropyl


2274.
Et
OCH3
Z29, wherein Re is cyclopropyl


2275.
cPr
H
Z29, wherein Re is cyclopropyl


2276.
cPr
F
Z29, wherein Re is cyclopropyl


2277.
cPr
OCH3
Z29, wherein Re is cyclopropyl


2278.
CH3
H
Z29, wherein Re is cyclobutyl


2279.
CH3
F
Z29, wherein Re is cyclobutyl


2280.
CH3
OCH3
Z29, wherein Re is cyclobutyl


2281.
Et
H
Z29, wherein Re is cyclobutyl


2282.
Et
F
Z29, wherein Re is cyclobutyl


2283.
Et
OCH3
Z29, wherein Re is cyclobutyl


2284.
cPr
H
Z29, wherein Re is cyclobutyl


2285.
cPr
F
Z29, wherein Re is cyclobutyl


2286.
cPr
OCH3
Z29, wherein Re is cyclobutyl


2287.
CH3
H
Z29, wherein Re is CH2-cyclopropyl


2288.
CH3
F
Z29, wherein Re is CH2-cyclopropyl


2289.
CH3
OCH3
Z29, wherein Re is CH2-cyclopropyl


2290.
Et
H
Z29, wherein Re is CH2-cyclopropyl


2291.
Et
F
Z29, wherein Re is CH2-cyclopropyl


2292.
Et
OCH3
Z29, wherein Re is CH2-cyclopropyl


2293.
cPr
H
Z29, wherein Re is CH2-cyclopropyl


2294.
cPr
F
Z29, wherein Re is CH2-cyclopropyl


2295.
cPr
OCH3
Z29, wherein Re is CH2-cyclopropyl


2296.
CH3
H
Z29, wherein Re is CH2CH2OCH3


2297.
CH3
F
Z29, wherein Re is CH2CH2OCH3


2298.
CH3
OCH3
Z29, wherein Re is CH2CH2OCH3


2299.
Et
H
Z29, wherein Re is CH2CH2OCH3


2300.
Et
F
Z29, wherein Re is CH2CH2OCH3


2301.
Et
OCH3
Z29, wherein Re is CH2CH2OCH3


2302.
cPr
H
Z29, wherein Re is CH2CH2OCH3


2303.
cPr
F
Z29, wherein Re is CH2CH2OCH3


2304.
cPr
OCH3
Z29, wherein Re is CH2CH2OCH3


2305.
CH3
H
Z30, wherein Re is CH3


2306.
CH3
F
Z30, wherein Re is CH3


2307.
CH3
OCH3
Z30, wherein Re is CH3


2308.
Et
H
Z30, wherein Re is CH3


2309.
Et
F
Z30, wherein Re is CH3


2310.
Et
OCH3
Z30, wherein Re is CH3


2311.
cPr
H
Z30, wherein Re is CH3


2312.
cPr
F
Z30, wherein Re is CH3


2313.
cPr
OCH3
Z30, wherein Re is CH3


2314.
CH3
H
Z30, wherein Re is ethyl


2315.
CH3
F
Z30, wherein Re is ethyl


2316.
CH3
OCH3
Z30, wherein Re is ethyl


2317.
Et
H
Z30, wherein Re is ethyl


2318.
Et
F
Z30, wherein Re is ethyl


2319.
Et
OCH3
Z30, wherein Re is ethyl


2320.
cPr
H
Z30, wherein Re is ethyl


2321.
cPr
F
Z30, wherein Re is ethyl


2322.
cPr
OCH3
Z30, wherein Re is ethyl


2323.
CH3
H
Z30, wherein Re is n-propyl


2324.
CH3
F
Z30, wherein Re is n-propyl


2325.
CH3
OCH3
Z30, wherein Re is n-propyl


2326.
Et
H
Z30, wherein Re is n-propyl


2327.
Et
F
Z30, wherein Re is n-propyl


2328.
Et
OCH3
Z30, wherein Re is n-propyl


2329.
cPr
H
Z30, wherein Re is n-propyl


2330.
cPr
F
Z30, wherein Re is n-propyl


2331.
cPr
OCH3
Z30, wherein Re is n-propyl


2332.
CH3
H
Z30, wherein Re is isopropyl


2333.
CH3
F
Z30, wherein Re is isopropyl


2334.
CH3
OCH3
Z30, wherein Re is isopropyl


2335.
Et
H
Z30, wherein Re is isopropyl


2336.
Et
F
Z30, wherein Re is isopropyl


2337.
Et
OCH3
Z30, wherein Re is isopropyl


2338.
cPr
H
Z30, wherein Re is isopropyl


2339.
cPr
F
Z30, wherein Re is isopropyl


2340.
cPr
OCH3
Z30, wherein Re is isopropyl


2341.
CH3
H
Z30, wherein Re is cyclopropyl


2342.
CH3
F
Z30, wherein Re is cyclopropyl


2343.
CH3
OCH3
Z30, wherein Re is cyclopropyl


2344.
Et
H
Z30, wherein Re is cyclopropyl


2345.
Et
F
Z30, wherein Re is cyclopropyl


2346.
Et
OCH3
Z30, wherein Re is cyclopropyl


2347.
cPr
H
Z30, wherein Re is cyclopropyl


2348.
cPr
F
Z30, wherein Re is cyclopropyl


2349.
cPr
OCH3
Z30, wherein Re is cyclopropyl


2350.
CH3
H
Z30, wherein Re is cyclobutyl


2351.
CH3
F
Z30, wherein Re is cyclobutyl


2352.
CH3
OCH3
Z30, wherein Re is cyclobutyl


2353.
Et
H
Z30, wherein Re is cyclobutyl


2354.
Et
F
Z30, wherein Re is cyclobutyl


2355.
Et
OCH3
Z30, wherein Re is cyclobutyl


2356.
cPr
H
Z30, wherein Re is cyclobutyl


2357.
cPr
F
Z30, wherein Re is cyclobutyl


2358.
cPr
OCH3
Z30, wherein Re is cyclobutyl


2359.
CH3
H
Z30, wherein Re is CH2-cyclopropyl


2360.
CH3
F
Z30, wherein Re is CH2-cyclopropyl


2361.
CH3
OCH3
Z30, wherein Re is CH2-cyclopropyl


2362.
Et
H
Z30, wherein Re is CH2-cyclopropyl


2363.
Et
F
Z30, wherein Re is CH2-cyclopropyl


2364.
Et
OCH3
Z30, wherein Re is CH2-cyclopropyl


2365.
cPr
H
Z30, wherein Re is CH2-cyclopropyl


2366.
cPr
F
Z30, wherein Re is CH2-cyclopropyl


2367.
cPr
OCH3
Z30, wherein Re is CH2-cyclopropyl


2368.
CH3
H
Z30, wherein Re is CH2CH2OCH3


2369.
CH3
F
Z30, wherein Re is CH2CH2OCH3


2370.
CH3
OCH3
Z30, wherein Re is CH2CH2OCH3


2371.
Et
H
Z30, wherein Re is CH2CH2OCH3


2372.
Et
F
Z30, wherein Re is CH2CH2OCH3


2373.
Et
OCH3
Z30, wherein Re is CH2CH2OCH3


2374.
cPr
H
Z30, wherein Re is CH2CH2OCH3


2375.
cPr
F
Z30, wherein Re is CH2CH2OCH3


2376.
cPr
OCH3
Z30, wherein Re is CH2CH2OCH3


2377.
CH3
H
Z31, wherein Re is CH3


2378.
CH3
F
Z31, wherein Re is CH3


2379.
CH3
OCH3
Z31, wherein Re is CH3


2380.
Et
H
Z31, wherein Re is CH3


2381.
Et
F
Z31, wherein Re is CH3


2382.
Et
OCH3
Z31, wherein Re is CH3


2383.
cPr
H
Z31, wherein Re is CH3


2384.
cPr
F
Z31, wherein Re is CH3


2385.
cPr
OCH3
Z31, wherein Re is CH3


2386.
CH3
H
Z31, wherein Re is ethyl


2387.
CH3
F
Z31, wherein Re is ethyl


2388.
CH3
OCH3
Z31, wherein Re is ethyl


2389.
Et
H
Z31, wherein Re is ethyl


2390.
Et
F
Z31, wherein Re is ethyl


2391.
Et
OCH3
Z31, wherein Re is ethyl


2392.
cPr
H
Z31, wherein Re is ethyl


2393.
cPr
F
Z31, wherein Re is ethyl


2394.
cPr
OCH3
Z31, wherein Re is ethyl


2395.
CH3
H
Z31, wherein Re is n-propyl


2396.
CH3
F
Z31, wherein Re is n-propyl


2397.
CH3
OCH3
Z31, wherein Re is n-propyl


2398.
Et
H
Z31, wherein Re is n-propyl


2399.
Et
F
Z31, wherein Re is n-propyl


2400.
Et
OCH3
Z31, wherein Re is n-propyl


2401.
cPr
H
Z31, wherein Re is n-propyl


2402.
cPr
F
Z31, wherein Re is n-propyl


2403.
cPr
OCH3
Z31, wherein Re is n-propyl


2404.
CH3
H
Z31, wherein Re is isopropyl


2405.
CH3
F
Z31, wherein Re is isopropyl


2406.
CH3
OCH3
Z31, wherein Re is isopropyl


2407.
Et
H
Z31, wherein Re is isopropyl


2408.
Et
F
Z31, wherein Re is isopropyl


2409.
Et
OCH3
Z31, wherein Re is isopropyl


2410.
cPr
H
Z31, wherein Re is isopropyl


2411.
cPr
F
Z31, wherein Re is isopropyl


2412.
cPr
OCH3
Z31, wherein Re is isopropyl


2413.
CH3
H
Z31, wherein Re is cyclopropyl


2414.
CH3
F
Z31, wherein Re is cyclopropyl


2415.
CH3
OCH3
Z31, wherein Re is cyclopropyl


2416.
Et
H
Z31, wherein Re is cyclopropyl


2417.
Et
F
Z31, wherein Re is cyclopropyl


2418.
Et
OCH3
Z31, wherein Re is cyclopropyl


2419.
cPr
H
Z31, wherein Re is cyclopropyl


2420.
cPr
F
Z31, wherein Re is cyclopropyl


2421.
cPr
OCH3
Z31, wherein Re is cyclopropyl


2422.
CH3
H
Z31, wherein Re is cyclobutyl


2423.
CH3
F
Z31, wherein Re is cyclobutyl


2424.
CH3
OCH3
Z31, wherein Re is cyclobutyl


2425.
Et
H
Z31, wherein Re is cyclobutyl


2426.
Et
F
Z31, wherein Re is cyclobutyl


2427.
Et
OCH3
Z31, wherein Re is cyclobutyl


2428.
cPr
H
Z31, wherein Re is cyclobutyl


2429.
cPr
F
Z31, wherein Re is cyclobutyl


2430.
cPr
OCH3
Z31, wherein Re is cyclobutyl


2431.
CH3
H
Z31, wherein Re is CH2-cyclopropyl


2432.
CH3
F
Z31, wherein Re is CH2-cyclopropyl


2433.
CH3
OCH3
Z31, wherein Re is CH2-cyclopropyl


2434.
Et
H
Z31, wherein Re is CH2-cyclopropyl


2435.
Et
F
Z31, wherein Re is CH2-cyclopropyl


2436.
Et
OCH3
Z31, wherein Re is CH2-cyclopropyl


2437.
cPr
H
Z31, wherein Re is CH2-cyclopropyl


2438.
cPr
F
Z31, wherein Re is CH2-cyclopropyl


2439.
cPr
OCH3
Z31, wherein Re is CH2-cyclopropyl


2440.
CH3
H
Z31, wherein Re is CH2CH2OCH3


2441.
CH3
F
Z31, wherein Re is CH2CH2OCH3


2442.
CH3
OCH3
Z31, wherein Re is CH2CH2OCH3


2443.
Et
H
Z31, wherein Re is CH2CH2OCH3


2444.
Et
F
Z31, wherein Re is CH2CH2OCH3


2445.
Et
OCH3
Z31, wherein Re is CH2CH2OCH3


2446.
cPr
H
Z31, wherein Re is CH2CH2OCH3


2447.
cPr
F
Z31, wherein Re is CH2CH2OCH3


2448.
cPr
OCH3
Z31, wherein Re is CH2CH2OCH3


2449.
CH3
H
Z32, wherein Re is CH3


2450.
CH3
F
Z32, wherein Re is CH3


2451.
CH3
OCH3
Z32, wherein Re is CH3


2452.
Et
H
Z32, wherein Re is CH3


2453.
Et
F
Z32, wherein Re is CH3


2454.
Et
OCH3
Z32, wherein Re is CH3


2455.
cPr
H
Z32, wherein Re is CH3


2456.
cPr
F
Z32, wherein Re is CH3


2457.
cPr
OCH3
Z32, wherein Re is CH3


2458.
CH3
H
Z32, wherein Re is ethyl


2459.
CH3
F
Z32, wherein Re is ethyl


2460.
CH3
OCH3
Z32, wherein Re is ethyl


2461.
Et
H
Z32, wherein Re is ethyl


2462.
Et
F
Z32, wherein Re is ethyl


2463.
Et
OCH3
Z32, wherein Re is ethyl


2464.
cPr
H
Z32, wherein Re is ethyl


2465.
cPr
F
Z32, wherein Re is ethyl


2466.
cPr
OCH3
Z32, wherein Re is ethyl


2467.
CH3
H
Z32, wherein Re is n-propyl


2468.
CH3
F
Z32, wherein Re is n-propyl


2469.
CH3
OCH3
Z32, wherein Re is n-propyl


2470.
Et
H
Z32, wherein Re is n-propyl


2471.
Et
F
Z32, wherein Re is n-propyl


2472.
Et
OCH3
Z32, wherein Re is n-propyl


2473.
cPr
H
Z32, wherein Re is n-propyl


2474.
cPr
F
Z32, wherein Re is n-propyl


2475.
cPr
OCH3
Z32, wherein Re is n-propyl


2476.
CH3
H
Z32, wherein Re is isopropyl


2477.
CH3
F
Z32, wherein Re is isopropyl


2478.
CH3
OCH3
Z32, wherein Re is isopropyl


2479.
Et
H
Z32, wherein Re is isopropyl


2480.
Et
F
Z32, wherein Re is isopropyl


2481.
Et
OCH3
Z32, wherein Re is isopropyl


2482.
cPr
H
Z32, wherein Re is isopropyl


2483.
cPr
F
Z32, wherein Re is isopropyl


2484.
cPr
OCH3
Z32, wherein Re is isopropyl


2485.
CH3
H
Z32, wherein Re is cyclopropyl


2486.
CH3
F
Z32, wherein Re is cyclopropyl


2487.
CH3
OCH3
Z32, wherein Re is cyclopropyl


2488.
Et
H
Z32, wherein Re is cyclopropyl


2489.
Et
F
Z32, wherein Re is cyclopropyl


2490.
Et
OCH3
Z32, wherein Re is cyclopropyl


2491.
cPr
H
Z32, wherein Re is cyclopropyl


2492.
cPr
F
Z32, wherein Re is cyclopropyl


2493.
cPr
OCH3
Z32, wherein Re is cyclopropyl


2494.
CH3
H
Z32, wherein Re is cyclobutyl


2495.
CH3
F
Z32, wherein Re is cyclobutyl


2496.
CH3
OCH3
Z32, wherein Re is cyclobutyl


2497.
Et
H
Z32, wherein Re is cyclobutyl


2498.
Et
F
Z32, wherein Re is cyclobutyl


2499.
Et
OCH3
Z32, wherein Re is cyclobutyl


2500.
cPr
H
Z32, wherein Re is cyclobutyl


2501.
cPr
F
Z32, wherein Re is cyclobutyl


2502.
cPr
OCH3
Z32, wherein Re is cyclobutyl


2503.
CH3
H
Z32, wherein Re is CH2-cyclopropyl


2504.
CH3
F
Z32, wherein Re is CH2-cyclopropyl


2505.
CH3
OCH3
Z32, wherein Re is CH2-cyclopropyl


2506.
Et
H
Z32, wherein Re is CH2-cyclopropyl


2507.
Et
F
Z32, wherein Re is CH2-cyclopropyl


2508.
Et
OCH3
Z32, wherein Re is CH2-cyclopropyl


2509.
cPr
H
Z32, wherein Re is CH2-cyclopropyl


2510.
cPr
F
Z32, wherein Re is CH2-cyclopropyl


2511.
cPr
OCH3
Z32, wherein Re is CH2-cyclopropyl


2512.
CH3
H
Z32, wherein Re is CH2CH2OCH3


2513.
CH3
F
Z32, wherein Re is CH2CH2OCH3


2514.
CH3
OCH3
Z32, wherein Re is CH2CH2OCH3


2515.
Et
H
Z32, wherein Re is CH2CH2OCH3


2516.
Et
F
Z32, wherein Re is CH2CH2OCH3


2517.
Et
OCH3
Z32, wherein Re is CH2CH2OCH3


2518.
cPr
H
Z32, wherein Re is CH2CH2OCH3


2519.
cPr
F
Z32, wherein Re is CH2CH2OCH3


2520.
cPr
OCH3
Z32, wherein Re is CH2CH2OCH3


2521.
CH3
H
Z33, wherein Re is CH3


2522.
CH3
F
Z33, wherein Re is CH3


2523.
CH3
OCH3
Z33, wherein Re is CH3


2524.
Et
H
Z33, wherein Re is CH3


2525.
Et
F
Z33, wherein Re is CH3


2526.
Et
OCH3
Z33, wherein Re is CH3


2527.
cPr
H
Z33, wherein Re is CH3


2528.
cPr
F
Z33, wherein Re is CH3


2529.
cPr
OCH3
Z33, wherein Re is CH3


2530.
CH3
H
Z33, wherein Re is ethyl


2531.
CH3
F
Z33, wherein Re is ethyl


2532.
CH3
OCH3
Z33, wherein Re is ethyl


2533.
Et
H
Z33, wherein Re is ethyl


2534.
Et
F
Z33, wherein Re is ethyl


2535.
Et
OCH3
Z33, wherein Re is ethyl


2536.
cPr
H
Z33, wherein Re is ethyl


2537.
cPr
F
Z33, wherein Re is ethyl


2538.
cPr
OCH3
Z33, wherein Re is ethyl


2539.
CH3
H
Z33, wherein Re is n-propyl


2540.
CH3
F
Z33, wherein Re is n-propyl


2541.
CH3
OCH3
Z33, wherein Re is n-propyl


2542.
Et
H
Z33, wherein Re is n-propyl


2543.
Et
F
Z33, wherein Re is n-propyl


2544.
Et
OCH3
Z33, wherein Re is n-propyl


2545.
cPr
H
Z33, wherein Re is n-propyl


2546.
cPr
F
Z33, wherein Re is n-propyl


2547.
cPr
OCH3
Z33, wherein Re is n-propyl


2548.
CH3
H
Z33, wherein Re is isopropyl


2549.
CH3
F
Z33, wherein Re is isopropyl


2550.
CH3
OCH3
Z33, wherein Re is isopropyl


2551.
Et
H
Z33, wherein Re is isopropyl


2552.
Et
F
Z33, wherein Re is isopropyl


2553.
Et
OCH3
Z33, wherein Re is isopropyl


2554.
cPr
H
Z33, wherein Re is isopropyl


2555.
cPr
F
Z33, wherein Re is isopropyl


2556.
cPr
OCH3
Z33, wherein Re is isopropyl


2557.
CH3
H
Z33, wherein Re is cyclopropyl


2558.
CH3
F
Z33, wherein Re is cyclopropyl


2559.
CH3
OCH3
Z33, wherein Re is cyclopropyl


2560.
Et
H
Z33, wherein Re is cyclopropyl


2561.
Et
F
Z33, wherein Re is cyclopropyl


2562.
Et
OCH3
Z33, wherein Re is cyclopropyl


2563.
cPr
H
Z33, wherein Re is cyclopropyl


2564.
cPr
F
Z33, wherein Re is cyclopropyl


2565.
cPr
OCH3
Z33, wherein Re is cyclopropyl


2566.
CH3
H
Z33, wherein Re is cyclobutyl


2567.
CH3
F
Z33, wherein Re is cyclobutyl


2568.
CH3
OCH3
Z33, wherein Re is cyclobutyl


2569.
Et
H
Z33, wherein Re is cyclobutyl


2570.
Et
F
Z33, wherein Re is cyclobutyl


2571.
Et
OCH3
Z33, wherein Re is cyclobutyl


2572.
cPr
H
Z33, wherein Re is cyclobutyl


2573.
cPr
F
Z33, wherein Re is cyclobutyl


2574.
cPr
OCH3
Z33, wherein Re is cyclobutyl


2575.
CH3
H
Z33, wherein Re is CH2-cyclopropyl


2576.
CH3
F
Z33, wherein Re is CH2-cyclopropyl


2577.
CH3
OCH3
Z33, wherein Re is CH2-cyclopropyl


2578.
Et
H
Z33, wherein Re is CH2-cyclopropyl


2579.
Et
F
Z33, wherein Re is CH2-cyclopropyl


2580.
Et
OCH3
Z33, wherein Re is CH2-cyclopropyl


2581.
cPr
H
Z33, wherein Re is CH2-cyclopropyl


2582.
cPr
F
Z33, wherein Re is CH2-cyclopropyl


2583.
cPr
OCH3
Z33, wherein Re is CH2-cyclopropyl


2584.
CH3
H
Z33, wherein Re is CH2CH2OCH3


2585.
CH3
F
Z33, wherein Re is CH2CH2OCH3


2586.
CH3
OCH3
Z33, wherein Re is CH2CH2OCH3


2587.
Et
H
Z33, wherein Re is CH2CH2OCH3


2588.
Et
F
Z33, wherein Re is CH2CH2OCH3


2589.
Et
OCH3
Z33, wherein Re is CH2CH2OCH3


2590.
cPr
H
Z33, wherein Re is CH2CH2OCH3


2591.
cPr
F
Z33, wherein Re is CH2CH2OCH3


2592.
cPr
OCH3
Z33, wherein Re is CH2CH2OCH3


2593.
CH3
H
Z34, wherein Re is CH3


2594.
CH3
F
Z34, wherein Re is CH3


2595.
CH3
OCH3
Z34, wherein Re is CH3


2596.
Et
H
Z34, wherein Re is CH3


2597.
Et
F
Z34, wherein Re is CH3


2598.
Et
OCH3
Z34, wherein Re is CH3


2599.
cPr
H
Z34, wherein Re is CH3


2600.
cPr
F
Z34, wherein Re is CH3


2601.
cPr
OCH3
Z34, wherein Re is CH3


2602.
CH3
H
Z34, wherein Re is ethyl


2603.
CH3
F
Z34, wherein Re is ethyl


2604.
CH3
OCH3
Z34, wherein Re is ethyl


2605.
Et
H
Z34, wherein Re is ethyl


2606.
Et
F
Z34, wherein Re is ethyl


2607.
Et
OCH3
Z34, wherein Re is ethyl


2608.
cPr
H
Z34, wherein Re is ethyl


2609.
cPr
F
Z34, wherein Re is ethyl


2610.
cPr
OCH3
Z34, wherein Re is ethyl


2611.
CH3
H
Z34, wherein Re is n-propyl


2612.
CH3
F
Z34, wherein Re is n-propyl


2613.
CH3
OCH3
Z34, wherein Re is n-propyl


2614.
Et
H
Z34, wherein Re is n-propyl


2615.
Et
F
Z34, wherein Re is n-propyl


2616.
Et
OCH3
Z34, wherein Re is n-propyl


2617.
cPr
H
Z34, wherein Re is n-propyl


2618.
cPr
F
Z34, wherein Re is n-propyl


2619.
cPr
OCH3
Z34, wherein Re is n-propyl


2620.
CH3
H
Z34, wherein Re is isopropyl


2621.
CH3
F
Z34, wherein Re is isopropyl


2622.
CH3
OCH3
Z34, wherein Re is isopropyl


2623.
Et
H
Z34, wherein Re is isopropyl


2624.
Et
F
Z34, wherein Re is isopropyl


2625.
Et
OCH3
Z34, wherein Re is isopropyl


2626.
cPr
H
Z34, wherein Re is isopropyl


2627.
cPr
F
Z34, wherein Re is isopropyl


2628.
cPr
OCH3
Z34, wherein Re is isopropyl


2629.
CH3
H
Z34, wherein Re is cyclopropyl


2630.
CH3
F
Z34, wherein Re is cyclopropyl


2631.
CH3
OCH3
Z34, wherein Re is cyclopropyl


2632.
Et
H
Z34, wherein Re is cyclopropyl


2633.
Et
F
Z34, wherein Re is cyclopropyl


2634.
Et
OCH3
Z34, wherein Re is cyclopropyl


2635.
cPr
H
Z34, wherein Re is cyclopropyl


2636.
cPr
F
Z34, wherein Re is cyclopropyl


2637.
cPr
OCH3
Z34, wherein Re is cyclopropyl


2638.
CH3
H
Z34, wherein Re is cyclobutyl


2639.
CH3
F
Z34, wherein Re is cyclobutyl


2640.
CH3
OCH3
Z34, wherein Re is cyclobutyl


2641.
Et
H
Z34, wherein Re is cyclobutyl


2642.
Et
F
Z34, wherein Re is cyclobutyl


2643.
Et
OCH3
Z34, wherein Re is cyclobutyl


2644.
cPr
H
Z34, wherein Re is cyclobutyl


2645.
cPr
F
Z34, wherein Re is cyclobutyl


2646.
cPr
OCH3
Z34, wherein Re is cyclobutyl


2647.
CH3
H
Z34, wherein Re is CH2-cyclopropyl


2648.
CH3
F
Z34, wherein Re is CH2-cyclopropyl


2649.
CH3
OCH3
Z34, wherein Re is CH2-cyclopropyl


2650.
Et
H
Z34, wherein Re is CH2-cyclopropyl


2651.
Et
F
Z34, wherein Re is CH2-cyclopropyl


2652.
Et
OCH3
Z34, wherein Re is CH2-cyclopropyl


2653.
cPr
H
Z34, wherein Re is CH2-cyclopropyl


2654.
cPr
F
Z34, wherein Re is CH2-cyclopropyl


2655.
cPr
OCH3
Z34, wherein Re is CH2-cyclopropyl


2656.
CH3
H
Z34, wherein Re is CH2CH2OCH3


2657.
CH3
F
Z34, wherein Re is CH2CH2OCH3


2658.
CH3
OCH3
Z34, wherein Re is CH2CH2OCH3


2659.
Et
H
Z34, wherein Re is CH2CH2OCH3


2660.
Et
F
Z34, wherein Re is CH2CH2OCH3


2661.
Et
OCH3
Z34, wherein Re is CH2CH2OCH3


2662.
cPr
H
Z34, wherein Re is CH2CH2OCH3


2663.
cPr
F
Z34, wherein Re is CH2CH2OCH3


2664.
cPr
OCH3
Z34, wherein Re is CH2CH2OCH3


2665.
CH3
H
Z35, wherein Re is CH3


2666.
CH3
F
Z35, wherein Re is CH3


2667.
CH3
OCH3
Z35, wherein Re is CH3


2668.
Et
H
Z35, wherein Re is CH3


2669.
Et
F
Z35, wherein Re is CH3


2670.
Et
OCH3
Z35, wherein Re is CH3


2671.
cPr
H
Z35, wherein Re is CH3


2672.
cPr
F
Z35, wherein Re is CH3


2673.
cPr
OCH3
Z35, wherein Re is CH3


2674.
CH3
H
Z35, wherein Re is ethyl


2675.
CH3
F
Z35, wherein Re is ethyl


2676.
CH3
OCH3
Z35, wherein Re is ethyl


2677.
Et
H
Z35, wherein Re is ethyl


2678.
Et
F
Z35, wherein Re is ethyl


2679.
Et
OCH3
Z35, wherein Re is ethyl


2680.
cPr
H
Z35, wherein Re is ethyl


2681.
cPr
F
Z35, wherein Re is ethyl


2682.
cPr
OCH3
Z35, wherein Re is ethyl


2683.
CH3
H
Z35, wherein Re is n-propyl


2684.
CH3
F
Z35, wherein Re is n-propyl


2685.
CH3
OCH3
Z35, wherein Re is n-propyl


2686.
Et
H
Z35, wherein Re is n-propyl


2687.
Et
F
Z35, wherein Re is n-propyl


2688.
Et
OCH3
Z35, wherein Re is n-propyl


2689.
cPr
H
Z35, wherein Re is n-propyl


2690.
cPr
F
Z35, wherein Re is n-propyl


2691.
cPr
OCH3
Z35, wherein Re is n-propyl


2692.
CH3
H
Z35, wherein Re is isopropyl


2693.
CH3
F
Z35, wherein Re is isopropyl


2694.
CH3
OCH3
Z35, wherein Re is isopropyl


2695.
Et
H
Z35, wherein Re is isopropyl


2696.
Et
F
Z35, wherein Re is isopropyl


2697.
Et
OCH3
Z35, wherein Re is isopropyl


2698.
cPr
H
Z35, wherein Re is isopropyl


2699.
cPr
F
Z35, wherein Re is isopropyl


2700.
cPr
OCH3
Z35, wherein Re is isopropyl


2701.
CH3
H
Z35, wherein Re is cyclopropyl


2702.
CH3
F
Z35, wherein Re is cyclopropyl


2703.
CH3
OCH3
Z35, wherein Re is cyclopropyl


2704.
Et
H
Z35, wherein Re is cyclopropyl


2705.
Et
F
Z35, wherein Re is cyclopropyl


2706.
Et
OCH3
Z35, wherein Re is cyclopropyl


2707.
cPr
H
Z35, wherein Re is cyclopropyl


2708.
cPr
F
Z35, wherein Re is cyclopropyl


2709.
cPr
OCH3
Z35, wherein Re is cyclopropyl


2710.
CH3
H
Z35, wherein Re is cyclobutyl


2711.
CH3
F
Z35, wherein Re is cyclobutyl


2712.
CH3
OCH3
Z35, wherein Re is cyclobutyl


2713.
Et
H
Z35, wherein Re is cyclobutyl


2714.
Et
F
Z35, wherein Re is cyclobutyl


2715.
Et
OCH3
Z35, wherein Re is cyclobutyl


2716.
cPr
H
Z35, wherein Re is cyclobutyl


2717.
cPr
F
Z35, wherein Re is cyclobutyl


2718.
cPr
OCH3
Z35, wherein Re is cyclobutyl


2719.
CH3
H
Z35, wherein Re is CH2-cyclopropyl


2720.
CH3
F
Z35, wherein Re is CH2-cyclopropyl


2721.
CH3
OCH3
Z35, wherein Re is CH2-cyclopropyl


2722.
Et
H
Z35, wherein Re is CH2-cyclopropyl


2723.
Et
F
Z35, wherein Re is CH2-cyclopropyl


2724.
Et
OCH3
Z35, wherein Re is CH2-cyclopropyl


2725.
cPr
H
Z35, wherein Re is CH2-cyclopropyl


2726.
cPr
F
Z35, wherein Re is CH2-cyclopropyl


2727.
cPr
OCH3
Z35, wherein Re is CH2-cyclopropyl


2728.
CH3
H
Z35, wherein Re is CH2CH2OCH3


2729.
CH3
F
Z35, wherein Re is CH2CH2OCH3


2730.
CH3
OCH3
Z35, wherein Re is CH2CH2OCH3


2731.
Et
H
Z35, wherein Re is CH2CH2OCH3


2732.
Et
F
Z35, wherein Re is CH2CH2OCH3


2733.
Et
OCH3
Z35, wherein Re is CH2CH2OCH3


2734.
cPr
H
Z35, wherein Re is CH2CH2OCH3


2735.
cPr
F
Z35, wherein Re is CH2CH2OCH3


2736.
cPr
OCH3
Z35, wherein Re is CH2CH2OCH3


2737.
CH3
H
Z36, wherein Re is CH3


2738.
CH3
F
Z36, wherein Re is CH3


2739.
CH3
OCH3
Z36, wherein Re is CH3


2740.
Et
H
Z36, wherein Re is CH3


2741.
Et
F
Z36, wherein Re is CH3


2742.
Et
OCH3
Z36, wherein Re is CH3


2743.
cPr
H
Z36, wherein Re is CH3


2744.
cPr
F
Z36, wherein Re is CH3


2745.
cPr
OCH3
Z36, wherein Re is CH3


2746.
CH3
H
Z36, wherein Re is ethyl


2747.
CH3
F
Z36, wherein Re is ethyl


2748.
CH3
OCH3
Z36, wherein Re is ethyl


2749.
Et
H
Z36, wherein Re is ethyl


2750.
Et
F
Z36, wherein Re is ethyl


2751.
Et
OCH3
Z36, wherein Re is ethyl


2752.
cPr
H
Z36, wherein Re is ethyl


2753.
cPr
F
Z36, wherein Re is ethyl


2754.
cPr
OCH3
Z36, wherein Re is ethyl


2755.
CH3
H
Z36, wherein Re is n-propyl


2756.
CH3
F
Z36, wherein Re is n-propyl


2757.
CH3
OCH3
Z36, wherein Re is n-propyl


2758.
Et
H
Z36, wherein Re is n-propyl


2759.
Et
F
Z36, wherein Re is n-propyl


2760.
Et
OCH3
Z36, wherein Re is n-propyl


2761.
cPr
H
Z36, wherein Re is n-propyl


2762.
cPr
F
Z36, wherein Re is n-propyl


2763.
cPr
OCH3
Z36, wherein Re is n-propyl


2764.
CH3
H
Z36, wherein Re is isopropyl


2765.
CH3
F
Z36, wherein Re is isopropyl


2766.
CH3
OCH3
Z36, wherein Re is isopropyl


2767.
Et
H
Z36, wherein Re is isopropyl


2768.
Et
F
Z36, wherein Re is isopropyl


2769.
Et
OCH3
Z36, wherein Re is isopropyl


2770.
cPr
H
Z36, wherein Re is isopropyl


2771.
cPr
F
Z36, wherein Re is isopropyl


2772.
cPr
OCH3
Z36, wherein Re is isopropyl


2773.
CH3
H
Z36, wherein Re is cyclopropyl


2774.
CH3
F
Z36, wherein Re is cyclopropyl


2775.
CH3
OCH3
Z36, wherein Re is cyclopropyl


2776.
Et
H
Z36, wherein Re is cyclopropyl


2777.
Et
F
Z36, wherein Re is cyclopropyl


2778.
Et
OCH3
Z36, wherein Re is cyclopropyl


2779.
cPr
H
Z36, wherein Re is cyclopropyl


2780.
cPr
F
Z36, wherein Re is cyclopropyl


2781.
cPr
OCH3
Z36, wherein Re is cyclopropyl


2782.
CH3
H
Z36, wherein Re is cyclobutyl


2783.
CH3
F
Z36, wherein Re is cyclobutyl


2784.
CH3
OCH3
Z36, wherein Re is cyclobutyl


2785.
Et
H
Z36, wherein Re is cyclobutyl


2786.
Et
F
Z36, wherein Re is cyclobutyl


2787.
Et
OCH3
Z36, wherein Re is cyclobutyl


2788.
cPr
H
Z36, wherein Re is cyclobutyl


2789.
cPr
F
Z36, wherein Re is cyclobutyl


2790.
cPr
OCH3
Z36, wherein Re is cyclobutyl


2791.
CH3
H
Z36, wherein Re is CH2-cyclopropyl


2792.
CH3
F
Z36, wherein Re is CH2-cyclopropyl


2793.
CH3
OCH3
Z36, wherein Re is CH2-cyclopropyl


2794.
Et
H
Z36, wherein Re is CH2-cyclopropyl


2795.
Et
F
Z36, wherein Re is CH2-cyclopropyl


2796.
Et
OCH3
Z36, wherein Re is CH2-cyclopropyl


2797.
cPr
H
Z36, wherein Re is CH2-cyclopropyl


2798.
cPr
F
Z36, wherein Re is CH2-cyclopropyl


2799.
cPr
OCH3
Z36, wherein Re is CH2-cyclopropyl


2800.
CH3
H
Z36, wherein Re is CH2CH2OCH3


2801.
CH3
F
Z36, wherein Re is CH2CH2OCH3


2802.
CH3
OCH3
Z36, wherein Re is CH2CH2OCH3


2803.
Et
H
Z36, wherein Re is CH2CH2OCH3


2804.
Et
F
Z36, wherein Re is CH2CH2OCH3


2805.
Et
OCH3
Z36, wherein Re is CH2CH2OCH3


2806.
cPr
H
Z36, wherein Re is CH2CH2OCH3


2807.
cPr
F
Z36, wherein Re is CH2CH2OCH3


2808.
cPr
OCH3
Z36, wherein Re is CH2CH2OCH3


2809.
CH3
H
Z37, wherein Re is CH3


2810.
CH3
F
Z37, wherein Re is CH3


2811.
CH3
OCH3
Z37, wherein Re is CH3


2812.
Et
H
Z37, wherein Re is CH3


2813.
Et
F
Z37, wherein Re is CH3


2814.
Et
OCH3
Z37, wherein Re is CH3


2815.
cPr
H
Z37, wherein Re is CH3


2816.
cPr
F
Z37, wherein Re is CH3


2817.
cPr
OCH3
Z37, wherein Re is CH3


2818.
CH3
H
Z37, wherein Re is ethyl


2819.
CH3
F
Z37, wherein Re is ethyl


2820.
CH3
OCH3
Z37, wherein Re is ethyl


2821.
Et
H
Z37, wherein Re is ethyl


2822.
Et
F
Z37, wherein Re is ethyl


2823.
Et
OCH3
Z37, wherein Re is ethyl


2824.
cPr
H
Z37, wherein Re is ethyl


2825.
cPr
F
Z37, wherein Re is ethyl


2826.
cPr
OCH3
Z37, wherein Re is ethyl


2827.
CH3
H
Z37, wherein Re is n-propyl


2828.
CH3
F
Z37, wherein Re is n-propyl


2829.
CH3
OCH3
Z37, wherein Re is n-propyl


2830.
Et
H
Z37, wherein Re is n-propyl


2831.
Et
F
Z37, wherein Re is n-propyl


2832.
Et
OCH3
Z37, wherein Re is n-propyl


2833.
cPr
H
Z37, wherein Re is n-propyl


2834.
cPr
F
Z37, wherein Re is n-propyl


2835.
cPr
OCH3
Z37, wherein Re is n-propyl


2836.
CH3
H
Z37, wherein Re is isopropyl


2837.
CH3
F
Z37, wherein Re is isopropyl


2838.
CH3
OCH3
Z37, wherein Re is isopropyl


2839.
Et
H
Z37, wherein Re is isopropyl


2840.
Et
F
Z37, wherein Re is isopropyl


2841.
Et
OCH3
Z37, wherein Re is isopropyl


2842.
cPr
H
Z37, wherein Re is isopropyl


2843.
cPr
F
Z37, wherein Re is isopropyl


2844.
cPr
OCH3
Z37, wherein Re is isopropyl


2845.
CH3
H
Z37, wherein Re is cyclopropyl


2846.
CH3
F
Z37, wherein Re is cyclopropyl


2847.
CH3
OCH3
Z37, wherein Re is cyclopropyl


2848.
Et
H
Z37, wherein Re is cyclopropyl


2849.
Et
F
Z37, wherein Re is cyclopropyl


2850.
Et
OCH3
Z37, wherein Re is cyclopropyl


2851.
cPr
H
Z37, wherein Re is cyclopropyl


2852.
cPr
F
Z37, wherein Re is cyclopropyl


2853.
cPr
OCH3
Z37, wherein Re is cyclopropyl


2854.
CH3
H
Z37, wherein Re is cyclobutyl


2855.
CH3
F
Z37, wherein Re is cyclobutyl


2856.
CH3
OCH3
Z37, wherein Re is cyclobutyl


2857.
Et
H
Z37, wherein Re is cyclobutyl


2858.
Et
F
Z37, wherein Re is cyclobutyl


2859.
Et
OCH3
Z37, wherein Re is cyclobutyl


2860.
cPr
H
Z37, wherein Re is cyclobutyl


2861.
cPr
F
Z37, wherein Re is cyclobutyl


2862.
cPr
OCH3
Z37, wherein Re is cyclobutyl


2863.
CH3
H
Z37, wherein Re is CH2-cyclopropyl


2864.
CH3
F
Z37, wherein Re is CH2-cyclopropyl


2865.
CH3
OCH3
Z37, wherein Re is CH2-cyclopropyl


2866.
Et
H
Z37, wherein Re is CH2-cyclopropyl


2867.
Et
F
Z37, wherein Re is CH2-cyclopropyl


2868.
Et
OCH3
Z37, wherein Re is CH2-cyclopropyl


2869.
cPr
H
Z37, wherein Re is CH2-cyclopropyl


2870.
cPr
F
Z37, wherein Re is CH2-cyclopropyl


2871.
cPr
OCH3
Z37, wherein Re is CH2-cyclopropyl


2872.
CH3
H
Z37, wherein Re is CH2CH2OCH3


2873.
CH3
F
Z37, wherein Re is CH2CH2OCH3


2874.
CH3
OCH3
Z37, wherein Re is CH2CH2OCH3


2875.
Et
H
Z37, wherein Re is CH2CH2OCH3


2876.
Et
F
Z37, wherein Re is CH2CH2OCH3


2877.
Et
OCH3
Z37, wherein Re is CH2CH2OCH3


2878.
cPr
H
Z37, wherein Re is CH2CH2OCH3


2879.
cPr
F
Z37, wherein Re is CH2CH2OCH3


2880.
cPr
OCH3
Z37, wherein Re is CH2CH2OCH3


2881.
CH3
H
Z38, wherein Re is CH3


2882.
CH3
F
Z38, wherein Re is CH3


2883.
CH3
OCH3
Z38, wherein Re is CH3


2884.
Et
H
Z38, wherein Re is CH3


2885.
Et
F
Z38, wherein Re is CH3


2886.
Et
OCH3
Z38, wherein Re is CH3


2887.
cPr
H
Z38, wherein Re is CH3


2888.
cPr
F
Z38, wherein Re is CH3


2889.
cPr
OCH3
Z38, wherein Re is CH3


2890.
CH3
H
Z38, wherein Re is ethyl


2891.
CH3
F
Z38, wherein Re is ethyl


2892.
CH3
OCH3
Z38, wherein Re is ethyl


2893.
Et
H
Z38, wherein Re is ethyl


2894.
Et
F
Z38, wherein Re is ethyl


2895.
Et
OCH3
Z38, wherein Re is ethyl


2896.
cPr
H
Z38, wherein Re is ethyl


2897.
cPr
F
Z38, wherein Re is ethyl


2898.
cPr
OCH3
Z38, wherein Re is ethyl


2899.
CH3
H
Z38, wherein Re is n-propyl


2900.
CH3
F
Z38, wherein Re is n-propyl


2901.
CH3
OCH3
Z38, wherein Re is n-propyl


2902.
Et
H
Z38, wherein Re is n-propyl


2903.
Et
F
Z38, wherein Re is n-propyl


2904.
Et
OCH3
Z38, wherein Re is n-propyl


2905.
cPr
H
Z38, wherein Re is n-propyl


2906.
cPr
F
Z38, wherein Re is n-propyl


2907.
cPr
OCH3
Z38, wherein Re is n-propyl


2908.
CH3
H
Z38, wherein Re is isopropyl


2909.
CH3
F
Z38, wherein Re is isopropyl


2910.
CH3
OCH3
Z38, wherein Re is isopropyl


2911.
Et
H
Z38, wherein Re is isopropyl


2912.
Et
F
Z38, wherein Re is isopropyl


2913.
Et
OCH3
Z38, wherein Re is isopropyl


2914.
cPr
H
Z38, wherein Re is isopropyl


2915.
cPr
F
Z38, wherein Re is isopropyl


2916.
cPr
OCH3
Z38, wherein Re is isopropyl


2917.
CH3
H
Z38, wherein Re is cyclopropyl


2918.
CH3
F
Z38, wherein Re is cyclopropyl


2919.
CH3
OCH3
Z38, wherein Re is cyclopropyl


2920.
Et
H
Z38, wherein Re is cyclopropyl


2921.
Et
F
Z38, wherein Re is cyclopropyl


2922.
Et
OCH3
Z38, wherein Re is cyclopropyl


2923.
cPr
H
Z38, wherein Re is cyclopropyl


2924.
cPr
F
Z38, wherein Re is cyclopropyl


2925.
cPr
OCH3
Z38, wherein Re is cyclopropyl


2926.
CH3
H
Z38, wherein Re is cyclobutyl


2927.
CH3
F
Z38, wherein Re is cyclobutyl


2928.
CH3
OCH3
Z38, wherein Re is cyclobutyl


2929.
Et
H
Z38, wherein Re is cyclobutyl


2930.
Et
F
Z38, wherein Re is cyclobutyl


2931.
Et
OCH3
Z38, wherein Re is cyclobutyl


2932.
cPr
H
Z38, wherein Re is cyclobutyl


2933.
cPr
F
Z38, wherein Re is cyclobutyl


2934.
cPr
OCH3
Z38, wherein Re is cyclobutyl


2935.
CH3
H
Z38, wherein Re is CH2-cyclopropyl


2936.
CH3
F
Z38, wherein Re is CH2-cyclopropyl


2937.
CH3
OCH3
Z38, wherein Re is CH2-cyclopropyl


2938.
Et
H
Z38, wherein Re is CH2-cyclopropyl


2939.
Et
F
Z38, wherein Re is CH2-cyclopropyl


2940.
Et
OCH3
Z38, wherein Re is CH2-cyclopropyl


2941.
cPr
H
Z38, wherein Re is CH2-cyclopropyl


2942.
cPr
F
Z38, wherein Re is CH2-cyclopropyl


2943.
cPr
OCH3
Z38, wherein Re is CH2-cyclopropyl


2944.
CH3
H
Z38, wherein Re is CH2CH2OCH3


2945.
CH3
F
Z38, wherein Re is CH2CH2OCH3


2946.
CH3
OCH3
Z38, wherein Re is CH2CH2OCH3


2947.
Et
H
Z38, wherein Re is CH2CH2OCH3


2948.
Et
F
Z38, wherein Re is CH2CH2OCH3


2949.
Et
OCH3
Z38, wherein Re is CH2CH2OCH3


2950.
cPr
H
Z38, wherein Re is CH2CH2OCH3


2951.
cPr
F
Z38, wherein Re is CH2CH2OCH3


2952.
cPr
OCH3
Z38, wherein Re is CH2CH2OCH3


2953.
CH3
H
Z39, wherein Re is CH3


2954.
CH3
F
Z39, wherein Re is CH3


2955.
CH3
OCH3
Z39, wherein Re is CH3


2956.
Et
H
Z39, wherein Re is CH3


2957.
Et
F
Z39, wherein Re is CH3


2958.
Et
OCH3
Z39, wherein Re is CH3


2959.
cPr
H
Z39, wherein Re is CH3


2960.
cPr
F
Z39, wherein Re is CH3


2961.
cPr
OCH3
Z39, wherein Re is CH3


2962.
CH3
H
Z39, wherein Re is ethyl


2963.
CH3
F
Z39, wherein Re is ethyl


2964.
CH3
OCH3
Z39, wherein Re is ethyl


2965.
Et
H
Z39, wherein Re is ethyl


2966.
Et
F
Z39, wherein Re is ethyl


2967.
Et
OCH3
Z39, wherein Re is ethyl


2968.
cPr
H
Z39, wherein Re is ethyl


2969.
cPr
F
Z39, wherein Re is ethyl


2970.
cPr
OCH3
Z39, wherein Re is ethyl


2971.
CH3
H
Z39, wherein Re is n-propyl


2972.
CH3
F
Z39, wherein Re is n-propyl


2973.
CH3
OCH3
Z39, wherein Re is n-propyl


2974.
Et
H
Z39, wherein Re is n-propyl


2975.
Et
F
Z39, wherein Re is n-propyl


2976.
Et
OCH3
Z39, wherein Re is n-propyl


2977.
cPr
H
Z39, wherein Re is n-propyl


2978.
cPr
F
Z39, wherein Re is n-propyl


2979.
cPr
OCH3
Z39, wherein Re is n-propyl


2980.
CH3
H
Z39, wherein Re is isopropyl


2981.
CH3
F
Z39, wherein Re is isopropyl


2982.
CH3
OCH3
Z39, wherein Re is isopropyl


2983.
Et
H
Z39, wherein Re is isopropyl


2984.
Et
F
Z39, wherein Re is isopropyl


2985.
Et
OCH3
Z39, wherein Re is isopropyl


2986.
cPr
H
Z39, wherein Re is isopropyl


2987.
cPr
F
Z39, wherein Re is isopropyl


2988.
cPr
OCH3
Z39, wherein Re is isopropyl


2989.
CH3
H
Z39, wherein Re is cyclopropyl


2990.
CH3
F
Z39, wherein Re is cyclopropyl


2991.
CH3
OCH3
Z39, wherein Re is cyclopropyl


2992.
Et
H
Z39, wherein Re is cyclopropyl


2993.
Et
F
Z39, wherein Re is cyclopropyl


2994.
Et
OCH3
Z39, wherein Re is cyclopropyl


2995.
cPr
H
Z39, wherein Re is cyclopropyl


2996.
cPr
F
Z39, wherein Re is cyclopropyl


2997.
cPr
OCH3
Z39, wherein Re is cyclopropyl


2998.
CH3
H
Z39, wherein Re is cyclobutyl


2999.
CH3
F
Z39, wherein Re is cyclobutyl


3000.
CH3
OCH3
Z39, wherein Re is cyclobutyl


3001.
Et
H
Z39, wherein Re is cyclobutyl


3002.
Et
F
Z39, wherein Re is cyclobutyl


3003.
Et
OCH3
Z39, wherein Re is cyclobutyl


3004.
cPr
H
Z39, wherein Re is cyclobutyl


3005.
cPr
F
Z39, wherein Re is cyclobutyl


3006.
cPr
OCH3
Z39, wherein Re is cyclobutyl


3007.
CH3
H
Z39, wherein Re is CH2-cyclopropyl


3008.
CH3
F
Z39, wherein Re is CH2-cyclopropyl


3009.
CH3
OCH3
Z39, wherein Re is CH2-cyclopropyl


3010.
Et
H
Z39, wherein Re is CH2-cyclopropyl


3011.
Et
F
Z39, wherein Re is CH2-cyclopropyl


3012.
Et
OCH3
Z39, wherein Re is CH2-cyclopropyl


3013.
cPr
H
Z39, wherein Re is CH2-cyclopropyl


3014.
cPr
F
Z39, wherein Re is CH2-cyclopropyl


3015.
cPr
OCH3
Z39, wherein Re is CH2-cyclopropyl


3016.
CH3
H
Z39, wherein Re is CH2CH2OCH3


3017.
CH3
F
Z39, wherein Re is CH2CH2OCH3


3018.
CH3
OCH3
Z39, wherein Re is CH2CH2OCH3


3019.
Et
H
Z39, wherein Re is CH2CH2OCH3


3020.
Et
F
Z39, wherein Re is CH2CH2OCH3


3021.
Et
OCH3
Z39, wherein Re is CH2CH2OCH3


3022.
cPr
H
Z39, wherein Re is CH2CH2OCH3


3023.
cPr
F
Z39, wherein Re is CH2CH2OCH3


3024.
cPr
OCH3
Z39, wherein Re is CH2CH2OCH3











embedded image


embedded image


embedded image


embedded image


In Z1 to Z39, # denotes the attachment point to NR4.


Among rings Z1 to Z39, particular preference is given to rings Z10.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is pyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-fluoropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-chloropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-bromopyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-cyanopyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-methoxypyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-fluoropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromopyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyanopyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methoxypyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluoropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromopyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyanopyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methoxypyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromopyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyanopyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methoxypyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,6-difluoropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,6-dichloropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,6-dibromopyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,6-dimethylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,6-dimethoxypyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-6-fluoropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-chloro-4-fluoropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-6-fluoropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-bromo-4-fluoropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-6-chloropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-bromo-4-chloropyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluoro-6-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-fluoro-4-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-6-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-chloro-4-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-6-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-bromo-4-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyano-6-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-cyano-4-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methoxy-6-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 6-methoxy-4-methylpyridin-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is pyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-fluoropyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-chloropyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-bromopyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-cyanopyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methylpyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methoxypyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoropyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloropyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromopyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyanopyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methylpyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methoxypyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2,6-difluoropyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2,6-dichloropyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2,6-dibromopyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2,6-dicyanopyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2,6-dimethylpyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2,6-dimethoxypyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-chloro-6-fluoropyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-bromo-6-fluoropyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-bromo-6-chloropyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-cyano-6-fluoropyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-chloro-6-cyanopyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-bromo-6-cyanopyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-fluoro-6-methylpyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-chloro-6-methylpyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-bromo-6-methylpyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-cyano-6-methylpyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methoxy-6-methylpyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-fluoro-6-methoxypyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-chloro-6-methoxypyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-bromo-6-methoxypyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-cyano-6-methoxypyridin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-fluoropyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-chloropyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-bromopyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-cyanopyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methylpyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methoxypyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-(trifluoromethyl)-pyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-(trifluoromethoxy)-pyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoropyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloropyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromopyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyanopyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methylpyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methoxypyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-(trifluoromethyl)-pyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-(trifluoromethoxy)-pyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluoropyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloropyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromopyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyanopyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methylpyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methoxypyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-(trifluoromethyl)-pyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-(trifluoromethoxy)-pyridin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoropyridazin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloropyridazin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromopyridazin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyanopyridazin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methylpyridazin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methoxypyridazin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoropyridazin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloropyridazin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromopyridazin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyanopyridazin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methylpyridazin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methoxypyridazin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoropyridazin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloropyridazin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromopyridazin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyanopyridazin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methylpyridazin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methoxypyridazin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-fluoropyrimidin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-chloropyrimidin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-bromopyrimidin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-cyanopyrimidin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methylpyrimidin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methoxypyrimidin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-fluoropyrimidin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-chloropyrimidin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-bromopyrimidin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-cyanopyrimidin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methylpyrimidin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methoxypyrimidin-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-fluoropyrimidin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-chloropyrimidin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-bromopyrimidin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-cyanopyrimidin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methylpyrimidin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methoxypyrimidin-6-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,4-difluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,4-dichlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,4-dibromothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound pound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,4-dicyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,4-dimethylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,4-dimethoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,4-di(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,5-difluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,5-dichlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,5-dibromothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,5-dicyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,5-dimethylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,5-dimethoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3,5-di(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,5-difluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,5-dichlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,5-dibromothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,5-dicyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,5-dimethylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,5-dimethoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4,5-di(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloro-4-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-3-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-4-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-3-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-4-chlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-3-chlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyano-4-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyano-3-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloro-4-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-3-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-4-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-3-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoro-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluoro-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloro-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoro-4-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluoro-3-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloro-4-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-3-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-4-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-3-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoro-4-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluoro-3-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloro-4-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-3-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-4-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-3-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyano-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyano-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyano-4-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyano-3-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyano-4-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyano-3-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methoxy-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methoxy-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-(methoxycarbonyl)-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-(methoxycarbonyl)-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-(methoxycarbonyl)-4-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-(methoxycarbonyl)-3-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloro-5-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloro-3-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-5-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-3-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-5-chlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-3-chlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyano-5-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyano-3-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloro-5-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloro-3-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-5-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-3-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoro-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-fluoro-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloro-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloro-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoro-5-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-fluoro-3-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloro-5-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloro-3-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-5-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-3-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoro-5-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-fluoro-3-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloro-5-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloro-3-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromo-5-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-3-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyano-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyano-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyano-5-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyano-3-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyano-5-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyano-3-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methoxy-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methoxy-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-(methoxycarbonyl)-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-(methoxycarbonyl)-3-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-(methoxycarbonyl)-5-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-(methoxycarbonyl)-3-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-5-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloro-4-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-5-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-4-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-5-chlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-4-chlorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyano-5-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyano-4-fluorothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-5-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloro-4-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-5-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-4-cyanothien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluoro-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-fluoro-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloro-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluoro-5-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-fluoro-4-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-5-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloro-4-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-5-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-4-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluoro-5-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-fluoro-4-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloro-5-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloro-4-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromo-5-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromo-4-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyano-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyano-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyano-5-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyano-4-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyano-5-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyano-4-(methoxycarbonyl)-thien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methoxy-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methoxy-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-(methoxycarbonyl)-5-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-(methoxycarbonyl)-4-methylthien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-(methoxycarbonyl)-5-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-(methoxycarbonyl)-4-methoxythien-2-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is thien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-fluorothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-chlorothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-bromothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-cyanothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methylthien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-methoxythien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 2-(methoxycarbonyl)-thien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluorothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chlorothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyanothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methylthien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methoxythien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-(methoxycarbonyl)-thien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-fluorothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chlorothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyanothien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methylthien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methoxythien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-(methoxycarbonyl)-thien-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is isoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-fluoroisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloroisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromoisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyanoisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methylisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-tert-butylisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methoxyisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-(methoxycarbonyl)-isoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluoroisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloroisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromoisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyanoisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methylisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-tert-butylisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methoxyisoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-(methoxycarbonyl)-isoxazol-3-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is isoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-fluoroisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-chloroisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-bromoisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-cyanoisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methylisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-tert-butylisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-methoxyisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-(methoxycarbonyl)-isoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoroisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloroisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromoisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyanoisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methylisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-tert-butylisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methoxyisoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-(methoxycarbonyl)-isoxazol-5-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is isoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-fluoroisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-chloroisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-bromoisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-cyanoisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methylisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-tert-butylisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-methoxyisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 3-(methoxycarbonyl)-isoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-fluoroisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-chloroisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-bromoisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-cyanoisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methylisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-tert-butylisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-methoxyisoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 5-(methoxycarbonyl)-isoxazol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 1-methyl-2-(methoxycarbonyl)-pyrrol-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1 and R4 are hydrogen, R2, R3 and —X—Y have one of the meanings as defined in a single line of table A and Q is 4-(methoxycarbonyl)-thiazol-2-yl.


The compounds of formula (I) according to the invention can be prepared by standard processes of organic chemistry, for example by the following processes:




embedded image


The compounds of formula (I) can be prepared according to methods or in analogy to methods that are described in the prior art. The synthesis takes advantage of starting materials that are commercially available or may be prepared according to conventional procedures starting from readily available compounds.


Compounds of the formula (I) can be prepared from the carboxylic acids (Ill) and commercially available amines (II) using an organic base and a coupling reagent. Thus, compounds of formula (I) can be synthesized from the corresponding carboxylic acids (1eq.) using a coupling reagent (1-2 eq.), for example T3P (propanephosphonic acid anhydride) or HATU (O-(7-azabenzotriazole-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorphosphate), an organic base (1-3 eq.) and the amines (II) (1-3 eq.). The reaction is typically carried out in an organic solvent. Preferably an aprotic organic solvent is used. Most preferably tetrahydrofuran (THF), N,N-dimethylformamide (DMF) or acetonitrile (ACN) are used. The reaction is carried out at temperatures between 0° C. and reflux. Preferably the reaction is carried out at room temperature. Preferably the organic base is triethylamine or N,N-diisopropylethylamine.




embedded image


The carboxylic acids (Ill) are commercially available or can be prepared from the corresponding esters (IV) (wherein RP is alkyl or benzyl). If RP is alkyl, esters (IV) may be cleaved using aqueous alkali metal hydroxides. Preferably lithium hydroxide, sodium hydroxide or potassium hydroxide (1-2 eq.) are employed. The reaction is typically carried out in mixtures of water and an organic solvent. Preferably the organic solvent is THF, methanol or acetonitrile. The reaction is carried out at temperatures between 0° C. and 100° C. Preferably the reaction is carried at room temperature. If RP is benzyl in (IV), then the ester may be cleaved using palladium on charcoal (0.001-1eq.) as catalyst and hydrogen gas at temperatures between 0° C. and reflux. Preferably the reaction is carried out at room temperature. Typically, an organic solvent is employed. Preferably TH F, methanol or ethanol are employed.




embedded image


Compounds of the formula (IV) can be prepared from the carboxylic acids (VI) and commercially available amines (V) using a base and a coupling reagent. Thus, compounds of formula (IV) can be synthesized from the corresponding carboxylic acids (1eq.) using a coupling reagent (1-2 eq.), for example T3P (propanephosphonic acid anhydride) or HATU (O-(7-azabenzotriazole-1-yl)-N,N,N,N-tetramethyluronium-hexafluorphosphate), an organic base (1-3 eq.) and the amines (V) (1-3 eq.). The reaction is typically carried out in an organic solvent. Preferably an aprotic organic solvent is used. Most preferably tetrahydrofuran (THF), N,N-dimethylformamide (DMF) or acetonitrile (ACN) are used. The reaction is carried out at temperatures between 0° C. to refluxing temperatures. Preferably the reaction is carried out at room temperature. Preferably the organic base is triethylamine or N,N-diisopropylethylamine.




embedded image


Carboxylic acid (VI) may be prepared from the corresponding diester by selective cleavage of one ester group. If Rq is an alkyl ester, selective ester cleavage may be achieved using an aqueous base. Preferably an alkali metal hydroxide is used. Most preferably lithium hydroxide, sodium hydroxide or potassium hydroxide are used. The reaction is typically carried out in mixtures of water and an organic solvent. Preferably THF, methanol or acetonitrile are employed. The reaction is carried out at temperatures between 0° C. and 100° C., preferably at room temperature.


Alternatively, trimethyltin hydroxide (e.g. 1eq.) in 1,2-dichlorethane at room temperature to reflux may be used (as described in Angew. Chem. Int. Ed, 2005, 44: 1378-1382), preferably at reflux. If Rq is benzyl in (VII), then the ester may be cleaved using palladium on charcoal (0.001-1eq.) as catalyst and hydrogen gas at temperatures between 0° C. and reflux. Preferably the reaction is carried out at room temperature. Typically, an organic solvent is employed. Preferably THF, methanol or ethanol are employed.




embedded image


The diesters (VII) are either commercially available or may be prepared from the corresponding diazo-compounds (VIII) using dirhodiumtetraacetat ([Rh(OAc)2]2) (0.001-0.1 eq.) and the alcohol HO-R7, yielding alkoxy malonates (VII) (R8=H). The reaction is typically carried out in an organic solvent, preferably in toluene at temperatures between 0° to 100° C. Preferably the reaction is done at 60° C. as described in Angew. Chem. Int. Ed. 2014, 53, 14230-14234. Diazo compounds (VIII), if not commercially available, may be prepared as described in Angew. Chem. Int. Ed. 2014, 53, 14230-14234.




embedded image


Alternatively, diesters (VII) may be synthesized from a commercially available monoes-ter (XI), a base and a chloroformate (XII) (1-3 eq.) as described in Bioorganic & Medic-inal Chemistry Letters, 12(11), 1501-1505; 2002. The reaction is typically carried out in an organic solvent, preferably in tetrahydrofuran. Suitable temperatures range between −78° C. and 25° C. Preferably the reaction is allowed to warm from −78° C. to 25° C. over a period of 16 h. Preferably lithiumdiisopropylamide (1eq.) is used as a base. Alternatively diesters (VII), wherein R8 is fluorine, can be prepared from the corresponding non-fluorinated malonates using 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octanebis(tetrafluoroborate) (Selectfluor) as described in WO12/129384. Water and/or an organic solvent are used. Preferably the reaction is carried out in acetonitrile. The reaction is carried out at a temperature between 0° C. and reflux temperature, preferably at 60° C. using 1 to 4 equivalents of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octanebis(tetrafluoroborate) (Selectfluor). Alternatively, N-Fluorobenzenesulfonimide (CAS 133745-75-2) may be employed (see for example Differding, E., & Ofner, H. (1991). N-Fluorobenzenesulfonimide: A practical reagent for electrophilic fluorinations. Synlett, 1991(03)) 187-189).




embedded image


Amines of the formula (XIII) can be prepared from the lactames (XIV), which are either commercially available or may be prepared by alkylation as described in Org. Process Res. Dev. 2018, 22, 337-343, and commercially available alcohols (XV) using thionyl chloride (2eq.) as described in Tetrahedron Lett. 2001, 42, 1347-1350. The reaction is typically carried out in the coupling alcohols (XV) as the solvent. The reaction is carried out at temperatures between 0° C. to refluxing temperatures. Preferably the reaction is carried out at room temperature.


To widen the spectrum of action, the compounds of formula (I) may be mixed with many representatives of other herbicidal or growth-regulating active ingredient groups and then applied concomitantly. Suitable components for combinations are, for example, herbicides from the classes of the acetamides, amides, aryloxyphenoxypropionates, benzamides, benzofuran, benzoic acids, benzothiadiazinones, bipyridylium, carbamates, chloroacetamides, chlorocarboxylic acids, cyclohexanediones, dinitroanilines, dinitrophenol, diphenyl ether, glycines, imidazolinones, isoxazoles, isoxazolidinones, nitriles, N-phenylphthalimides, oxadiazoles, oxazolidinediones, oxyacetamides, phenoxycarboxylic acids, phenylcarbamates, phenylpyrazoles, phenylpyrazolines, phenylpyridazines, phosphinic acids, phosphoroamidates, phosphorodithioates, phthalamates, pyrazoles, pyridazinones, pyridines, pyridinecarboxylic acids, pyridinecarboxamides, pyrimidinediones, pyrimidinyl(thio)benzoates, quinolinecarboxylic acids, semicarbazones, sulfonylaminocarbonyltriazolinones, sulfonylureas, tetrazolinones, thiadiazoles, thiocarbamates, triazines, triazinones, triazoles, triazolinones, triazolocarboxamides, triazolopyrimidines, triketones, uracils, ureas.


It may furthermore be beneficial to apply the compounds of formula (I) alone or in combination with other herbicides, or else in the form of a mixture with other crop protection agents, for example together with agents for controlling pests or phytopathogenic fungi or bacteria. Also of interest is the miscibility with mineral salt solutions, which are employed for treating nutritional and trace element deficiencies. Other additives such as non-phytotoxic oils and oil concentrates may also be added.


In one embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) (compound A or component A) and at least one further active compound selected from herbicides B (compound B), preferably herbicides B of class b1) to b15), and safeners C (compound C).


In another embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) and at least one further active compound B (herbicide B).


Examples of herbicides B which can be used in combination with the compounds A of formula (I) according to the present invention are:

    • b1) from the group of the lipid biosynthesis inhibitors:
    • ACC-herbicides such as alloxydim, alloxydim-sodium, butroxydim, clethodim, clodinafop, clodinafop-propargyl, cycloxydim, cyhalofop, cyhalofop-butyl, diclofop, di-clofop-methyl, fenoxaprop, fenoxaprop-ethyl, fenoxaprop-P, fenoxaprop-P-ethyl, fluazifop, fluazifop-butyl, fluazifop-P, fluazifop-P-butyl, haloxyfop, haloxyfop-methyl, halox-yfop-P, haloxyfop-P-methyl, metamifop, pinoxaden, profoxydim, propaquizafop, quizalofop, quizalofop-ethyl, quizalofop-tefuryl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, sethoxydim, tepraloxydim, tralkoxydim, 4-(4′-Chloro-4-cyclopropyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1312337-72-6); 4-(2′,4′-Dichloro-4-cyclopropyl[1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1312337-45-3); 4-(4′-Chloro-4-ethyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1033757-93-5); 4-(2′,4′-Dichloro-4-ethyl[1,1′-biphenyl]-3-yl)-2,2,6,6-tetramethyl-2H-pyran-3,5(4H,6H)-dione (CAS 1312340-84-3); 5-(Acetyloxy)-4-(4′-chloro-4-cyclopropyl-2′-fluoro[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1312337-48-6); 5-(Acetyloxy)-4-(2′,4′-dichloro-4-cyclopropyl- [1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one; 5-(Acetyloxy)-4-(4′-chloro-4-ethyl-2′-fluoro[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1312340-82-1); 5-(Acetyloxy)-4-(2′,4′-dichloro-4-ethyl[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1033760-55-2); 4-(4′-Chloro-4-cyclopropyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1312337-51-1); 4-(2′,4′-Dichloro-4-cyclopropyl−[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester; 4-(4′-Chloro-4-ethyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1312340-83-2); 4-(2′,4′-Dichloro-4-ethyl[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1033760-58-5); and non ACC herbicides such as benfuresate, butylate, cycloate, dalapon, dimepiperate, EPTC, esprocarb, ethofumesate, flupro-panate, molinate, orbencarb, pebulate, prosulfocarb, TCA, thiobencarb, tiocarbazil, triallate and vernolate;
    • b2) from the group of the ALS inhibitors:
    • sulfonylureas such as amidosulfuron, azimsulfuron, bensulfuron, bensulfuron-methyl, chlorimuron, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethametsulfuron, ethametsulfuron-methyl, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, flupyrsulfuron-methyl-sodium, foramsulfuron, halosulfuron, halosulfuron-methyl, imazosulfuron, iodosulfuron, iodosulfuron-methyl-sodium, iofensulfuron, iofensulfuron-sodium, mesosulfuron, metazosulfuron, metsulfuron, metsulfuron-methyl, nicosulfuron, orthosulfamuron, oxasulfuron, primisulfuron, primisulfuron-methyl, propyrisulfuron, prosulfuron, pyrazosulfuron, pyrazosulfuron-ethyl, rimsulfuron, sulfometuron, sulfometuron-methyl, sulfosulfuron, thifensulfuron, thifensulfuron-methyl, triasulfuron, tribenuron, tribenuron-methyl, trifloxysulfuron, triflusulfuron, triflusulfuron-methyl and tritosulfuron, imidazolinones such as imazamethabenz, imazamethabenz-methyl, imazamox, imazapic, imazapyr, imazaquin and imazethapyr, triazolopyrimidine herbicides and sulfonanilides such as cloransulam, cloransulam-methyl, diclosulam, flumetsulam, florasulam, metosulam, penoxsulam, pyrimisulfan and pyroxsulam, pyrimidinylbenzoates such as bispyribac, bispyribac-sodium, pyribenzoxim, pyriftalid, pyriminobac, pyriminobac-methyl, pyrithiobac, pyrithiobac-sodium, 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino]-benzoic acid-1-methylethyl ester (CAS 420138-41-6), 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino]-benzoic acid propyl ester (CAS 420138-40-5), N-(4-bromophenyl)-2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]benzenemethanamine (CAS 420138-01-8), sulfonylaminocarbonyl-triazolinone herbicides such as flucarbazone, flucarbazone-sodium, propoxycarbazone, propoxycarbazone-sodium, thiencarbazone and thiencarbazone-methyl; and triafamone; among these, a preferred embodiment of the invention relates to those compositions comprising at least one imidazolinone herbicide;
    • b3) from the group of the photosynthesis inhibitors:
    • amicarbazone, inhibitors of the photosystem II, e.g. 1-(6-tert-butylpyrimidin-4-yl)-2-hydroxy-4-methoxy-3-methyl-2H-pyrrol-5-one (CAS 1654744-66-7), 1-(5-tert-butylisoxazol-3-yl)-2-hydroxy-4-methoxy-3-methyl-2H-pyrrol-5-one (CAS 1637455-12-9), 1-(5-tert-butylisoxazol-3-yl)-4-chloro-2-hydroxy-3-methyl-2H-pyrrol-5-one (CAS 1637453-94-1), 1-(5-tert-butyl-1-methyl-pyrazol-3-yl)-4-chloro-2-hydroxy-3-methyl-2H-pyrrol-5-one (CAS 1654057-29-0), 1-(5-tert-butyl-1-methyl-pyrazol-3-yl)-3-chloro-2-hydroxy-4-methyl-2H-pyrrol-5-one (CAS 1654747-80-4), 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one; (CAS 2023785-78-4), 4-hydroxy-1,5-dimethyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 2023785-79-5), 5-ethoxy-4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 1701416-69-4), 4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 1708087-22-2), 4-hydroxy-1,5-dimethyl-3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]imidazolidin-2-one (CAS 2023785-80-8), 1-(5-tert-butylisoxazol-3-yl)-4-ethoxy-5-hydroxy-3-methyl-imidazolidin-2-one (CAS 1844836-64-1), triazine herbicides, including of chlorotriazine, triazinones, triazindiones, methylthiotriazines and pyridazinones such as ametryn, atrazine, chloridazone, cyanazine, desmetryn, dimethametryn, hexazinone, metribuzin, prometon, prometryn, propazine, simazine, simetryn, terbumeton, terbuthylazin, terbutryn and trietazin, aryl urea such as chlorobromuron, chlorotoluron, chloroxuron, dimefuron, diuron, fluometuron, isoproturon, isouron, linuron, metamitron, methabenzthiazuron, metobenzuron, metoxuron, monolinuron, neburon, siduron, tebuthiuron and thiadiazuron, phenyl carbamates such as desmedipham, karbutilat, phenmedipham, phenmedipham-ethyl, nitrile herbicides such as bromofenoxim, bromoxynil and its salts and esters, ioxynil and its salts and esters, uraciles such as bromacil, lenacil and terbacil, and bentazon and bentazon-sodium, pyridate, pyridafol, pentanochlor and propanil and inhibitors of the photosystem I such as diquat, diquat-dibromide, paraquat, paraquat-dichloride and paraquat-dimetilsulfate. Among these, a preferred embodiment of the invention relates to those compositions comprising at least one aryl urea herbicide. Among these, likewise a preferred embodiment of the invention relates to those compositions comprising at least one triazine herbicide. Among these, likewise a preferred embodiment of the invention relates to those compositions comprising at least one nitrile herbicide;
    • b4) from the group of the protoporphyrinogen-IX oxidase inhibitors: acifluorfen, acifluorfen-sodium, azafenidin, bencarbazone, benzfendizone, bifenox, butafenacil, carfentrazone, carfentrazone-ethyl, chlomethoxyfen, chlorphthalim, cinidon-ethyl, cyclopyranil, fluazolate, flufenpyr, flufenpyr-ethyl, flumiclorac, flumiclorac-pentyl, flumioxazin, fluoroglycofen, fluoroglycofen-ethyl, fluthiacet, fluthiacet-methyl, fomesafen, halosafen, lactofen, oxadiargyl, oxadiazon, oxyfluorfen, pentoxazone, profluazol, pyraclonil, pyraflufen, pyraflufen-ethyl, saflufenacil, sulfentrazone, thidiazimin, tiafenacil, trifludimoxazin, ethyl [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate (CAS 353292-31-6; S-3100), N-ethyl-3-(2,6-dichloro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452098-92-9), N-tetrahydrofurfuryl-3-(2,6-dichloro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 915396-43-9), N-ethyl-3-(2-chloro-6-fluoro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452099-05-7), N-tetrahydrofurfuryl-3-(2-chloro-6-fluoro-4-trifluoro-methylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452100-03-7), 3-[7-fluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-1,5-dimethyl-6-thioxo-[1,3,5]triazinan-2,4-dione (CAS 451484-50-7), 2-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4,5,6,7-tetrahydro-isoindole-1,3-dione (CAS 1300118-96-0), 1-methyl-6-trifluoromethyl-3-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-1H-pyrimidine-2,4-dione (CAS 1304113-05-0), methyl (E)-4-[2-chloro-5-[4-chloro-5-(difluoromethoxy)-1H-methyl-pyrazol-3-yl]-4-fluoro-phenoxy]-3-methoxy-but-2-enoate (CAS 948893-00-3), and 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)-1H-pyrimidine-2,4-dione (CAS 212754-02-4), 2-[2-chloro-5-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-4-fluorophenoxy]-2-methoxy-acetic acid methyl ester (CAS 1970221-16-9), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]-acetic acid methyl ester (CAS 2158274-96-3), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy] acetic acid ethyl ester (CAS 158274-50-9), methyl 2-[[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy]acetate (CAS 2271389-22-9), ethyl 2-[[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy]acetate (CAS 2230679-62-4), 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-acetic acid methyl ester (CAS 2158275-73-9), 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy] acetic acid ethyl ester (CAS 2158274-56-5), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]-N-(methylsulfonyl)-acetamide (CAS 2158274-53-2), 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-N-(methylsulfonyl)-acetamide (CAS 2158276-22-1);
    • b5) from the group of the bleacher herbicides:
    • PDS inhibitors: beflubutamid, diflufenican, fluridone, flurochloridone, flurtamone, norflurazon, picolinafen, and 4-(3-trifluoromethylphenoxy)-2-(4-trifluoromethylphenyl)-pyrimidine (CAS 180608-33-7), HPPD inhibitors: benzobicyclon, benzofenap, bicyclopyrone, clomazone, fenquinotrione, isoxaflutole, mesotrione, oxotrione (CAS 1486617-21-3), pyrasulfotole, pyrazolynate, pyrazoxyfen, sulcotrione, tefuryltrione, tembotrione, tolpyralate, topramezone, bleacher, unknown target: aclonifen, amitrole flumeturon 2-chloro-3-methylsulfanyl-N-(1-methyltetrazol-5-yl)-4-(trifluoromethyl)benzamide (CAS 1361139-71-0), bixlozone and 2-(2,5-dichlorophenyl)methyl-4,4-dimethyl-3-isoxazolidinone (CAS 81778-66-7);
    • b6) from the group of the EPSP synthase inhibitors: glyphosate, glyphosate-isopropylammonium, glyposate-potassium and glyphosate-trimesium (sulfosate);
    • b7) from the group of the glutamine synthase inhibitors: bilanaphos (bialaphos), bilanaphos-sodium, glufosinate, glufosinate-P and glufosinate-ammonium;
    • b8) from the group of the DHP synthase inhibitors:
    • asulam;
    • b9) from the group of the mitosis inhibitors:
    • compounds of group K1: dinitroanilines such as benfluralin, butralin, dinitramine, ethalfluralin, fluchloralin, oryzalin, pendimethalin, prodiamine and trifluralin, phosphoramidates such as amiprophos, amiprophos-methyl, and butamiphos, benzoic acid herbicides such as chlorthal, chlorthal-dimethyl, pyridines such as dithiopyr and thiazopyr, benzamides such as propyzamide and tebutam; compounds of group K2: carbetamide, chlorpropham, flamprop, flamprop-isopropyl, flamprop-methyl, flamprop-M-isopropyl, flamprop-M-methyl and propham; among these, compounds of group K1, in particular dinitroanilines are preferred;
    • b10) from the group of the VLCFA inhibitors:
    • chloroacetamides such as acetochlor, alachlor, amidochlor, butachlor, dimethachlor, dimethenamid, dimethenamid-P, metazachlor, metolachlor, metolachlor-S, pethoxamid, pretilachlor, propachlor, propisochlor and thenylchlor, oxyacetanilides such as flufenacet and mefenacet, acetanilides such as diphenamid, naproanilide, napropamide and napropamide-M, tetrazolinones such fentrazamide, and other herbicides such as anilofos, cafenstrole, fenoxasulfone, ipfencarbazone, piperophos, pyroxasulfone and isoxazoline compounds of the formulae II.1, II.2, II.3, II.4, II.5, II.6, II.7, II.8 and II.9




embedded image


embedded image






      • the isoxazoline compounds of the formula (II) are known in the art, e.g. from WO 2006/024820, WO 2006/037945, WO 2007/071900 and WO 2007/096576;

      • among the VLCFA inhibitors, preference is given to chloroacetamides and oxyacetamides;



    • b11) from the group of the cellulose biosynthesis inhibitors:

    • chlorthiamid, dichlobenil, flupoxam, indaziflam, isoxaben, triaziflam and 1-cyclohexyl-5-pentafluorphenyloxy-14-[1,2,4,6]thiatriazin-3-ylamine (CAS 175899-01-1);

    • b12) from the group of the decoupler herbicides:

    • dinoseb, dinoterb and DNOC and its salts;

    • b13) from the group of the auxinic herbicides:

    • 2,4-D and its salts and esters such as clacyfos, 2,4-DB and its salts and esters, aminocyclopyrachlor and its salts and esters, aminopyralid and its salts such as aminopyralid-dimethylammonium, aminopyralid-tris(2-hydroxypropyl)ammonium and its esters, benazolin, benazolin-ethyl, chloramben and its salts and esters, clomeprop, clopyralid and its salts and esters, dicamba and its salts and esters, dichlorprop and its salts and esters, dichlorprop-P and its salts and esters, flopyrauxifen, fluroxypyr, fluroxypyr-butometyl, fluroxypyr-meptyl, halauxifen and its salts and esters (CAS 943832-60-8); MCPA and its salts and esters, MCPA-thioethyl, MCPB and its salts and esters, mecoprop and its salts and esters, mecoprop-P and its salts and esters, picloram and its salts and esters, quinclorac, quinmerac, TBA (2,3,6) and its salts and esters, triclopyr and its salts and esters, florpyrauxifen, florpyrauxifen-benzyl (CAS 1390661-72-9) and 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)picolinic acid (CAS 1629965-65-6);

    • b14) from the group of the auxin transport inhibitors: diflufenzopyr, diflufenzopyr-sodium, naptalam and naptalam-sodium;

    • b15) from the group of the other herbicides: bromobutide, chlorflurenol, chlorflurenol-methyl, cinmethylin, cumyluron, cyclopyrimorate (CAS 499223-49-3) and its salts and esters, dalapon, dazomet, difenzoquat, difenzoquat-metilsulfate, dimethipin, DSMA, dymron, endothal and its salts, etobenzanid, flurenol, flurenol-butyl, flurprimidol, fosamine, fosamine-ammonium, indanofan, maleic hydrazide, mefluidide, metam, methiozolin, methyl azide, methyl bromide, methyl-dymron, methyl iodide, MSMA, oleic acid, oxaziclomefone, pelargonic acid, pyributicarb, quinoclamine tetflupyrolimet, and tridiphane.





Moreover, it may be useful to apply the compounds of formula (I) in combination with safeners. Safeners are chemical compounds which prevent or reduce damage on useful plants without having a major impact on the herbicidal action of the compounds of the formula (I) towards undesired vegetation. They can be applied either before sowings (e.g. on seed treatments, shoots or seedlings) or in the pre-emergence application or post-emergence application of the useful plant. The safeners and the compounds of formula (I) and optionally the herbicides B can be applied simultaneously or in succession.


In another embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) and at least one safener C (component C).


Examples of safeners are e.g. (quinolin-8-oxy)acetic acids, 1-phenyl-5-haloalkyl-1H-1,2,4-triazol-3-carboxylic acids, 1-phenyl-4,5-dihydro-5-alkyl-1H-pyrazol-3,5-dicarboxylic acids, 4,5-dihydro-5,5-diaryl-3-isoxazol carboxylic acids, dichloroacetamides, alpha-oximinophenylacetonitriles, acetophenonoximes, 4,6-dihalo-2-phenylpyrimidines, N-[[4-(aminocarbonyl)phenyl]sulfonyl]-2-benzoic amides, 1,8-naphthalic anhydride, 2-halo-4-(haloalkyl)-5-thiazol carboxylic acids, phosphorthiolates and N-alkyl-O-phenylcarbamates and their agriculturally acceptable salts and their agriculturally acceptable derivatives such amides, esters, and thioesters, provided they have an acid group.


Examples of safener compounds C are benoxacor, cloquintocet, cyometrinil, cyprosulfamide, dichlormid, dicyclonon, dietholate, fenchlorazole, fenclorim, flurazole, fluxofenim, furilazole, isoxadifen, mefenpyr, mephenate, naphthalic anhydride, oxabetrinil, 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (MON4660, CAS 71526-07-3), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (R-29148, CAS 52836-31-4), metcamifen and BPCMS (CAS 54091-06-4).


The active compounds B of groups b1) to b15) and the active compounds C are known herbicides and safeners, see, for example, The Compendium of Pesticide Common Names (http://www.alanwood.net/pesticides/); Farm Chemicals Handbook 2000 volume 86, Meister Publishing Company, 2000; B. Hock, C. Fedtke, R. R. Schmidt, Herbizide [Herbicides], Georg Thieme Verlag, Stuttgart 1995; W. H. Ahrens, Herbicide Handbook, 7th edition, Weed Science Society of America, 1994; and K. K. Hatzios, Herbicide Handbook, Supplement for the 7th edition, Weed Science Society of America, 1998. 2,2,5-Trimethyl-3-(dichloroacetyl)-1,3-oxazolidine [CAS No. 52836-31-4] is also referred to as R-29148. 4-(Dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane [CAS No. 71526-07-3] is also referred to as AD-67 and MON 4660.


The assignment of the active compounds to the respective mechanisms of action is based on current knowledge. If several mechanisms of action apply to one active compound, this substance was only assigned to one mechanism of action.


The invention also relates to formulations comprising at least an auxiliary and at least one compound of formula (I) according to the invention.


A formulation comprises a pesticidally effective amount of a compound of formula (I). The term “effective amount” denotes an amount of the combination or of the compound of formula (I), which is sufficient for controlling undesired vegetation, especially for controlling undesired vegetation in crops (i.e. cultivated plants) and which does not result in a substantial damage to the treated crop plants. Such an amount can vary in a broad range and is dependent on various factors, such as the undesired vegetation to be controlled, the treated crop plants or material, the climatic conditions and the specific compound of formula (I) used.


The compounds of formula (I), their salts, amides, esters or thioesters can be convert-ed into customary types of formulations, e.g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. Examples for formulation types are suspensions (e.g. SC, OD, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME), capsules (e.g. CS, ZC), pastes, pastilles, wet-table powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GF). These and further formulation types are defined in the “Catalogue of pesticide formulation types and international coding system”, Technical Monograph No. 2, 6th Ed. May 2008, CropLife International.


The formulations are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.


Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetting agents, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders.


Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e.g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e.g. toluene, paraffin, tetra-hydronaphthalene, alkylated naphthalenes; alcohols, e.g. ethanol, propanol, butanol, benzylalcohol, cyclohexanol; glycols; DMSO; ketones, e.g. cyclohexanone; esters, e.g. lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phospho-nates; amines; amides, e.g. N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof.


Suitable solid carriers or fillers are mineral earths, e.g. silicates, silica gels, talc, kao-lins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e.g. cellulose, starch; fertilizers, e.g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e.g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.


Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof.


Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol.1: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).


Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylarylsulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignine sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccin-ates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.


Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides.


Examples of polymeric surfactants are home- or copolymers of vinylpyrrolidone, vinyl-alcohols, or vinylacetate.


Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of poly-ethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, poly-ethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinylamines or polyethyleneamines.


Suitable adjuvants are compounds, which have a neglectable or even no pesticidal activity themselves, and which improve the biological performance of the compounds of formula (I) on the target. Examples are surfactants, mineral or vegetable oils, and other auxiliaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.


Suitable thickeners are polysaccharides (e.g. xanthan gum, carboxymethylcellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.


Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothia-zolinones and benzisothiazolinones.


Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.


Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.


Suitable colorants (e.g. in red, blue, or green) are pigments of low water solubility and water-soluble dyes. Examples are inorganic colorants (e.g. iron oxide, titan oxide, iron hexacyanoferrate) and organic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).


Suitable tackifiers or binders are polyvinylpyrrolidons, polyvinylacetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.


Examples for formulation types and their preparation are:


i) Water-Soluble Concentrates (SL, LS)

10-60 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 5-15 wt % wetting agent (e.g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e.g. alcohols) ad 100 wt %. The active substance dissolves upon dilution with water.


ii) Dispersible Concentrates (DC)

5-25 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 1-10 wt % dispersant (e.g. polyvinylpyrrolidone) are dissolved in organic solvent (e.g. cyclohexanone) ad 100 wt %. Dilution with water gives a dispersion.


iii) Emulsifiable Concentrates (EC)


15-70 wt % of compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 5-10 wt % emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in water-insoluble organic solvent (e.g. aromatic hydrocarbon) ad 100 wt %. Dilution with water gives an emulsion.


iv) Emulsions (EW, EO, ES)

5-40 wt % of compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 1-10 wt % emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40 wt % water-insoluble organic solvent (e.g. aromatic hydrocarbon). This mixture is introduced into water ad 100 wt % by means of an emulsifying machine and made into a homogeneous emulsion. Dilution with water gives an emulsion.


v) Suspensions (SC, OD, FS)

In an agitated ball mill, 20-60 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are comminuted with addition of 2-10 wt % dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate), 0, 1-2 wt % thickener (e.g. xanthan gum) and water ad 100 wt % to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS type formulation up to 40 wt % binder (e.g. polyvinylalcohol) is added.


vi) Water-Dispersible Granules and Water-Soluble Granules (WG, SG)

50-80 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are ground finely with addition of dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt % and prepared as water-dispersible or water-soluble granules by means of technical appliances (e.g. extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active substance.


vii) Water-Dispersible Powders and Water-Soluble Powders (WP, SP, WS)


50-80 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are ground in a rotor-stator mill with addition of 1-5 wt % dispersants (e.g. sodium lignosulfonate), 1-3 wt % wetting agents (e.g. alcohol ethoxylate) and solid carrier (e.g. silica gel) ad 100 wt %. Dilution with water gives a stable dispersion or solution of the active substance.


viii) Gel (GW, GF)


In an agitated ball mill, 5-25 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are comminuted with addition of 3-10 wt % dispersants (e.g. sodium lignosulfonate), 1-5 wt % thickener (e.g. carboxymethylcellulose) and water ad 100 wt % to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.


iv) Microemulsion (ME)

5-20 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are added to 5-30 wt % organic solvent blend (e.g. fatty acid dimethyl-amide and cyclohexanone), 10-25 wt % surfactant blend (e.g. alcohol ethoxylate and arylphenol ethoxylate), and water ad 100%. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion.


iv) Microcapsules (CS)

An oil phase comprising 5-50 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention, 0-40 wt % water insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 wt % acrylic monomers (e.g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 wt % of a compound of formula (I) according to the invention, 0-40 wt % water insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocya-nate monomer (e.g. diphenylmethene-4,4′-diisocyanate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). The addition of a polyamine (e.g. hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1-10 wt %. The wt % relate to the total CS formulation.


ix) Dustable Powders (DP, DS)

1-10 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are ground finely and mixed intimately with solid carrier (e.g. finely di-vided kaolin) ad 100 wt %.


x) Granules (GR, FG)

0.5-30 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention is ground finely and associated with solid carrier (e.g. silicate) ad 100 wt %. Granulation is achieved by extrusion, spray-drying or the fluidized bed.


xi) Ultra-Low Volume Liquids (UL)

1-50 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are dissolved in organic solvent (e.g. aromatic hydrocarbon) ad 100 wt %.


The formulation types i) to xi) may optionally comprise further auxiliaries, such as 0, 1-1 wt % bactericides, 5-15 wt % anti-freezing agents, 0, 1-1 wt % anti-foaming agents, and 0, 1-1 wt % colorants.


The formulations and/or combinations generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of the compounds of formula (I).


The compounds of formula (I) are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).


Solutions for seed treatment (LS), suspoemulsions (SE), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES), emulsifiable concentrates (EC) and gels (GF) are usually employed for the purposes of treatment of plant propagation materials, particularly seeds. The formulations in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40% by weight, in the ready-to-use preparations. (nach unten verschoben)


Methods for applying compounds of formula (I), formulations and/or combinations thereof, on to plant propagation material, especially seeds, include dressing, coating, pelleting, dusting, soaking and in-furrow application methods of the propagation material. Preferably, compounds of formula (I), formulations and/or combinations thereof, respectively, are applied on to the plant propagation material by a method such that germination is not induced, e.g. by seed dressing, pelleting, coating and dusting.


Various types of oils, wetting agents, adjuvants, fertilizer, or micronutrients, and further pesticides (e.g. herbicides, insecticides, fungicides, growth regulators, safeners) may be added to the compounds of formula (I), the formulations and/or the combinations comprising them as premix or, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the formulations according to the invention in a weight ratio of 1:100 to 100:1, preferably 1:10 to 10:1.


The user applies the compounds of formula (I) according to the invention, the formulations and/or the combinations comprising them usually from a pre-dosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the formulation is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the formulation according to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.


According to one embodiment, either individual components of the formulation according to the invention or partially premixed components, e.g. components comprising compounds of formula (I) and optionally active substances from the groups B and/or C), may be mixed by the user in a spray tank and further auxiliaries and additives may be added, if appropriate.


In a further embodiment, individual components of the formulation according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank and further auxiliaries may be added, if appropriate.


In a further embodiment, either individual components of the formulation according to the invention or partially premixed components, e.g components comprising compounds of formula (I) and optionally active substances from the groups B and/or C), can be applied jointly (e.g. after tank mix) or consecutively.


The compounds of formula (I), are suitable as herbicides. They are suitable as such, as an appropriate formulation or in combination with at least one further compound selected from the herbicidal active compounds B (component B) and safeners C (component C).


The compounds of formula (I), or the formulations and/or combinations comprising the compounds of formula (I), control undesired vegetation on non-crop areas very efficiently, especially at high rates of application. They act against broad-leaved weeds and grass weeds in crops such as wheat, rice, maize, soya and cotton without causing any significant damage to the crop plants. This effect is mainly observed at low rates of application.


The compounds of the invention are useful for controlling for example following weeds: Abutilon theophrasti (ABUTH), Alopercurus myosuroides (ALOMY), Amaranthus retroflexus (AMARE), Apera spica-venti(APESV), Avena fatua (AVEFA), Echinocloa crusgalli (ECHCG), Setaria faberi(SETFA), Setaria viridis (SETVI), to name just a few representative examples.


The compounds of formula (I), or the formulations and/or the combinations comprising them, are applied to the plants mainly by spraying the leaves. Here, the application can be carried out using, for example, water as carrier by customary spraying techniques using spray liquor amounts of from about 100 to 1000 l/ha (for example from 300 to 400 l/ha). The compounds of formula (I), or the formulations and/or the combinations comprising them, may also be applied by the low-volume or the ultra-low-volume method, or in the form of microgranules.


Application of the compounds of formula (I), or the formulations and/or the combinations comprising them, can be done before, during and/or after, preferably during and/or after, the emergence of the undesired vegetation.


Application of the compounds of formula (I), or the formulations and/or the combinations can be carried out before or during sowing.


The compounds of formula (I), or the formulations and/or the combinations comprising them, can be applied pre-, post-emergence or pre-plant, or together with the seed of a crop plant. It is also possible to apply the compounds of formula (I), or the formulations and/or the combinations comprising them, by applying seed, pretreated with the compounds of formula (I), or the formulations and/or the combinations comprising them, of a crop plant. If the active ingredients are less well tolerated by certain crop plants, application techniques may be used in which the combinations are sprayed, with the aid of the spraying equipment, in such a way that as far as possible they do not come into contact with the leaves of the sensitive crop plants, while the active ingredients reach the leaves of undesired vegetation growing underneath, or the bare soil surface (post-directed, lay-by).


In a further embodiment, the compounds of formula (I), or the formulations and/or the combinations comprising them, can be applied by treating seed. The treatment of seeds comprises essentially all procedures familiar to the person skilled in the art (seed dressing, seed coating, seed dusting, seed soaking, seed film coating, seed multilayer coating, seed encrusting, seed dripping and seed pelleting) based on the compounds of formula (I), or the formulations and/or the combinations prepared therefrom. Here, the combinations can be applied diluted or undiluted.


The term “seed” comprises seed of all types, such as, for example, corns, seeds, fruits, tubers, seedlings and similar forms. Here, preferably, the term seed describes corns and seeds. The seed used can be seed of the crop plants mentioned above, but also the seed of transgenic plants or plants obtained by customary breeding methods.


When employed in plant protection, the amounts of active substances applied, i.e. the compounds of formula (I), component B and, if appropriate, component C without formulation auxiliaries, are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha and in particular from 0.1 to 0.75 kg per ha.


In another embodiment of the invention, the application rate of the compounds of formula (I), component B and, if appropriate, component C, is from 0.001 to 3 kg/ha, preferably from 0.005 to 2.5 kg/ha and in particular from 0.01 to 2 kg/ha of active substance (a.s.).


In another preferred embodiment of the invention, the rates of application of the compounds of formula (I) according to the present invention (total amount of compounds of formula (I)) are from 0.1 g/ha to 3000 g/ha, preferably 10 g/ha to 1000 g/ha, depending on the control target, the season, the target plants and the growth stage.


In another preferred embodiment of the invention, the application rates of the compounds of formula (I) are in the range from 0.1 g/ha to 5000 g/ha and preferably in the range from 1 g/ha to 2500 g/ha or from 5 g/ha to 2000 g/ha.


In another preferred embodiment of the invention, the application rate of the compounds of formula (I) is 0.1 to 1000 g/ha, preferably 1 to 750 g/ha, more preferably 5 to 500 g/ha.


The required application rates of herbicidal compounds B are generally in the range of from 0.0005 kg/ha to 2.5 kg/ha and preferably in the range of from 0.005 kg/ha to 2 kg/ha or 0.01 kg/ha to 1.5 kg/h of a.s.


The required application rates of safeners C are generally in the range of from 0.0005 kg/ha to 2.5 kg/ha and preferably in the range of from 0.005 kg/ha to 2 kg/ha or 0.01 kg/ha to 1.5 kg/h of a.s.


In treatment of plant propagation materials such as seeds, e.g. by dusting, coating or drenching seed, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seeds) are generally required.


In another embodiment of the invention, to treat the seed, the amounts of active substances applied, i.e. the compounds of formula (I), component B and, if appropriate, component C are generally employed in amounts of from 0.001 to 10 kg per 100 kg of seed.


When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect.


Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.


In case of combinations according to the present invention it is immaterial whether the compounds of formula (I), and the further component B and/or the component C are formulated and applied jointly or separately.


In the case of separate application, it is of minor importance, in which order the application takes place. It is only necessary, that the compounds of formula (I), and the further component B and/or the component C are applied in a time frame that allows simulta-neous action of the active ingredients on the plants, preferably within a time-frame of at most 14 days, in particular at most 7 days.


Depending on the application method in question, the compounds of formula (I), or the formulations and/or combinations comprising them, can additionally be employed in a further number of crop plants for eliminating undesired vegetation. Examples of suitable crops are the following: Allium cepa, Ananas comosus, Arachis hypogaea, Asparagus officinalis, Avena sativa, Beta vulgaris spec. altissima, Beta vulgaris spec. rapa, Brassica napus var. napus, Brassica napus var. napobrassica, Brassica rapa var. silvestris, Brassica oleracea, Brassica nigra, Camellia sinensis, Carthamus tinctorius, Carya illinoinensis, Citrus limon, Citrus sinensis, Coffea arabica (Coffea canephora, Coffea liberica), Cucumis sativus, Cynodon dactylon, Daucus carota, Elaeis guineensis, Fragaria vesca, Glycine max, Gossypium hirsutum, (Gossypium arboreum, Gossypium herbaceum, Gossypium vitifolium), Helianthus annuus, Hevea brasiliensis, Hordeum vulgare, Humulus lupulus, lpomoea batatas, Juglans regia, Lens culinaris, Linum usitatissimum, Lycopersicon lycopersicum, Malus spec., Manihot esculenta, Medicago sativa, Musa spec., Nicotiana tabacum (N. rustiica), Olea europaea, Oryza sativa, Phaseolus lunatus, Phaseolus vulgaris, Picea abies, Pinus spec., Pistacia vera, Pisum sativum, Prunus avium, Prunus persica, Pyrus communis, Prunus armeniaca, Prunus cerasus, Prunus dulcis and Prunus domestica, Ribes sylvestre, Ricinus communis, Saccharum officinarum, Secale cereale, Sinapis alba, Solanum tuberosum, Sorghum bicolor (S. vulgare), Theobroma cacao, Trifolium pratense, Triticum aestivum, Triticale, Triticum durum, Vicia faba, Vitis vinifera and Zea mays.


Preferred crops are Arachis hypogaea, Beta vulgaris spec. altissima, Brassica napus var. napus, Brassica oleracea, Citrus limon, Citrus sinensis, Coffea arabica (Coffea canephora, Coffea liberica), Cynodon dactylon, Glycine max, Gossypium hirsutum, (Gossypium arboreum, Gossypium herbaceum, Gossypium vitifolium), Helianthus annuus, Hordeum vulgare, Juglans regia, Lens culinaris, Linum usitatissimum, Lycopersicon lycopersicum, Malus spec., Medicago sativa, Nicotiana tabacum (N. rustica), Olea europaea, Oryza sativa, Phaseolus lunatus, Phaseolus vulgaris, Pistacia vera, Pisum sativum, Prunus dulcis, Saccharum officinarum, Secale cereale, Solanum tuberosum, Sorghum bicolor (S. vulgare), Triticale, Triticum aestivum, Triticum durum, Vicia faba, Vitis vinifera and Zea mays.


Especially preferred crops are crops of cereals, corn, soybeans, rice, oilseed rape, cotton, potatoes, peanuts or permanent crops.


The compounds of formula (I) according to the invention, or the formulations and/or combinations comprising them, can also be used in crops which have been modified by mutagenesis or genetic engineering in order to provide a new trait to a plant or to modify an already present trait.


The term “crops” as used herein includes also (crop) plants which have been modified by mutagenesis or genetic engineering in order to provide a new trait to a plant or to modify an already present trait.


Mutagenesis includes techniques of random mutagenesis using X-rays or mutagenic chemicals, but also techniques of targeted mutagenesis, in order to create mutations at a specific locus of a plant genome. Targeted mutagenesis techniques frequently use oligonucleotides or proteins like CRISPR/Cas, zinc-finger nucleases, TALENs or me-ganucleases to achieve the targeting effect.


Genetic engineering usually uses recombinant DNA techniques to create modifications in a plant genome which under natural circumstances cannot readily be obtained by cross breeding, mutagenesis or natural recombination. Typically, one or more genes are integrated into the genome of a plant in order to add a trait or improve a trait. These integrated genes are also referred to as transgenes in the art, while plant comprising such transgenes are referred to as transgenic plants. The process of plant transformation usually produces several transformation events, which differ in the genomic locus in which a transgene has been integrated. Plants comprising a specific transgene on a specific genomic locus are usually described as comprising a specific “event”, which is referred to by a specific event name. Traits which have been introduced in plants or have been modified include in particular herbicide tolerance, insect resistance, increased yield and tolerance to abiotic conditions, like drought.


Herbicide tolerance has been created by using mutagenesis as well as using genetic engineering. Plants which have been rendered tolerant to acetolactate synthase (ALS) inhibitor herbicides by conventional methods of mutagenesis and breeding comprise plant varieties commercially available under the name Clearfield®. However, most of the herbicide tolerance traits have been created via the use of transgenes.


Herbicide tolerance has been created to glyphosate, glufosinate, 2,4-D, dicamba, oxynil herbicides, like bromoxynil and ioxynil, sulfonylurea herbicides, ALS inhibitor herbicides and 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors, like isoxaflutole and mesotrione.


Transgenes which have been used to provide herbicide tolerance traits comprise: for tolerance to glyphosate: cp4 epsps, epsps grg23ace5, mepsps, 2mepsps, gat4601, gat4621 and goxv247, for tolerance to glufosinate: pat and bar, for tolerance to 2,4-D: aad-1 and aad-12, for tolerance to dicamba: dmo, for tolerance to oxynil herbicies: bxn, for tolerance to sulfonylurea herbicides: zm-hra, csr1-2, gm-hra, S4-HrA, for tolerance to ALS inhibitor herbicides: csr1-2, for tolerance to HPPD inhibitor herbicides: hppdPF, W336 and avhppd-03.


Transgenic corn events comprising herbicide tolerance genes are for example, but not excluding others, DAS40278, MON801, MON802, MON809, MON810, MON832, MON87411, MON87419, MON87427, MON88017, MON89034, NK603, GA21, MZHGOJG, HCEM485, VCO-01981-5, 676, 678, 680, 33121, 4114, 59122, 98140, Bt10, Bt176, CBH-351, DBT418, DLL25, MS3, MS6, MZIR098, T25, TC1507 and TC6275.


Transgenic soybean events comprising herbicide tolerance genes are for example, but not excluding others, GTS 40-3-2, MON87705, MON87708, MON87712, MON87769, MON89788, A2704-12, A2704-21, A5547-127, A5547-35, DP356043, DAS44406-6, DAS68416-4, DAS-81419-2, GU262, SYHTOH2, W62, W98, FG72 and CV127.


Transgenic cotton events comprising herbicide tolerance genes are for example, but not excluding others, 19-51a, 31707, 42317, 81910, 281-24-236, 3006-210-23, BXN10211, BXN10215, BXN10222, BXN10224, MON1445, MON1698, MON88701, MON88913, GHB119, GHB614, LLCotton25, T303-3 and T304-40.


Transgenic canola events comprising herbicide tolerance genes are for example, but not excluding others, MON88302, HCR-1, HCN10, HCN28, HCN92, MS1, MS8, PHY14, PHY23, PHY35, PHY36, RF1, RF2and RF3.


Insect resistance has mainly been created by transferring bacterial genes for insecticidal proteins to plants. Transgenes which have most frequently been used are toxin genes of Bacillus spec. and synthetic variants thereof, like cry1A, cry1Ab, cry1Ab-Ac, cry1Ac, cry1A.105, cry1F, cry1Fa2, cry2Ab2, cry2Ae, mcry3A, ecry3.1Ab, cry3Bb1, cry34Ab1, cry35Ab1, cry9C, vip3A(a), vip3Aa20. However, also genes of plant origin have been transferred to other plants. In particular genes coding for protease inhibitors, like CpTI and pinII. A further approach uses transgenes in order to produce double stranded RNA in plants to target and downregulate insect genes. An example for such a transgene is dvsnf7.


Transgenic corn events comprising genes for insecticidal proteins or double stranded RNA are for example, but not excluding others, Bt10, Bt11, Bt176, MON801, MON802, MON809, MON810, MON863, MON87411, MON88017, MON89034, 33121, 4114, 5307, 59122, TC1507, TC6275, CBH-351, MIR162, DBT418 and MZIR098.


Transgenic soybean events comprising genes for insecticidal proteins are for example, but not excluding others, MON87701, MON87751 and DAS-81419.


Transgenic cotton events comprising genes for insecticidal proteins are for example, but not excluding others, SGK321, MON531, MON757, MON1076, MON15985, 31707, 31803, 31807, 31808, 42317, BNLA-601, Event1, COT67B, COT102, T303-3, T304-40, GFM Cry1A, GK12, MLS 9124, 281-24-236, 3006-210-23, GHB119 and SGK321.


Increased yield has been created by increasing ear biomass using the transgene athb17, being present in corn event MON87403, or by enhancing photosynthesis using the transgene bbx32, being present in the soybean event MON87712.


Crops comprising a modified oil content have been created by using the transgenes: gm-fad2-1, Pj.D6D, Nc.Fad3, fad2-1A and fatb1-A. Soybean events comprising at least one of these genes are: 260-05, MON87705 and MON87769.


Tolerance to abiotic conditions, in particular to tolerance to drought, has been created by using the transgene cspB, comprised by the corn event MON87460 and by using the transgene Hahb-4, comprised by soybean event IND-00410-5.


Traits are frequently combined by combining genes in a transformation event or by combining different events during the breeding process. Preferred combination of traits are herbicide tolerance to different groups of herbicides, insect tolerance to different kind of insects, in particular tolerance to lepidopteran and coleopteran insects, herbicide tolerance with one or several types of insect resistance, herbicide tolerance with increased yield as well as a combination of herbicide tolerance and tolerance to abiotic conditions.


Plants comprising singular or stacked traits as well as the genes and events providing these traits are well known in the art. For example, detailed information as to the muta-genized or integrated genes and the respective events are available from websites of the organizations “International Service for the Acquisition of Agri-biotech Applications (ISAAA)” (http://www.isaaa.org/gmapprovaldatabase) and the “Center for Environmen-tal Risk Assessment (CERA)” (http://cera-gmc.org/GMCropDatabase), as well as in patent applications, like EP3028573 and WO2017/011288.


The use of the compounds of formula (I) or formulations or combinations comprising them according to the invention on crops may result in effects which are specific to a crop comprising a certain gene or event. These effects might involve changes in growth behavior or changed resistance to biotic or abiotic stress factors. Such effects may in particular comprise enhanced yield, enhanced resistance or tolerance to insects, nematodes, fungal, bacterial, mycoplasma, viral or viroid pathogens as well as early vigor, early or delayed ripening, cold or heat tolerance as well as changed amino acid or fatty acid spectrum or content.


Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of ingredients or new ingredients, specifically to improve raw material production, e.g., potatoes that produce increased amounts of amylopectin (e.g. Amflora® potato, BASF SE, Germany).


Furthermore, it has been found that the compounds of formula (I) according to the invention, or the formulations and/or combinations comprising them, are also suitable for the defoliation and/or desiccation of plant parts of crops such as cotton, potato, oilseed rape, sunflower, soybean or field beans, in particular cotton. In this regard, formulations and/or combinations for the desiccation and/or defoliation of crops, processes for preparing these formulations and/or combinations and methods for desiccating and/or defoliating plants using the compounds of formula (I) have been found.


As desiccants, the compounds of formula (I) are particularly suitable for desiccating the above-ground parts of crop plants such as potato, oilseed rape, sunflower and soybean, but also cereals. This makes possible the fully mechanical harvesting of these important crop plants.


Also of economic interest is to facilitate harvesting, which is made possible by concentrating within a certain period of time the dehiscence, or reduction of adhesion to the tree, in citrus fruit, olives and other species and varieties of pernicious fruit, stone fruit and nuts. The same mechanism, i.e. the promotion of the development of abscission tissue between fruit part or leaf part and shoot part of the plants is also essential for the controlled defoliation of useful plants, in particular cotton.


Moreover, a shortening of the time interval in which the individual cotton plants mature leads to an increased fiber quality after harvesting.


A SYNTHESIS EXAMPLES

Chemical bonds, drawn as bars in chemical formulae, indicate the relative stereochemistry on the ring system.


Example 1: Synthesis of 3-[[(1R,4S)-4-isopropoxycarbonylcyclopent-2-en-1-yl]amino]-2-methoxy-3-oxo-propanoic acid (Inter A)



embedded image


To a solution of (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one (CAS 79200-56-9) (33.3 g, 305 mmol) (3.0 g, 24 mmol) in isopropanol (100 mL) thionyl chloride (72.6 g, 610 mmol) were added at 0° C. After stirring for 2 h and letting the mixture warm up to room temperature, the solvent was removed under reduced pressure to afford Inter C (54 g, 86%) as a colorless salt.



1H NMR (400 MHz, D2O) δ 6.23 (ddd, J=5.7, 2.4, 1.6 Hz, 1H), 5.99 (dt, J=5.7, 2.3 Hz, 1H), 5.03 (hept, J=6.2 Hz, 1H), 4.42 (ddt, J=6.7, 4.9, 1.9 Hz, 1H), 3.75 (dddd, J=10.4, 4.1, 3.3, 2.0 Hz, 1H), 2.70 (dt, J=14.4, 8.5 Hz, 1H), 2.08 (dt, J=14.4, 5.2 Hz, 1H), 1.28 (dd, J=6.3, 3.0 Hz, 6H).




embedded image


To a solution of the lithium 2,3-dimethoxy-3-oxo-propanoate (3) (37.5 g, 243 mmol) in dimethylformamide (DMF, 250 mL) the hydrochloride salt of isopropyl (1S,4R)-4-aminocyclopent-2-ene-1-carboxylate (2) (50 g, 243 mmol) (CAS 229613-83-6) was added. To the resulting solution was added HATU (101 g, 729 mmol) (CAS: 148893-10-1) and then diisopropylethylamine (124 mL). After stirring overnight, the reaction was quenched with water (50 mL) and sat. aqueous bicarbonate solution (50 mL) The aqueous layer was separated and extracted with ethyl acetate (3×100 mL). The combined organic phases were dried (sodium sulfate), filtered and evaporated under reduced pressure. The crude product (4) (72 g, 99%) was obtained as a 1:1 mixture of diastereoisomers and was used in the next step without further purification.



1H NMR (500 MHz, Chloroform-d) δ 7.10-6.98 (m, 1H), 5.98-5.79 (m, 2H), 5.13-4.97 (m, 2H), 4.34-4.25 (m, 1H), 3.83 (s, 3H), 3.56-3.44 (m, 4H), 2.55-2.41 (m, 1H), 1.96-1.85 (m, 1H), 1.29-1.23 (m, 6H).




embedded image


To a solution of isopropyl (1S,4R)-4-[(2,3-dimethoxy-3-oxo-propanoyl)amino]cyclopent-2-ene-1-carboxylate (4) (21.1 g, 70.5 mmol) in 1,2-dichloroethane (200 mL) was added trimethyltin hydroxide (Me3SnOH) (25.5 g, 141 mmol) at room temperature. The reaction mixture was stirred at room temperature for 16 h, then the reaction mixture was extracted with saturated sodium bicarbonate solution in water (3×100 mL). The combined organic phases were adjusted to pH 1 using concentrated hydrogen chloride solution in water. The resulting mixture was extracted with ethyl acetate (3×100 mL).


The organic phases were dried over sodium sulfate. The dried organic phase was filtered and concentrated under reduced pressure to afford the 3-[[(1R,4S)-4-isopropoxycarbonylcyclopent-2-en-1-yl]amino]-2-methoxy-3-oxo-propanoic acid (20 g, quantitative) as a mixture of diastereoisomers (1:1).



1H NMR (500 MHz, Chloroform-d) δ 9.64 (s, 1H), 7.65-7.43 (m, 1H), 6.05-5.79 (m, 2H), 5.13-4.96 (m, 2H), 4.32 (s, 1H), 3.70-3.60 (m, 3H), 3.55-3.45 (m, 1H), 2.55-2.41 (m, 1H), 2.01-1.89 (m, 1H), 1.31-1.21 (m, 6H).


Example 2: Synthesis of isopropyl (1S,4R)-4-[[3-[(5-tert-butylisoxazol-3-yl)amino]-2-methoxy-3-oxo-propanoyl]amino]cyclopent-2-ene-1-carboxylate (Cpd. 1.1 in Table 1 Below)



embedded image


To a solution of Inter A (300 mg, 1.05 mmol) in dimethylformamide (DMF, 5 mL) 5-tert-butylisoxazol-3-amine (1) (50 g, 243 mmol) (CAS 55809-36-4) was added. To the resulting solution was added HATU (460 mg, 1.21 mmol) (CAS: 148893-10-1) and diisopropylethylamine (0.36 mL, 2.1 mmol). After stirring overnight, the reaction was quenched with water (5 mL) and sat. aqueous bicarbonate solution (5 mL) The aqueous layer was separated and extracted with ethyl acetate (3×10 mL). The combined organic phases were dried (sodium sulfate), filtered and evaporated under reduced pressure. The residue was purified by column chromatography using ethyl acetate to afford the title compound (40 mg, 9%) as a 1:1 mixture of diastereoisomers.



1H N M R (500 MHz, THF-d) δ 10.20-10.09 (m, 1H), 7.46 (t, J=7.7 Hz, 1H), 6.69 (d, J=2.2 Hz, 1H), 5.84 (dddt, J=50.0, 7.7, 5.6, 2.5 Hz, 2H), 4.98 (ddtd, J=15.4, 12.5, 6.3, 2.4 Hz, 2H), 4.32 (d, J=3.4 Hz, 1H), 3.49-3.41 (m, 4H), 2.47 (dtd, J=13.4, 8.3, 5.0 Hz, 1H), 1.85 (dtd, J=13.4, 5.6, 3.5 Hz, 1H), 1.32 (s, 9H), 1.23 (dd, J=6.3, 3.7 Hz, 6H).


Example 3: Synthesis of isopropyl (1S,4R)-4-[[3-[(4-chloro-2-pyridyl)amino]-2-methoxy-3-oxo-propanoyl]amino]cyclopent-2-ene-1-carboxylate (Cpd. 1.4 in Table 1 Below)



embedded image


1-Propanephosphonic anhydride solution (T3P) (1.14 g, 1.79 mmol, 50% in ethyl acetate) and triethylamine (0.44 mL, 3.2 mmol) were added to a solution of 3-[[(1R,4S)-4-isopropoxycarbonylcyclopent-2-en-1-yl]amino]-2-methoxy-3-oxo-propanoic acid (Inter A) (300 mg, 1.05 mmol) and 4-chloropyridin-2-amine (1) (149 mg, 1.26 mmol) in tetrahydrofuran (30 mL). After stirring at room temperature overnight, the mixture was poured into ice water and extracted with ethyl acetate (3×). The extracts were washed with brine, dried, concentrated, purified by column chromatography using ethyl acetate as solvent to yield the title compound Cpd 1.4 (290 mg, 66% yield) as a 1:1 mixture of diastereoisomers.



1H NMR (400 MHz, Chloroform-d) δ 9.58-9.47 (m, 1H), 8.26 (d, J=1.9 Hz, 1H), 8.23-8.15 (m, 1H), 7.39-7.27 (m, 1H), 7.11-6.99 (m, 1H), 5.98-5.80 (m, 2H), 5.16-4.96 (m, 2H), 4.46-4.37 (m, 1H), 3.68-3.57 (m, 3H), 3.53-3.45 (m, 1H), 2.53-2.41 (m, 1H), 2.01-1.87 (m, 1H), 1.32-1.16 (m, 6H).


Example 4: Synthesis of isopropyl (1S,4R)-4-[[3-[(2-chloro-6-methyl-4-pyridyl)amino]-2-methoxy-3-oxo-propanoyl]amino]cyclopent-2-ene-1-carboxylate (Cpd. 1.6 in Table 1 Below)



embedded image


1-Propanephosphonic anhydride solution (T3P) (1.14 g, 1.79 mmol, 50% in ethyl acetate) and triethylamine (0.44 mL, 3.2 mmol) were added to a solution of 3-[[(1R,4S)-4-isopropoxycarbonylcyclopent-2-en-1-yl]amino]-2-methoxy-3-oxo-propanoic acid (Inter A) (300 mg, 1.05 mmol) and 2-chloro-6-methyl-pyridin-4-amine (1) (165 mg, 1.16 mmol) in tetrahydrofuran (30 mL). After stirring at room temperature overnight, the mixture was poured into ice water and extracted with ethyl acetate (3×). The extracts were washed with brine, dried, concentrated, purified by column chromatography using ethyl acetate as solvent to yield the title compound Cpd 1.6 (290 mg, 66% yield) as a 1:1 mixture of diastereoisomers.



1H NMR (400 MHz, Chloroform-d) δ 9.81-9.60 (m, 1H), 7.58-7.42 (m, 2H), 7.35-7.20 (m, 1H), 6.05-5.80 (m, 2H), 5.15-4.94 (m, 2H), 4.50-4.41 (m, 1H), 3.65-3.45 (m, 4H), 2.55-2.16 (m, 4H), 2.08-1.94 (m, 1H), 1.36-1.14 (m, 6H).


Example 5: Synthesis of isopropyl (1S,4R)-4-[[3-[(4-chloro-2-thienyl)amino]-2-methoxy-3-oxo-propanoyl]amino]cyclopent-2-ene-1-carboxylate (Cpd 1.20)



embedded image


To a solution of Inter A (200 mg, 0.701 mmol) in dimethylformamide (DMF, 5 mL) 4-chlorothiophen-2-amine (1) (137 mg, 0.806 mmol) was added. To the resulting solution was added HATU (307 mg, 0.806 mmol) (CAS: 148893-10-1) and diisopropylethylamine (0.24 mL, 1.4 mmol). After stirring overnight, the reaction was quenched with water (5 mL) and sat. aqueous bicarbonate solution (5 mL) The aqueous layer was separated and extracted with ethyl acetate (3×10 mL). The combined organic phases were dried (sodium sulfate), filtered and evaporated under reduced pressure. The residue was purified by column chromatography using ethyl acetate to afford the title compound Cpd 1.20 (60 mg, 21%) as a 1:1 mixture of diastereoisomers.



1H NMR (500 MHz, Chloroform-d) δ 9.09-8.96 (m, 1H), 7.32-7.28 (m, 1H), 7.24-7.17 (m, 1H), 6.97-6.93 (m, 1H), 5.99-5.80 (m, 2H), 5.10-4.95 (m, 2H), 4.27-4.21 (m, 1H), 3.69-3.60 (m, 3H), 3.52-3.42 (m, 1H), 2.53-2.38 (m, 1H), 1.98-1.87 (m, 1H), 1.28-1.19 (m, 6H).


High Performance Liquid Chromatography: HPLC-column Kinetex XB C18 1,7μ (50×2.1 mm); eluent: acetonitrile/water+0.1% trifluoroacetic acid (gradient from 5:95 to 100:0 in 1.5 min at 60° C., flow gradient from 0.8 to 1.0 ml/min in 1.5 min).


In analogy to the examples described above, the following compounds of formula (I), wherein R1 and R4 are hydrogen, were prepared, starting from commercially available diesters and using commercially available amines:




embedded image














TABLE 1





Cpd
Q-N′
R2
R3
N*-X-Y
HPLC/MS







I.1 


embedded image


CH3
H


embedded image


408.1





I.2 


embedded image


CH3
H


embedded image


377.8





I.3 


embedded image


CH3
H


embedded image


402.1





I.4 


embedded image


CH3
H


embedded image


395.9





I.5 


embedded image


CH3
H


embedded image


476.1





I.6 


embedded image


CH3
H


embedded image


410.1





I.7 


embedded image


CH3
H


embedded image


395.9





I.8 


embedded image


CH3
H


embedded image


406.1





I.9 


embedded image


CH3
H


embedded image


429.9





I.10


embedded image


CH3
H


embedded image


410.1





I.11


embedded image


CH3
H


embedded image


455.9





I.12


embedded image


CH3
H


embedded image


410.1





I.13


embedded image


CH3
H


embedded image


380.2





I.14


embedded image


CH3
H


embedded image


426.2





I.15


embedded image


CH3
H


embedded image


387.2





I.16


embedded image


CH3
H


embedded image


387.3





I.17


embedded image


CH3
H


embedded image


378.2





I.18


embedded image


CH3
H


embedded image


338.9





I.19


embedded image


CH3
H


embedded image


397.2





I.20


embedded image


CH3
H


embedded image


400.9





I.21


embedded image


CH3
H


embedded image


397.9





I.22


embedded image


CH3
H


embedded image


475.9





I.23


embedded image


CH3
H


embedded image


396.9





I.24


embedded image


CH3
H


embedded image


380.0





I.25


embedded image


CH3
H


embedded image


429.9





I.26


embedded image


CH3
H


embedded image


351.9





I.27


embedded image


CH3
H


embedded image


380.9





I.28


embedded image


CH3
H


embedded image


396.8





I.29


embedded image


CH3
H


embedded image


396.9





I.30


embedded image


CH3
H


embedded image


422.2





I.31


embedded image


CH3
H


embedded image


426.2





I.32


embedded image


CH3
H


embedded image


406.0





I.33


embedded image


CH3
H


embedded image


395.9





I.34


embedded image


CH3
H


embedded image


379.9





I.35


embedded image


CH3
H


embedded image


380.2





I.36


embedded image


CH3
H


embedded image


396.2





I.37


embedded image


CH3
H


embedded image


446.0





I.38


embedded image


CH3
H


embedded image


327.7





I.39


embedded image


CH3
H


embedded image


327.8





I.40


embedded image


CH3
H


embedded image


343.7





I.41


embedded image


CH3
H


embedded image


343.7





I.42


embedded image


CH3
H


embedded image


376.3





I.43


embedded image


CH3
H


embedded image


345.2





I.44


embedded image


CH3
H


embedded image


369.1





HPLC/MS = MassChargeRatio






B BIOLOGICAL EXAMPLES

The herbicidal activity of the compounds of formula (I) was demonstrated by the following greenhouse experiments: The culture containers used were plastic flowerpots containing loamy sand with approximately 3.0% of humus as the substrate. The seeds of the test plants were sown separately for each species.


For the pre-emergence treatment, the active ingredients, which had been suspended or emulsified in water, were applied directly after sowing by means of finely distributing nozzles. The containers were irrigated gently to promote germination and growth and subsequently covered with transparent plastic hoods until the test plants had rooted.


This cover caused uniform germination of the test plants, unless this had been impaired by the active ingredients.


For the post-emergence treatment, the test plants were first grown to a height of 3 to 15 cm, depending on the plant habit, and only then treated with the active ingredients which had been suspended or emulsified in water. For this purpose, the test plants were either sown directly and grown in the same containers, or they were first grown separately as seedlings and transplanted into the test containers a few days prior to treatment.


Depending on the species, the test plants were kept at 10-25° C. or 20-35° C., respectively.


The test period extended over 2 to 4 weeks. During this time, the test plants were tended, and their response to the individual treatments was evaluated.


Evaluation was carried out using a scale from 0 to 100. 100 means no emergence of the test plants, or complete destruction of at least the aerial moieties, and 0 means no damage, or normal course of growth. A good herbicidal activity is given at values of 70 to <90 and a very good herbicidal activity is given at values of 90 to 100.


The test plants used in the greenhouse experiments were of the following species:
















Bayer code
Scientific name









ABUTH

Abutilon theophrasti




ALOMY

Alopercurus myosuroides




AMARE

Amaranthus retroflexus




APESV

Apera spica-venti




AVEFA

Avena fatua




ECHCG

Echinocloa crus-galli




SETFA

Setaria faberi




SETVI

Setaria viridis











At an application rate of 0.125 kg/ha, applied by the pre-emergence method:

    • compound 1.1, 1.16 showed very good herbicidal activity against AMARE


At an application rate of 0.125 kg/ha, applied by the post-emergence method:

    • compounds 1.11 showed good herbicidal activity against ALOMY
    • compounds 1.11 showed good herbicidal activity against AVEFA


At an application rate of 0.250 kg/ha, applied by the pre-emergence method:

    • compounds 1.13 showed very good herbicidal activity against ABUTH
    • compounds 1.20 showed very good herbicidal activity against AMARE
    • compounds 1.19, 1.23, showed good herbicidal activity against AMARE
    • compounds 1.3, 1.13, 1.18, 1.20, 1.21, 1.25 showed very good herbicidal activity against APESV
    • compounds 1.19, 1.22, 1.23 showed good herbicidal activity against APESV
    • compounds 1.20, 1.21, 1.25 showed very good herbicidal activity against ECHCG
    • compounds 1.7 showed good herbicidal activity against ECHCG
    • compounds 1.25 showed very good herbicidal activity against SETFA


At an application rate of 0.250 kg/ha, applied by the post-emergence method:

    • compounds 1.7, 1.13, 1.14, 1.20, 1.21 showed very good herbicidal activity against ABUTH
    • compounds 1.4, 1.5, 1.6, 1.9, 1.12, 1.15, 1.22, 1.23, 1.25 showed good herbicidal activity against ABUTH
    • compounds 1.4, 1.5, 1.8, 1.14, 1.25, 1.35 showed very good herbicidal activity against ALOMY
    • compounds 1.2, 1.9, 1.12, 1.20, 1.38, 1.40 showed good herbicidal activity against ALOMY
    • compounds 1.13, 1.18, 1.35, 1.36 showed very good herbicidal activity against AMARE
    • compounds 1.4, 1.6, 1.9, 1.18, 1.36 showed very good herbicidal activity against AVEFA
    • compounds 1.3, 1.5, 1.23, 1.38, 1.39, 1.40, 1.41 showed good herbicidal activity against AVEFA
    • compounds 1.7, 1.8, 1.13, 1.14, 1.21, 1.35, 1.36, 1.39 showed very good herbicidal activity against ECHCG
    • compounds 1.3 showed good herbicidal activity against ECHCG
    • compounds 1.3, 1.6, 1.7, 1.18, 1.21, 1.38, 1.41 showed very good herbicidal activity against SETVI
    • compounds 1.8, 1.23, 1.25, 1.39, 1.40 showed good herbicidal activity against SETVI

Claims
  • 1. A compound of formula (I)
  • 2. The as claimed in claim 1, wherein the substituents have the following meaning: R1 is hydrogen or (C1-C3)-alkyl; andR4 is hydrogen or (C1-C3)-alkyl.
  • 3. The compound as claimed in claim 2, where R1 and R4 are hydrogen.
  • 4. The compound as claimed in claim 1, wherein one or both of the following conditions a) and b) apply: a) R2 is (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C3-C6)-cycloalkyl, (C3-C6)-alkenyl, or (C3-C6)-alkynyl;b) R3 is hydrogen, halogen, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, (C3-C6)-cycloalkoxy, (C3-C6)-alkenyloxy, or (C3-C6)-alkynyloxy.
  • 5. The compound as claimed in claim 4, wherein one or both of the following conditions a) and b) apply: a) R2 is (C1-C6)-alkyl;b) R3 is hydrogen or halogen.
  • 6. The compound as claimed in claim 5, wherein one or both of the following conditions a) and b) apply: a) R2 is methyl or ethyl;b) R3 is hydrogen.
  • 7. The compound as claimed in claim 1, wherein X is a bond; andY is Z, where Z is a three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated carbocyclic ring, except phenyl, which is substituted by m radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf, C(Rb)═NORe, Ra, Rc, Re, and Rf, and where the carbon ring atoms bear n oxo groups; where Z is optionally substituted by m1 radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, and PORfRf, C(Rb)═NORe, and by m2 radicals selected from the group consisting of Ra, Rc, Re and Rf, where m1 is 1 or 2 and m2 is 0, 1, or 2.
  • 8. The compound as claimed in claim 7, where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl.
  • 9. The compound as claimed in claim 8, where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by one radical CO2Re, where Re is hydrogen or (C1-C6)-alkyl.
  • 10. The compound as claimed in claim 1, wherein X is a divalent unit (X1), where R5 and R6 are as defined in claim 1; andY is (C1-C8)-alkyl which is substituted by m radicals selected from the group consisting of S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf, and C(Rb)═NORe.
  • 11. The compound as claimed in claim 10, where Y is (C1-C4)-alkyl which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl.
  • 12. The compound as claimed in claim 1, where m is 1 or 2.
  • 13. The compound as claimed in claim 14, where Q is a 5-membered heteroaromatic ring containing 1 or 2 heteroatoms selected from the group consisting of N, O, and S as ring members or a 6-membered heteroaromatic ring containing 1 or 2 nitrogen atoms as ring members, where ring Q carries k substituents RQ1 and n substituents RQ2; where RQ1 is selected from the group consisting of halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, and (C1-C3)-haloalkoxy, and RQ2 is phenyl-(C1-C3)-alkyl, (C1-C4)-alkylcarbonyl, (C1-C4)-alkylaminocarbonyl, di-(C1-C4-alkyl)aminocarbonyl, (C1-C4)-alkoxycarbonyl, benzyloxycarbonyl, fluorenyloxycarbonyl, allyloxycarbonyl, or (C1-C3)-alkoxy-(C1-C3)-alkyl; where k is 0, 1, 2, or 3 and n is 0 or 1.
  • 14. The compound as claimed in claim 13, where Q is a 5-membered heteroaromatic ring containing 1 or 2 heteroatoms selected from the group consisting of N, O, and S as ring members or a 6-membered heteroaromatic ring containing 1 or 2 nitrogen atoms as ring members, where ring Q carries k substituents RQ1 and n substituents RQ2; where RQ1 is selected from the group consisting of halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy and (C1-C3)-haloalkoxy, and RQ2 is (C1-C4)-alkoxycarbonyl; where k is 0, 1, or 2 and n is 0 or 1.
  • 15. The compound as claimed in claim 1, where Q is a 5-membered heteroaromatic ring containing 1 or 2 heteroatoms selected from the group consisting of N, O, and S as ring members or a 6-membered heteroaromatic ring containing 1 or 2 nitrogen atoms as ring members, where ring Q carries k substituents RQ1 and n substituents RQ2; where RQ1 is selected from the group consisting of halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, and (C1-C3)-haloalkoxy, and RQ2 is (C1-C4)-alkoxycarbonyl; where k is 0, 1, 2, or 3; and n is 0 or 1;R1 hydrogen;R2 is (C1-C6)-alkyl;R3 is hydrogen or halogen;R4 is hydrogen;X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl and m is 1 or 2; orX is a divalent unit (X1), where R5 and R6 are independently of each other hydrogen or (C1-C6)-alkyl; and Y is (C1-C4)-alkyl which is substituted by m radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl and m is 1 or 2.
  • 16. The compound as claimed in claim 15, where Q is a 5-membered heteroaromatic ring containing 1 or 2 heteroatoms selected from the group consisting of N, O, and S as ring members or a 6-membered heteroaromatic ring containing 1 or 2 nitrogen atoms as ring members, where ring Q carries k substituents RQ1 and n substituents RQ2; where RQ1 is selected from the group consisting of halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, and (C1-C3)-haloalkoxy, and RQ2 is (C1-C4)-alkoxycarbonyl; where k is 0, 1, 2, or 3; and n is 0 or 1;R1 hydrogen;R2 is methyl or ethyl;R3 is hydrogen;R4 is hydrogen;X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by one radical CO2Re, where Re is (C1-C6)-alkyl; orX is a divalent unit (X1), where one of R5 and R6 is hydrogen and the other is hydrogen or methyl; and Y is (C1-C4)-alkyl which is substituted by one radical CO2Re, where Re is (C1-C6)-alkyl.
  • 17. A composition comprising at least one compound as claimed in claim 1, and at least one auxiliary, which is customary for formulating crop protection compounds.
  • 18. The composition as claimed in claim 17, comprising a further herbicide.
  • 19. (canceled)
  • 20. A method for controlling unwanted vegetation comprising applying an herbicidally effective amount of at least one compound as claimed in claim 1 to act on a plant, a plant seed, and/or their habitat.
Priority Claims (1)
Number Date Country Kind
21193987.1 Aug 2021 EP regional
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2022/074086 8/30/2022 WO